<SEC-DOCUMENT>0001193125-25-055610.txt : 20250317
<SEC-HEADER>0001193125-25-055610.hdr.sgml : 20250317
<ACCEPTANCE-DATETIME>20250317160524
ACCESSION NUMBER:		0001193125-25-055610
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250508
FILED AS OF DATE:		20250317
DATE AS OF CHANGE:		20250317

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IN8BIO, INC.
		CENTRAL INDEX KEY:			0001740279
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				825462585
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39692
		FILM NUMBER:		25744389

	BUSINESS ADDRESS:	
		STREET 1:		EMPIRE STATE BUILDING
		STREET 2:		350 5TH AVENUE, SUITE 5330
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10118
		BUSINESS PHONE:		(646) 600-6438

	MAIL ADDRESS:	
		STREET 1:		EMPIRE STATE BUILDING
		STREET 2:		350 5TH AVENUE, SUITE 5330
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10118

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Incysus Therapeutics, Inc.
		DATE OF NAME CHANGE:	20180510
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d888198ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Amendment No.&#8195;) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&#8194;&#9746; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by a party other than the Registrant&#8194;&#9744; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>&#9744;<B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential, for Use of the Commission Only (as permitted by Rule
<FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT></B></P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Additional Materials </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting Material Pursuant to <FONT STYLE="white-space:nowrap">&#167;240.14a-12</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>IN8bio, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of
Registrant as Specified In Its Charter) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if Other Than The Registrant) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No fee required. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee paid previously with preliminary materials. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules
<FONT STYLE="white-space:nowrap">14a-6(i)(1)</FONT> and <FONT STYLE="white-space:nowrap">0-11.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
   <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g888198g02x02.jpg" ALT="LOGO" STYLE="width:1.5in;height:0.59375in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>350 5th Avenue, Suite 5330 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>New York, New York 10118 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF 2025 ANNUAL MEETING OF STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>To Be Held on May&nbsp;8, 2025 at 9:00 a.m. Eastern Time </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Stockholder: </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of our board of directors, we
are pleased to invite you to attend the 2025 Annual Meeting of Stockholders of IN8bio, Inc., a Delaware corporation. The Annual Meeting will be held virtually on May&nbsp;8, 2025<B> </B>at 9:00 a.m. Eastern Time. Stockholders attending the virtual
meeting will be afforded the same rights and opportunities to participate as they would at an <FONT STYLE="white-space:nowrap">in-person</FONT> meeting. You will be able to attend the Annual Meeting, vote your shares and ask questions during the
meeting by visiting <I>www.proxydocs.com/INAB</I>. You will not be able to attend the meeting in person as the meeting is being held virtually. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Your vote is very important. Whether or not you plan to attend the meeting, we urge you to vote by proxy to ensure your vote is counted. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Annual Meeting will be held for the following purposes, which are more fully described in the proxy statement accompanying this Notice: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To elect the three Class&nbsp;I directors named in the attached proxy statement, each to serve until our 2028
Annual Meeting of Stockholders. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To ratify the selection of CohnReznick LLP as our independent registered public accounting firm for the fiscal
year ending December&nbsp;31, 2025. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To approve a series of alternate amendments to our amended and restated certificate of incorporation to effect,
at the option of our board of directors, a reverse stock split of our common stock at a ratio in the range of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-15</FONT></FONT> to <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">1-for-30,</FONT></FONT> inclusive, with such ratio to be determined by our board of directors in its sole discretion. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To conduct any other business properly brought before the meeting or any adjournment or postponement
thereof.</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To participate in the Annual Meeting, you will need to register using the control number located on the Notice of Internet
Availability of Proxy Materials for the 2025 Annual Meeting of Stockholders, your proxy card or voting instruction form. Additional details regarding access to the Annual Meeting and the business to be conducted at the Annual Meeting are described
in the accompanying proxy statement. We recommend that you log in a few minutes early to ensure you are logged in when the Annual Meeting starts. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
record date for the Annual Meeting is the close of business on March 12, 2025. Only stockholders of record at the close of business on that date may vote at the Annual Meeting or any adjournment thereof. A complete list of our stockholders of record
will be available for examination on a reasonably accessible electronic network by any stockholder for any purpose germane to the Annual Meeting for a period of 10 days ending on the day before the Annual Meeting date. If you would like to view the
list, please email us at ir@in8bio.com. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By Order of the Board of Directors, </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g888198g03g03.jpg" ALT="LOGO" STYLE="width:0.77975in;height:0.511482in;">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Patrick McCall </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Chief
Financial Officer and Corporate Secretary </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March 17, 2025</P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>You are cordially invited to attend the virtual
Annual Meeting. You will not be able to attend the Annual Meeting in person. Whether or not you expect to attend the meeting, please vote over the telephone or the internet as instructed in these materials, or, if you receive a paper proxy card by
mail, by completing and returning the proxy mailed to you, as promptly as possible in order to ensure your representation at the meeting. Even if you have voted by proxy, you may still vote online if you attend the meeting. Please note, however,
that if your shares are held of record by a broker, bank or other similar organization and you wish to vote during the meeting, you must follow the instructions from such organization. </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc888198_1">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc888198_2">PROPOSAL 1: ELECTION OF DIRECTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc888198_3">INFORMATION REGARDING DIRECTOR NOMINEES AND CONTINUING
DIRECTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc888198_4">INFORMATION REGARDING THE BOARD AND CORPORATE GOVERNANCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc888198_5">PROPOSAL 2: RATIFICATION OF THE SELECTION OF THE INDEPENDENT REGISTERED PUBLIC
 ACCOUNTING FIRM</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc888198_6">PROPOSAL 3: APPROVAL OF THE REVERSE STOCK SPLIT PROPOSAL</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc888198_7">EXECUTIVE OFFICERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc888198_8">EXECUTIVE OFFICER AND DIRECTOR COMPENSATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc888198_9">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</A></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc888198_10">EQUITY COMPENSATION PLAN INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc888198_11">TRANSACTIONS WITH RELATED PERSONS AND INDEMNIFICATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc888198_12">OTHER INFORMATION FOR STOCKHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc888198_13">OTHER MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Website References </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may also access additional information about IN8bio, Inc. at <I>www.in8bio.com</I> and <I>invesors.in8bio.com</I>. References to our websites throughout
this proxy statement are provided for convenience only and the content on our website does not constitute a part of this proxy statement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g888198g02x02.jpg" ALT="LOGO" STYLE="width:1.5in;height:0.59375in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>350 5th Avenue, Suite 5330 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>New York, New York 10118 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY STATEMENT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE
2025 ANNUAL MEETING OF STOCKHOLDERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>To Be Held on May&nbsp;8, 2025 at 9:00 a.m. Eastern Time </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc888198_1"></A>QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Why did I receive a Notice of Internet Availability of Proxy Materials (&#147;</B><B><I>Notice</I></B><B>&#148;) on the internet instead of a full set of
Proxy Materials? </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to rules adopted by the Securities and Exchange Commission (the &#147;<B><I>SEC</I></B>&#148;), we have elected to provide
access to our proxy materials over the internet. Accordingly, we have sent you a Notice because the Board of Directors of IN8bio, Inc. (the &#147;<B><I>Board</I></B>&#148;) is soliciting your proxy to vote at the 2025 Annual Meeting of Stockholders
(the &#147;<B><I>Annual Meeting</I></B>&#148;), including at any adjournments or postponements thereof. All stockholders will have the ability to access the proxy materials on the website referred to in the Notice or to request a printed set of the
proxy materials. Instructions on how to access the proxy materials over the internet or to request a printed copy may be found in the Notice. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We
intend to mail the Notice of Internet Availability on or about March&nbsp;17, 2025 to all stockholders of record entitled to vote at the Annual Meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Will I receive any other Proxy Materials by mail? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You
will not receive any additional proxy materials via mail unless you request a printed copy in accordance with the instructions set forth in the Notice. We may elect, in our discretion, to send you a proxy card and a second Notice, on or after 10
calendar days have passed since our first mailing of the Notice. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>When is the record date for the Annual Meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has fixed the record date for the Annual Meeting as of the close of business on March&nbsp;12, 2025<B> </B>(the &#147;<B><I>Record
Date</I></B>&#148;). </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How do I attend the Annual Meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will be hosting the Annual Meeting via live webcast only. You may attend, vote and ask questions at the Annual Meeting by following the instructions
provided on the Notice or proxy card to log in to <I>www.proxydocs.com/INAB</I>. If you are a stockholder of record, you will be asked to provide the control number from your Notice or proxy card. If you are a beneficial owner of shares registered
in the name of your broker, bank or other agent, follow the instructions from your broker or bank. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You are entitled to attend the Annual Meeting if you
were a stockholder as of the close of business on the Record Date or hold a valid proxy for the meeting. To be admitted to the Annual Meeting, you will need to visit <I>www.proxydocs.com/INAB</I> and enter the control number found on your Notice or
proxy card. If you are a beneficial stockholder, you should contact the bank, broker or other institution where you hold your account well in advance of the meeting if you have questions about obtaining your control number/proxy to vote. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We recommend that you log in a few minutes before the start of the Annual Meeting to ensure that you are
logged in when the meeting starts. Information on how to vote online during the Annual Meeting is discussed below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What if I cannot find my Control
Number? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please note that if you do not have your control number and you are a stockholder of record, please contact us at ir@in8bio.com and we will be
able to provide your control number to you. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a beneficial owner (that is, you hold your shares in an account at a bank, broker or other holder
of record), you will need to contact that bank, broker or other holder of record to obtain your control number prior to the Annual Meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For the
Annual Meeting, how do we ask questions of management and the Board? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholders may submit questions relevant to the proposals to be voted on at the
Annual Meeting in advance of the Annual Meeting through <I>www.proxydocs.com/INAB. </I>We plan to answer questions related to the proposals after all of the proposals have been presented at the Annual Meeting. If we receive substantially similar
questions, we will group such questions together and provide a single response to avoid repetition. Questions that are not relevant to the proposals to be voted on at the Annual Meeting will not be responded to. Questions may be submitted during the
Annual Meeting through <I>www.proxydocs.com/INAB. </I> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What do I do if I have technical difficulties in connection with the Annual Meeting? </B></P>
 <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will have technicians ready to assist you with any technical difficulties you may have accessing the virtual Annual Meeting. If you encounter any
difficulties accessing the virtual Annual Meeting during the <FONT STYLE="white-space:nowrap">check-in</FONT> or meeting time, please call the technical support number that will be delivered to shareholders via
<FONT STYLE="white-space:nowrap">e-mail</FONT> prior to the meeting&#146;s start time. Technical support will be available starting at 8:00 a.m. Eastern Time, on May&nbsp;8, 2025. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Will a list of stockholders as of the Record Date be available? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A complete list of our stockholders as of the Record Date will be available for examination on a reasonably accessible electronic network by any stockholder
for any purpose germane to the Annual Meeting for a period of 10 days ending on the day before the Annual Meeting date. If you would like to view the list, please email us at ir@in8bio.com. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who can vote at the Annual Meeting? </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Only
stockholders of record at the close of business on the Record Date will be entitled to vote online during the Annual Meeting. On the Record Date, there were a total of 81,258,763 shares of common stock outstanding and entitled to vote. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Stockholder of Record: Shares Registered in Your Name</I></B>. If on the Record Date, your shares were
registered directly in your name with our transfer agent, Computershare Trust Company, N.A., then you are a stockholder of record. As a stockholder of record, you may vote online during the meeting, vote by proxy over the telephone or through the
internet, or vote by proxy using a proxy card that you may request or that we may elect to deliver at a later time. Whether or not you plan to attend the Annual Meeting, we urge you to vote by proxy to ensure your vote is counted.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Beneficial Owner: Shares Registered in the Name of a Broker, Bank or Similar Organization</I></B>. If on
the Record Date, your shares were held, not in your name, but rather in an account at a brokerage firm, bank, dealer or other similar organization, then you are the beneficial owner of shares held in &#147;street name&#148; and the Notice is being
forwarded to you by that organization. The organization holding your account is considered to be the stockholder of record for purposes of voting at the Annual Meeting. As a beneficial owner, you have the right to direct your broker or other agent
regarding how to vote the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
shares in your account. You are also invited to attend the Annual Meeting. However, since you are not the stockholder of record, you may not vote your shares online during the Annual Meeting
unless you request and obtain a valid proxy from your broker or other agent, as required. Check with your brokerage firm, bank, dealer or other similar organization, and further follow the instructions you receive during the registration process
prior to the Annual Meeting. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How many votes do I have? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For each matter to be voted upon, each holder of shares of our common stock will have one vote per share of common stock held as of the Record Date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What am I voting on? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are three matters scheduled
for a vote: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Proposal 1</I></B>: Election of three Class&nbsp;I directors to hold office until the 2028 Annual Meeting
of Stockholders. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Proposal 2</I></B>: Ratification of the selection of CohnReznick LLP as our independent registered public
accounting firm for the fiscal year ending December&nbsp;31, 2025. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Proposal 3</I></B>: Approval of a series of alternate amendments to our amended and restated certificate of
incorporation to effect, at the option of our Board, a reverse stock split of our common stock at a ratio in the range of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-15</FONT></FONT> to <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">1-for-30,</FONT></FONT> inclusive, with such ratio to be determined by our Board in its sole discretion (the &#147;<B><I>Reverse Stock Split Proposal</I></B>&#148;). </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What if another matter is properly brought before the meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the
meeting, the proxies will vote as recommended by the Board or, if no recommendation is given, will vote on those matters in accordance with their best judgment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What are the Board&#146;s recommendations on how to vote my shares? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board recommends a vote: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Proposal 1</I></B>: <B>FOR</B> the election of the three Class&nbsp;I director nominees; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Proposal 2</I></B>: <B>FOR</B> the ratification of the selection of CohnReznick LLP as our independent
registered public accounting firm for the year ending December&nbsp;31, 2025. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Proposal 3</I></B>: <B>FOR</B> the approval of the Reverse Stock Split Proposal. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How do I vote? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a stockholder of record and
your shares are registered directly in your name, you may vote: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>By Internet</I></B>. To vote through the internet, go to <I>www.proxypush.com/INAB</I> to complete an
electronic proxy card. You will be asked to provide the control number from the Notice. Your internet vote must be received prior to the start of the Annual Meeting to be counted. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>By Telephone</I></B>. Call <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">1-866-601-1589</FONT></FONT></FONT> toll-free from the United States, U.S. territories and Canada, and follow the instructions on the Notice. You will be asked to provide your control number from the Notice. Your telephone
vote must be received prior to the start of the Annual Meeting to be counted. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>By Proxy Card</I></B>. Complete and mail the proxy card that may be requested and return it promptly in the
envelope provided. If you return your signed proxy card to us before the Annual Meeting, we will vote your shares as you direct. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Online During the Annual Meeting</I></B>. Access the Annual Meeting by visiting
<I>www.proxydocs.com/INAB</I> and providing your control number from your Notice. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Internet and telephone voting facilities for
stockholders of record will be available for 24 hours a day and will close at 9:00 a.m. Eastern Time on May&nbsp;8, 2025. If you are a stockholder of record and do not vote by completing your proxy card, by telephone, through the internet or online
at the Annual Meeting, your shares will not be voted. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a beneficial owner of shares held in &#147;street name&#148; (i.e., held for your
account by a broker, bank or other nominee), you should have received a notice containing voting instructions from that organization rather than from us. You should follow the instructions in the notice to ensure your vote is counted. To vote online
during the Annual Meeting, you may be required to obtain a valid proxy card from your broker or other nominee. Follow the instructions from your broker, bank or other nominee or contact your broker, bank or other nominee to request a proxy card, and
access the Annual Meeting by following the instructions you receive after your successful registration at <I>www.proxydocs.com/INAB</I> using the control number provided by your bank, broker or other nominee. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Internet proxy voting will be provided to allow you to vote your
shares online, with procedures designed to ensure the authenticity and correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your internet access, such as usage charges from internet
access providers and telephone companies.</B></P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Can I vote my shares by filling out and returning the Notice? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No. The Notice identifies the items to be voted on at the Annual Meeting, but you cannot vote by marking the Notice and returning it. The Notice provides
instructions on how to vote by proxy in advance of the Annual Meeting through the internet, by telephone or by using a printed proxy card. You may also vote online during the Annual Meeting by visiting <I>www.proxydocs.com/INAB</I>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What does it mean if I receive more than one Notice? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If
you receive more than one Notice, your shares may be registered in more than one name or in different accounts. Please follow the voting instructions on the Notices to ensure that all of your shares are voted. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>If I am a stockholder of record and I do not vote, or if I return a proxy card or otherwise vote without giving specific voting instructions, what happens?
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a stockholder of record and do not vote through the internet, by telephone, by completing the proxy card that may be delivered to you or
online during the Annual Meeting, your shares will not be voted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you return a signed and dated proxy card or otherwise vote without marking voting
selections, your shares will be voted in accordance with the recommendations of the Board: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;<B>FOR</B>&#148; the election of each of the three nominees for director; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;<B>FOR</B>&#148; the ratification of the selection of CohnReznick LLP as our independent registered public
accounting firm for the fiscal year ending December&nbsp;31, 2025; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>&#147;FOR&#148;</B> the approval of the Reverse Stock Split Proposal. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any other matter is properly presented at the Annual Meeting, your proxyholder (one of the individuals named on your proxy card) will vote your shares as
recommended by the Board or, if no recommendation is given, will vote your shares using his or her best judgment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>If I am a beneficial owner of shares held in &#147;street name&#148; and I do not provide my broker or
bank with voting instructions, what happens? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a beneficial owner and do not instruct your broker, bank or other agent how to vote your
shares, the question of whether your broker or nominee will still be able to vote your shares depends on whether, pursuant to stock exchange rules, the particular proposal is deemed to be a &#147;routine&#148; matter. Brokers and nominees can use
their discretion to vote &#147;uninstructed&#148; shares with respect to matters that are considered to be &#147;routine,&#148; but not with respect to <FONT STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> matters. Under applicable rules
and interpretations, <FONT STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> matters are matters that may substantially affect the rights or privileges of stockholders, such as mergers, stockholder proposals, elections of directors (even if
not contested), executive compensation and certain corporate governance proposals, even if management supported. Accordingly, your broker or nominee may vote your shares on Proposals 2 and 3. Your broker or nominee, however, may <U>not</U> vote your
shares on Proposal 1 without your instructions. Such an event would result in a &#147;broker <FONT STYLE="white-space:nowrap">non-vote&#148;</FONT> and these shares will not be counted as having been voted on the applicable proposal. Please instruct
your bank, broker or other agent to ensure that your vote will be counted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If you a beneficial owner of shares held in street name, and you do not
plan to attend the Annual Meeting, in order to ensure your shares are voted in the way you would prefer, you must provide voting instructions to your broker, bank or other agent by the deadline provided in the materials you receive from your broker,
bank or other agent. </I></B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What are &#147;broker <FONT STYLE="white-space:nowrap">non-votes&#148;?</FONT></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As discussed above, when a beneficial owner of shares held in &#147;street name&#148; does not give instructions to the broker or nominee holding the shares as
to how to vote on matters deemed to be <FONT STYLE="white-space:nowrap">&#147;non-routine,&#148;</FONT> the broker or nominee cannot vote the shares. These unvoted shares are counted as &#147;broker
<FONT STYLE="white-space:nowrap">non-votes.&#148;</FONT><B>&nbsp;</B> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Can I change my vote after submitting my proxy? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stockholder of Record: Shares Registered in Your Name. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a stockholder of record, then yes, you can revoke your proxy at any time before the final vote at the Annual Meeting. You may revoke your proxy in
any one of the following ways: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">submit another properly completed proxy with a later date; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">transmit a subsequent vote over the internet or by telephone prior to the start of the Annual Meeting;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">register and attend the Annual Meeting and vote online during the Annual Meeting; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">send a timely written notice that you are revoking your proxy via email at ir@in8bio.com. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your last vote, whether prior to or at the Annual Meeting, is the vote that we will count. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Beneficial Owner: Shares Registered in the Name of a Broker, Bank or Similar Organization. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a beneficial owner and your shares are held in &#147;street name&#148; by your broker, bank or other agent, you should follow the instructions
provided by your broker, bank or other agent. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What vote is required to approve each item and how are votes counted? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the minimum vote needed to approve each proposal and the effect of abstentions and broker
<FONT STYLE="white-space:nowrap">non-votes.</FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="21%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="14%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Proposal</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposal Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Vote Required for Approval</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Effect of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Abstentions</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Effect of Broker</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">Non-Votes</FONT></B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Election of Directors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Nominees receiving the most &#147;For&#148; votes; withheld votes will have no effect.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Not applicable</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">No effect</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="21%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="14%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Proposal</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposal Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Vote Required for Approval</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Effect of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Abstentions</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Effect of Broker</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">Non-Votes</FONT></B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Ratification of the selection of CohnReznick LLP as the Company&#146;s independent registered public accounting firm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&#147;For&#148; votes from the holders of a majority of the voting power of the shares present by remote communication or represented by proxy at the meeting and voting affirmatively or negatively (excluding abstentions and
broker <FONT STYLE="white-space:nowrap">non-votes)</FONT> on such matter.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">No effect</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Not&nbsp;applicable<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Reverse Stock Split</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&#147;For&#148; votes from the holders of a majority of the voting power of the shares present by remote communication or represented by proxy at the meeting and voting affirmatively or negatively (excluding abstentions and
broker <FONT STYLE="white-space:nowrap">non-votes)</FONT> on such matter.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">No effect</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Not&nbsp;applicable<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">This proposal is considered to be a &#147;routine&#148; matter. Accordingly, if you hold your shares in street
name and do not provide voting instructions to your broker, bank or other agent that holds your shares, your broker, bank or other agent has discretionary authority to vote your shares on this proposal. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How is a quorum reached? </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A quorum of stockholders is
necessary to hold a valid meeting. A quorum will be present if stockholders holding at least a majority of the outstanding shares entitled to vote are present at the Annual Meeting or represented by proxy. On the record date, there were 81,258,763
shares outstanding and entitled to vote. Thus, the holders of 40,629,382 shares must be present or represented by proxy at the Annual Meeting to have a quorum. The inspector(s) of election appointed for the Annual Meeting will determine whether or
not a quorum is present. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes,</FONT> if any, will be counted towards the quorum
requirement. If there is no quorum, the holders of a majority of shares present at the meeting or represented by proxy may adjourn the meeting to another date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How can I find out the results of the voting at the Annual Meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will announce preliminary voting results at our Annual Meeting. We will publish final voting results in a Current Report on Form <FONT
STYLE="white-space:nowrap">8-K</FONT> that we will file with the SEC within four business days after the Annual Meeting. If final voting results are not available at that time, we will disclose the preliminary results in the Current Report on Form <FONT
STYLE="white-space:nowrap">8-K</FONT> and, within four business days after the final voting results are known to us, file an amended Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> to disclose the final voting results. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who pays the cost for soliciting proxies? </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will
pay the entire cost of soliciting proxies. In addition to these proxy materials, our directors and employees may also solicit proxies in person, by telephone or by other means of communication. Directors and employees will not be paid any additional
compensation for soliciting proxies. We will also reimburse brokers, banks, custodians, other nominees and fiduciaries for forwarding these materials to their principals to obtain the authorization for the execution of proxies. In addition, we have
hired Morrow Sodali LLC to solicit proxies. We expect to pay Morrow Sodali LLC a fee of $20,000 plus reasonable expenses for these services.<SUP STYLE="font-size:75%; vertical-align:top"> </SUP> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc888198_2"></A>PROPOSAL 1: ELECTION OF DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of
incorporation provides for a classified Board consisting of three classes of directors, with only one class of directors being elected in each year and each class, Class I, Class II and Class III, serving a three-year term. Vacancies on our Board
may be filled by the affirmative vote of a majority of directors then in office. A director elected by our Board to fill a vacancy in a class, including vacancies created by an increase in the number of directors, shall serve for the remainder of
the full term of that class and until the director&#146;s successor is duly elected and qualified. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board is currently composed of eight directors.
Travis Whitfill, a Class II director, will be departing the Board following the Annual Meeting and the Board expects to reduce the size of the Board to seven directors. Each Class I director has a term that expires in 2025. Upon the recommendation
of the Nominating and Corporate Governance Committee, our Board has considered and nominated the three incumbent directors listed below for election as directors at the Annual Meeting: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Emily Fairbairn </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Jeremy Graff </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Luba Greenwood </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All of the nominees for election at the Annual Meeting have previously been elected by our stockholders, other than Dr.&nbsp;Graff, who was appointed by our
Board on May&nbsp;1, 2023. Dr.&nbsp;Graff was identified as a potential director nominee by a third-party search firm and a member of management. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
biographies below under &#147;Information Regarding Director Nominees and Current Directors&#148; include information, as of the date of this proxy statement, regarding the specific and particular experience, qualifications, attributes or skills of
each director nominee that led the Nominating and Corporate Governance Committee to believe that that nominee should continue to serve on the Board. If you elect the nominees listed above, they will each hold office until the 2028 Annual Meeting of
Stockholders and until each of their successors has been duly elected and qualified, or, if sooner, until the director&#146;s death, resignation or removal. All nominees have consented to being named in this proxy statement and to serve if elected.
The Board has no reason to believe that any of the nominees would prove unable to serve if elected. There are no family relationships among any of our executive officers or directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Directors are elected by a plurality of
the votes of the holders of shares present in person, by remote communication, if applicable, or represented by proxy and entitled to vote on the election of directors. Accordingly, the three nominees receiving the highest number of &#147;FOR&#148;
votes will be elected as directors. You may not vote your shares cumulatively for the election of directors. Shares represented by executed proxies will be voted, if authority to do so is not withheld, for the election of the three nominees named
above. If any nominee becomes unavailable for election as a result of an unexpected occurrence, your shares may be voted for the election of a substitute nominee proposed by our Board. Your proxy cannot be voted for a greater number of persons than
the number of director nominees named in this proxy statement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Recommendation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD UNANIMOUSLY RECOMMENDS A VOTE FOR EACH OF THE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DIRECTOR NOMINEES FOR CLASS I DIRECTOR </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(PROPOSAL 1 ON YOUR NOTICE OF INTERNET AVAILABILITY) </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc888198_3"></A>INFORMATION REGARDING DIRECTOR NOMINEES AND CONTINUING DIRECTORS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth, for the Class&nbsp;I nominees and our other directors, their ages and position or office held with us
as of March&nbsp;14, 2025: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Position(s)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Director&nbsp;Since</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="10"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Class&nbsp;I Directors for Election at the 2025 Annual Meeting of
Stockholders</I></B></P></TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Emily Fairbairn</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jeremy Graff</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Luba Greenwood</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="11"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="10"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Class&nbsp;II Directors Continuing in Office Until the 2026 Annual Meeting of
Stockholders</I></B></P></TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Peter Brandt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corinne Epperly</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="11"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="10"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Class&nbsp;III Directors Continuing in Office Until the 2027 Annual Meeting of
Stockholders</I></B></P></TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&nbsp;</P></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William Ho</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">President&nbsp;&amp; Chief Executive Officer</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alan S. Roemer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Chairman of the Board</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="11"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="10"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Resigning Director</I></B></P></TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Travis Whitfill<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Whitfill provided notice as of March 4, 2025 that he intends to resign as a member of the Board, with
such resignation to be effective May&nbsp;9, 2025. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Set forth below is biographical information for the director nominees and each
person whose term of office as a director will continue after the Annual Meeting. This includes information regarding each director&#146;s experience, qualifications, attributes or skills that led our Board to recommend them for board service. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Nominees for Election at the 2025 Annual Meeting of Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Emily Fairbairn</I></B> has served as a member of our Board since July 2021. From 2018, she has also served as the chair of the board of directors at
Movano Inc. Ms.&nbsp;Fairbairn has spent the majority of her career in executive leadership and management positions and as a seasoned investor and mentor to early-stage companies. In 1999, Ms.&nbsp;Fairbairn was
<FONT STYLE="white-space:nowrap">co-founder</FONT> and chief executive officer of Ascend Capital, a multi-billion-dollar hedge fund, which she ran until 2018. The firm focused on managing assets for institutional clients such as pensions,
endowments, and public companies. Prior to Ascend Capital, she spent a decade building a successful practice of equity portfolio construction and financial planning for high <FONT STYLE="white-space:nowrap">net-worth</FONT> clients for Merrill
Lynch. Today, Ms.&nbsp;Fairbairn is an active investor, and since 2017 serving on the funding board of the MIT Sandbox Fund to mentor aspiring entrepreneurs. She is also a dedicated advocate of funding research for a realizable diagnostic and cure
for Lyme+, which affects around 500,000 people annually in the United States. Emily holds a B.S. in Chemical Engineering from California State Polytechnic University. We believe that Ms.&nbsp;Fairbairn&#146;s expertise in investment and finance
matters and her extensive executive leadership and management experience qualify her to serve on our Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Jeremy Graff</I></B> has served as a
member of our Board since May 2023. Since October 2024, Dr.&nbsp;Graff has served as president and chief development officer for Allarity Therapeutics, Inc., a public precision medicine company. He previously served as an executive advisor for
numerous companies, including Allarity Therapeutics, Inc., from August 2023 until September 2024. He served as chief scientific officer for IMV, Inc., an immune-oncology company, from June 2021 to January 2024, pursuing novel cancer vaccine
technologies. Before that, he served as chief development officer and senior vice president, research at HiberCell, a biotechnology company developing novel therapeutics for cancer relapse and metastasis, from June 2020 to March 2021. Prior to that,
he was employed at Biothera Pharmaceuticals, Inc., serving as president from November 2018 to June 2020 and as chief </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
scientific officer from November 2014 to November 2018, where he led the sale of Bother Pharmaceuticals to Hibercell in June 2020. Dr.&nbsp;Graff received a B.A. and A.A. in Biology and Chemistry
from Thomas More College (now University), a Ph.D. from the University of Kentucky&#146;s Markey Cancer Center and completed a post-doctoral fellowship at the Johns Hopkins University School of Medicine, Oncology Center. We believe that
Dr.&nbsp;Graff is qualified to serve as a member of our Board because of his extensive industry experience. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Luba Greenwood</I></B> has served as a
member of our Board since July 2021. Since July 2024, Ms.&nbsp;Greenwood has served as chief executive officer of Gallop Oncology. She is also an
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">entrepreneur-in-residence</FONT></FONT> at PureTech Health, a biotherapeutics company, where she plays a key role in PureTech&#146;s oncology program and works with the senior
leadership team and board of directors on PureTech&#146;s corporate strategy. From December 2020 through October 2024, Ms.&nbsp;Greenwood served as managing partner of Binney Street Capital, LLC, a venture capital fund she established for the
Dana-Farber Cancer Institute. From September 2021 to November 2023, Ms.&nbsp;Greenwood served as chief executive officer and chair of the board of directors of Kojin Therapeutics, Inc., a private biopharmaceutical company. From April 2019 until
December 2021, Ms.&nbsp;Greenwood served as chief executive officer and member of the board of directors of LUCA Biologics, Inc., a women&#146;s health initiative and microbiome company, and from April 2019 to December 2020, Ms.&nbsp;Greenwood
served as senior advisor to the chief executive officer of the Dana-Farber Cancer Institute. From February 2018 to July 2019, Ms.&nbsp;Greenwood was the head of strategic business development and corporate ventures for Verily Life Sciences LLC, a
research subsidiary of Alphabet Inc. focused on life sciences and healthcare. From 2015 to February 2018, Ms.&nbsp;Greenwood was the vice president of global business development and mergers and acquisitions at
<FONT STYLE="white-space:nowrap">F.&nbsp;Hoffmann-La</FONT> Roche Ltd., a multinational healthcare company, as well as the head of the Roche Diagnostics Innovation Center, East Coast. Beginning in 2021, Ms.&nbsp;Greenwood has also served on the
board of directors of OS Acquisition Corp., a blank check company. Ms.&nbsp;Greenwood received a B.A. in Biology from Brandeis University and a J.D. from Northeastern University Law School. We believe that Ms.&nbsp;Greenwood&#146;s extensive
experience in the pharmaceutical, biotechnology and digital health industries qualifies her to serve on our Board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Directors Continuing in Office
Until the 2026 Annual Meeting of Stockholders </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Peter Brandt</I></B> has served as a member of our Board since July 2019. From September 2010 to
November 2020, Mr.&nbsp;Brandt served on the board of directors, and from June 2015 until November 2020 as chair of the board of directors, of Rexahn Pharmaceuticals, Inc., a public biotechnology company (until its merger with Ocuphire Pharma,
Inc.). From 2011 to 2013, Mr.&nbsp;Brandt served on the board of directors, and as chair from December 2012, of ePocrates, Inc., a point of care medical applications company (until its acquisition by athenahealth, Inc.). From 2011 to 2012,
Mr.&nbsp;Brandt also served as interim chief executive officer and president of ePocrates, Inc. Prior to that, from 2008 to 2009, Mr.&nbsp;Brandt served as president, chief executive officer, and as a member of the board of directors of Noven
Pharmaceuticals, Inc., a specialty pharmaceutical company (until its acquisition by Hisamitsu Pharmaceutical Co., Inc.). Prior to leading Noven, Mr.&nbsp;Brandt spent 28 years at Pfizer Inc. where he served various roles, including as Pfizer&#146;s
president&#151;U.S. pharmaceuticals operations, where he helped deliver revenue and earnings growth while engineering major change within Pfizer&#146;s U.S. pharmaceuticals organization. Prior to running U.S. operations, he led Pfizer&#146;s Latin
American pharmaceuticals operations, as well as the following Pfizer Worldwide Pharmaceuticals functions: finance, information technology, planning and business development. He also oversaw the operations of Pfizer&#146;s care management subsidiary,
Pfizer Healthcare Solutions. Mr.&nbsp;Brandt also served as a director of Auxilium Pharmaceuticals, Inc. from December 2010 to January 2015 (until its acquisition by Endo International PLC). Mr.&nbsp;Brandt received a B.A. from the University of
Connecticut and an MBA from the Columbia School of Business. We believe that Mr.&nbsp;Brandt&#146;s broad operational management experience in the life sciences industry and experience serving on numerous boards of directors of life sciences
companies qualifies him to serve on our Board.<B><I>&nbsp;</I></B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Corrine Epperly</I></B> has served as a member of our Board since December 2023.
Dr.&nbsp;Epperly served as the chief operating officer of Cargo Therapeutics, Inc. (previously Syncopation Life Sciences, Inc.), a public clinical-stage biotechnology company focused on advancing curative cell therapies for cancer patients, from May
2021 to June 2023. Prior to that role, from January 2019 to March 2021, Dr.&nbsp;Epperly was a senior vice president of strategy </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and operations at Iovance Biotherapeutics, Inc., a public clinical-stage immuno-oncology company. From June 2017 to December 2018, she served as the chief operating officer at Vascular Biogenics
Ltd., a public biopharmaceutical focused on cancer treatments. Prior to these roles, Dr.&nbsp;Epperly held the various positions at Bristol Myers Squibb and, prior to joining Bristol Myers Squibb, Dr.&nbsp;Epperly was an equity analyst in Global
Pharmaceutical and Biotechnology Investment Research at Goldman Sachs International. Dr.&nbsp;Epperly served on the board of directors of Aveo Oncology, a formerly public commercial stage, oncology-focused biopharmaceutical company, from January
2020 to January 2023. Dr.&nbsp;Epperly received a B.Sc. in Biochemistry and Biology from the University of Virginia, an M.D. from the University of North Carolina Chapel Hill and an M.P.H. from the University of North Carolina Chapel Hill. We
believe that Dr.&nbsp;Epperly&#146;s extensive experience as a senior financial executive in the life sciences industry and experience serving on several boards of directors of life sciences companies qualifies her to serve on our
Board.<B><I>&nbsp;</I></B> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Directors Continuing in Office Until the 2027 Annual Meeting of Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>William Ho</I></B> is our <FONT STYLE="white-space:nowrap">co-founder,</FONT> and has served as our president, chief executive officer and director since
our inception in November 2015 and also served as our chief financial officer from October 2020 to February 2021. Prior to this, from April 2014 to November 2017, Mr.&nbsp;Ho was the founder and managing partner at AlephPoint Capital, a private
healthcare fund. Prior to AlephPoint, Mr.&nbsp;Ho launched the public investments and cross-over portfolio at New Leaf Venture Partners, a leading healthcare venture capital firm, and served as its Public Investment Director from 2010 to 2014.
Previously, Mr.&nbsp;Ho also served as a Senior Equity Research Analyst at Bank of America from 2006 to 2009 and an Equity Research Analyst at Piper Jaffray&nbsp;&amp; Co. from 2003 to 2006, covering the biotechnology and life-science tools sectors.
Earlier in his career, Mr.&nbsp;Ho was responsible for FP&amp;A and operational analysis at CuraGen Corporation and worked as an associate on the Healthcare Investment Banking team at Cowen. Mr.&nbsp;Ho was an inductee into the McMaster University
Alumni Gallery in 2020 and previously served as a member of their Dean&#146;s Advisory Board for the Faculty of Science. Mr.&nbsp;Ho received an MBA from the University of Notre Dame and a B.S. in Biochemistry from McMaster University. We believe
that Mr.&nbsp;Ho&#146;s extensive knowledge of our company as founder, president and chief executive officer and his experience in the healthcare industry qualifies him to serve on our Board.<B><I>&nbsp;</I></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Alan S. Roemer </I></B>has served as chair and a member of our Board since September 2020. Mr.&nbsp;Roemer currently serves as chair and member of the
board of directors of UTILITY therapeutics Ltd., a private biotechnology company; and member of the board of trustees and treasurer of the Helene Fuld College of Nursing. Mr.&nbsp;Roemer previously served as a member of the board of directors and
chair of the audit, finance and compensation committees of Bit.Bio Ltd., a private synthetic biology company, from August 2021 to November 2024; as a director and chair of the audit committee of NexImmune, Inc., a public biotechnology company, from
February 2017 to August 2024; as a member of the board of directors of SomPharmaceuticals SA, a private biopharmaceutical company, until its acquisition by Amryt Pharma plc; and a member of the board of directors of Envisagenics, Inc., a private RNA
therapeutics company, from September 2021 to February 2023. Mr.&nbsp;Roemer was a founding leadership team member and senior vice president of Roivant Sciences, Inc., a public biopharmaceutical company, from the company&#146;s inception in May 2014
to August 2019, where he held various senior management roles responsible for finance, operations and corporate development. In 2015, he also served as principal financial and accounting officer of Axovant Sciences Ltd., a public biopharmaceutical
company, and a founding leadership team member and chief financial officer of its wholly owned subsidiary, Axovant Sciences, Inc. Prior to launching Roivant and Axovant, Mr.&nbsp;Roemer served in various executive roles, including managing director
of the Trout Group LLC and Trout Capital LLC, chief financial officer and treasurer of Zelos Therapeutics, Inc., and vice president of Pharmasset, Inc., which was subsequently acquired by Gilead Sciences, Inc. Mr.&nbsp;Roemer received a B.S. in
Business Administration from Georgetown University and his MBA and MPH degrees from Emory University&#146;s Goizueta Business School and Rollins School of Public Health. We believe that Mr.&nbsp;Roemer&#146;s significant executive and board
leadership experience in the biopharmaceutical industry qualifies him to serve on our Board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Resigning from the Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Travis</I></B><B><I> </I></B><B><I>Whitfill</I></B><B><I> </I></B>has served as a member of our Board since May 2018. Mr.&nbsp;Whitfill is the founder
and has served in various roles at Azitra Inc., including Chief Operating Officer since July 2023, Executive Director of Advanced Technology from September 2019 to October 2022 and Chief Scientific Officer from January 2014 to September 2019, as
well as on the board of directors since its founding in 2014. He has also been a Senior Analyst at Bios Research from September 2014 to June 2023 and served as a partner at Bios Equity Partners, LP, a biotechnology-focused venture capital firm, from
October 2015 to June 2023. Mr. Whitfill has also served as an assistant professor adjunct at Yale University since March 2022 and previously served as an associate research scientist with appointments in the Departments of Pediatrics and Emergency
Medicine at Yale University from July 2016 to March 2022. Mr. Whitfill has led numerous grant-funded projects, holds several patents and has <FONT STYLE="white-space:nowrap">co-authored</FONT> over 50&nbsp;publications. Mr.&nbsp;Whitfill received a
B.S. from Dallas Baptist University, a MPhil from UCL in the United Kingdom, and an MPH from Yale University. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Whitfill will resign from the
Board effective May&nbsp;9, 2025. The Board wishes to thank Mr.&nbsp;Whitfill for his years of dedicated service and work on behalf of the Company and its stockholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc888198_4"></A>INFORMATION REGARDING THE BOARD AND CORPORATE GOVERNANCE
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Independence of Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As required under The
Nasdaq Stock Market (&#147;<B><I>Nasdaq</I></B>&#148;) listing standards, a majority of the members of a listed company&#146;s Board must qualify as &#147;independent,&#148; as affirmatively determined by the Board. The Board consults with our
counsel to ensure that its determinations are consistent with relevant securities and other laws and regulations regarding the definition of &#147;independent,&#148; including those set forth in pertinent listing standards of Nasdaq, as in effect
from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has reviewed the independence of each director. Based on information provided by each director concerning her or his
background, employment and affiliations, the Board has determined that none of our directors, other than Mr.&nbsp;Ho, has any relationships that would interfere with the exercise of independent judgment in carrying out the responsibilities of a
director and that each of the directors is &#147;independent&#148; as that term is defined under the Nasdaq listing standards. In making these determinations, our Board considered the current and prior relationships that each <FONT
STYLE="white-space:nowrap">non-employee</FONT> director has with us and all other facts and circumstances our Board deemed relevant in determining their independence, including the beneficial ownership of our securities by each <FONT
STYLE="white-space:nowrap">non-employee</FONT> director and the transactions described in the section titled &#147;Transactions with Related Persons.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Leadership Structure </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Corporate Governance Guidelines
specify that the Board will select our Chief Executive Officer and Chair of the Board in the manner that it determines to be in the best interests of our stockholders and in accordance with any stockholder agreements. The Board does not believe
there should be a fixed rule regarding the positions of Chief Executive Officer and Chair being held by different individuals, or whether the Chair should be an employee of the Company or should be elected from among the <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors. The needs of the Company and the individuals available to assume these roles may require different outcomes at different times, and the Board believes that retaining flexibility in these
decisions is in the best interests of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to its charter, the Nominating and Corporate Governance Committee periodically reviews this
matter and make recommendations to the Board. The Nominating Committee has recommended, and the Board has determined, that the roles of Chief Executive Officer and Chair of the Board should be separate. The role of chairperson is currently held by
Alan S. Roemer, an independent, <FONT STYLE="white-space:nowrap">non-employee</FONT> director. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risk Oversight of the Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One of the Board&#146;s key functions is informed oversight of our risk management process. In particular, our Board is responsible for monitoring and
assessing strategic risk exposure, including a determination of the nature and level of risk appropriate for the Company. The Board does not have a standing risk management committee, but rather administers this oversight function directly through
the Board as a whole, as well as through various Board standing committees that address risks inherent in their respective areas of oversight. Our Board and its committees consider specific risk topics, including risks associated with our strategic
plan, business operations, capital structure, information technology, data privacy and cyber security. It is the responsibility of the committee chairs to report findings regarding material risk exposures to the Board as quickly as possible. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Audit Committee has the responsibility to consider and discuss with management and the auditors, as appropriate, the Company&#146;s guidelines and
policies with respect to financial risk management and financial risk assessment, including the Company&#146;s major financial risk exposures and the steps taken by management to monitor and control these exposures. In addition, the Audit Committee
considers management risks relating to data privacy, technology and information security, including cyber security, and <FONT STYLE="white-space:nowrap">back-up</FONT> of information systems and the steps the Company has taken to monitor and control
such exposures as well as overseeing the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
performance of our internal audit function, as applicable. Our Compensation Committee assesses and monitors whether any of our compensation policies and programs has the potential to encourage
excessive risk-taking, including risks related to executive compensation and overall compensation and benefit strategies, plans, arrangements, practices and policies. Our Nominating and Corporate Governance Committee monitors the effectiveness of
our corporate governance guidelines, including whether they are successful in preventing illegal or improper liability-creating conduct. The Nominating and Corporate Governance Committee also oversees and reviews with management the Company&#146;s
major legal compliance risk exposures and the steps management has taken to monitor or mitigate such exposures, including the Company&#146;s procedures and any related policies with respect to risk assessment and risk management. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with its reviews of the operations and corporate functions of our company, our Board addresses the primary risks associated with those
operations and corporate functions. In addition, our Board reviews the risks associated with our company&#146;s business strategies periodically throughout the year as part of its consideration of undertaking any such business strategies. While the
Board and its committees oversee risk management strategy, management is responsible for implementing and supervising <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> risk management processes and reporting
to the Board and its committees on such matters. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Meetings of the Board; Executive Sessions; Annual Meeting Attendance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board met 11 times during the fiscal year ended December&nbsp;31, 2024. During the fiscal year ended December&nbsp;31, 2024, each director attended at
least 75% of the aggregate number of meetings of our Board and of the committees on which they served (held during the period for which he or she was a director). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As required under applicable Nasdaq listing standards, during the fiscal year ended December&nbsp;31, 2024, our
<FONT STYLE="white-space:nowrap">non-management</FONT> directors met seven times in regularly scheduled executive sessions at which only <FONT STYLE="white-space:nowrap">non-management</FONT> directors were present. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">It is our policy to encourage directors and nominees for director to attend the Annual Meeting. Seven of our current directors who served at the time of our
2024 Annual Meeting of Stockholders attended that meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Committees</B><B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board has established three standing committees: an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. Our
Board may establish other committees to facilitate the management of our business. Our Board has adopted a written charter for each of our standing committees, which are available to stockholders on our investor relations website at
<I>investors.in8bio.com</I>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides membership and meeting information for the fiscal year ended December&nbsp;31,
2024 for each of the committees of our Board. Each Board member attended 75% or more of the aggregate number of meetings of the standing committee on which she or he served, held during the portion of the last fiscal year for which she or he was a
committee member. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD style="width:19pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:19pt"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD style="width:24pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:24pt"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD style="width:21pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:21pt"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Audit<BR>Committee</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Compensation<BR>Committee</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nominating<BR>and<BR>Corporate<BR>Governance<BR>Committee</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alan S. Roemer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">


<IMG SRC="g888198g01z16.jpg" ALT="LOGO" STYLE="width:0.0845542in;height:0.130385in;">
</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">


<IMG SRC="g888198g01r16.jpg" ALT="LOGO" STYLE="width:0.0845472in;height:0.130385in;">
</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Peter Brandt


<IMG SRC="g888198g01x16.jpg" ALT="LOGO" STYLE="width:0.103568in;height:0.113767in;">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">


<IMG SRC="g888198g01r16.jpg" ALT="LOGO" STYLE="width:0.0845472in;height:0.130385in;">
</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">


<IMG SRC="g888198g01z16.jpg" ALT="LOGO" STYLE="width:0.0845542in;height:0.130385in;">
</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corrine Epperly</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">


<IMG SRC="g888198g01z16.jpg" ALT="LOGO" STYLE="width:0.0845542in;height:0.130385in;">
</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Emily Fairbairn</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">


<IMG SRC="g888198g01z16.jpg" ALT="LOGO" STYLE="width:0.0845542in;height:0.130385in;">
</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jeremy Graff</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">


<IMG SRC="g888198g01z16.jpg" ALT="LOGO" STYLE="width:0.0845542in;height:0.130385in;">
</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Luba Greenwood</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">


<IMG SRC="g888198g01z16.jpg" ALT="LOGO" STYLE="width:0.0845542in;height:0.130385in;">
</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">


<IMG SRC="g888198g01z16.jpg" ALT="LOGO" STYLE="width:0.0845542in;height:0.130385in;">
</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Travis Whitfill<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">


<IMG SRC="g888198g01z16.jpg" ALT="LOGO" STYLE="width:0.0845542in;height:0.130385in;">
</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">


<IMG SRC="g888198g01r16.jpg" ALT="LOGO" STYLE="width:0.0845472in;height:0.130385in;">
</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total meetings in 2024</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">


<IMG SRC="g888198g01x16.jpg" ALT="LOGO" STYLE="width:0.103568in;height:0.113767in;">
</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Financial Expert </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">


<IMG SRC="g888198g01r16.jpg" ALT="LOGO" STYLE="width:0.0845472in;height:0.130385in;">
</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Committee Chair </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">


<IMG SRC="g888198g01z16.jpg" ALT="LOGO" STYLE="width:0.0845542in;height:0.130385in;">
</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Committee Member </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Whitfill stepped down from the Compensation Committee in February 2024. Mr.&nbsp;Whitfill has resigned
from the Board and all committees thereof effective as of May&nbsp;9, 2025. Dr. Graff will serve as Chair of the Nominating and Corporate Governance Committee upon the effectiveness of Mr. Whitfill&#146;s resignation. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Below is a description of each committee of our Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Audit Committee </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee currently
consists of Alan S. Roemer, Peter Brandt and Luba Greenwood, with Mr.&nbsp;Brandt serving as Chair. The Board has determined each member satisfies the independence requirements under Nasdaq listing standards and
<FONT STYLE="white-space:nowrap">Rule&nbsp;10A-3(b)(1)</FONT> of the Exchange Act. The Board has determined that Mr.&nbsp;Brandt is an &#147;audit committee financial expert&#148; within the meaning of SEC regulations. Each member of the audit
committee can read and understand fundamental financial statements in accordance with applicable requirements. In arriving at these determinations, the Board has examined each audit committee member&#146;s scope of experience and the nature of their
employment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The primary purpose of the Audit Committee is to discharge the responsibilities of our Board with respect to our corporate accounting and
financial reporting processes, systems of internal control and financial statement audits, and to oversee our independent registered public accounting firm. Specific responsibilities of our audit committee include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">helping our Board oversee our corporate accounting and financial reporting processes; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">managing the selection, engagement, qualifications, independence and performance of a qualified firm to serve as
the independent registered public accounting firm to audit our financial statements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">discussing the scope and results of the audit with the independent registered public accounting firm, and
reviewing, with management and the independent accountants, our interim and <FONT STYLE="white-space:nowrap">year-end</FONT> operating results; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing procedures for employees to submit concerns anonymously about questionable accounting or audit
matters; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">conferring with management and the independent registered public accounting firm concerning the scope, design,
adequacy, and effectiveness of internal control over financial reporting and our disclosure controls and procedures; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing related person transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing the Company&#146;s investment philosophy and policies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and assessing of our risk management, risk assessment and major risk exposures, including privacy,
cybersecurity and information technology risks; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approving or, as permitted, <FONT STYLE="white-space:nowrap">pre-approving,</FONT> audit and permissible <FONT
STYLE="white-space:nowrap">non-audit</FONT> services to be performed by the independent registered public accounting firm. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Audit Committee Report </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The
material in this report is not &#147;soliciting material,&#148; is not deemed filed with the SEC and is not to be incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made
before or after the date hereof and irrespective of any general incorporation language in any such filing. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee has reviewed and
discussed the audited financial statements for the fiscal year ended December&nbsp;31, 2024 with management of the Company. The Audit Committee has discussed with the independent registered public accounting firm the matters required to be discussed
by the applicable requirements of the Public Company Accounting Oversight Board (&#147;<B><I>PCAOB</I></B>&#148;) and the SEC. The Audit Committee has also received the written disclosures and the letter from the independent registered public
accounting firm required by applicable requirements of the PCAOB regarding the independent accountants&#146; communications with the Audit Committee concerning independence and has discussed with the independent registered public accounting firm the
accounting firm&#146;s independence. Based on the foregoing, the Audit Committee has recommended to the Board that the audited financial statements be included in the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT>
for the fiscal year ended December&nbsp;31, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IN8bio, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Audit Committee </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Peter Brandt (chair) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Luba Greenwood </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alan S. Roemer </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Committee </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation Committee
currently consists of Alan S. Roemer, Corinne Epperly and Luba Greenwood, with Mr.&nbsp;Roemer serving as Chair. Travis Whitfill stepped down from the Compensation Committee in February 2024. The Board has determined that each member of the
Compensation Committee is independent under the Nasdaq listing standards and a <FONT STYLE="white-space:nowrap">&#147;non-employee</FONT> director&#148; as defined in Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange
Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The primary purpose of our Compensation Committee is to discharge the responsibilities of our Board in overseeing our compensation policies, plans
and programs and to review and determine the compensation to be paid to our executive officers, directors and other senior management, as appropriate. Specific responsibilities of our Compensation Committee include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and establishing general policies relating to compensation and benefits of our employees, including our
overall compensation philosophy; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the compensation, individual and corporate performance goals and objectives, and other
terms of employment of our chief executive officer, other executive officers and other senior management; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving (or making recommendations to the Board for approval of) the type and amount of
compensation to be paid or awarded to Board members, including perquisites; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">administering our equity incentive plans and other benefit programs; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">monitoring our regulatory compliance with respect to compensation matters; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">assisting the Board in its oversight of our policies and strategies relating to human capital management.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Committee Processes and Procedures </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation Committee generally meets quarterly and with greater frequency if necessary. The agenda for each meeting is usually developed by the Chair of
the Compensation Committee, in consultation with our Chief Executive Officer. The Compensation Committee meets regularly in executive session. However, from time to time, various members of management and other employees as well as outside advisers
or consultants may be invited by the Compensation Committee to make presentations, to provide financial or other background information or advice or to otherwise participate in Compensation Committee meetings. The Chief Executive Officer may not
participate in, or be present during, any deliberations or determinations of the Compensation Committee regarding his compensation or individual performance objectives. The charter of the Compensation Committee grants the Compensation Committee full
access to all books, records, facilities and personnel of the Company. In addition, under the charter, the Compensation Committee has the authority to obtain, at our expense, advice and assistance from compensation consultants and internal and
external legal, accounting or other advisers and other external resources that the Compensation Committee considers necessary or appropriate in the performance of its duties. The Compensation Committee has direct responsibility for the oversight of
the work of any consultants or advisers engaged for the purpose of advising the Compensation Committee. In particular, the Compensation Committee has the authority to retain compensation consultants to assist in its evaluation of executive and
director compensation, including authority to approve the consultant&#146;s reasonable fees and other retention terms. Under the charter, the Compensation Committee may select, or receive advice from, a compensation consultant, legal counsel or
other adviser to the Compensation Committee, other than <FONT STYLE="white-space:nowrap">in-house</FONT> legal counsel and certain other types of advisers, only after assessing the independence of such person in accordance with SEC and Nasdaq
requirements that bear upon the adviser&#146;s independence; however, there is no requirement that any adviser be independent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation Committee
may also form and delegate authority to subcommittees for any purpose that the Committee deems appropriate, including (a)&nbsp;a subcommittee consisting of a single member, and (b)&nbsp;a subcommittee consisting of at least two members, each of whom
qualify as <FONT STYLE="white-space:nowrap">&#147;non-employee</FONT> directors&#148; for purposes of Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> under the Exchange Act. In 2024, the Compensation Committee delegated authority to Chief
Executive Officer to grant equity awards to <FONT STYLE="white-space:nowrap">non-executive</FONT> employees, with such awards not to exceed a specified share cap. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the past fiscal year, after taking into consideration the six factors prescribed by the SEC and Nasdaq, the Compensation Committee engaged Aon&#146;s
Human Capital Solutions (&#147;<B><I>Aon</I></B>&#148;), an independent compensation consultant, to provide it with information, recommendations and other advice relating to executive compensation on an ongoing basis. The Compensation Committee has
assessed Aon&#146;s independence and determined that Aon had no conflicts of interest in connection with its provisions of services to the Compensation Committee. In 2024, the Compensation Committee engaged Aon to provide market data, peer group
analysis and conduct an executive compensation assessment analyzing the cash and equity compensation of our executive officers and directors against compensation for similarly situated executives and directors at our peer group. Our Compensation
Committee utilizes the data and analysis from Aon to evaluate and determine appropriate levels of overall compensation for our executive officers, as well as each separate element of compensation, to be consistent and competitive with our peer
group. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Compensation Committee makes most of the significant adjustments to annual compensation, determines bonus and equity awards and establishes
new performance objectives at one or more meetings held during the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
first quarter of the year. However, our Compensation Committee also considers matters related to individual compensation, such as compensation for new executive hires, as well as high-level
strategic issues, such as the efficacy of our compensation strategy, potential modifications to that strategy and new trends, plans or approaches to compensation, at various meetings throughout the year. Generally, the Compensation Committee&#146;s
process comprises two related elements: the determination of compensation levels and the establishment of performance objectives for the current year. For executives other than the Chief Executive Officer, our Compensation Committee solicits and
considers evaluations and recommendations submitted to the Compensation Committee by the Chief Executive Officer. In the case of the Chief Executive Officer, the evaluation of his performance is conducted by the Compensation Committee, which
determines any adjustments to his compensation as well as awards to be granted. For all executives and directors as part of its deliberations, the Compensation Committee may review and consider, as appropriate, materials such as executive and
director stock ownership information, Company stock performance data, analyses of historical executive compensation levels and current Company-wide compensation levels, including analyses of executive and director compensation paid at a peer group
of other companies approved by our Compensation Committee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Nominating and Corporate Governance Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance Committee consists of Peter Brandt, Emily Fairbairn, Jeremy Graff and Travis Whitfill, with Mr.&nbsp;Whitfill serving
as Chair. Upon Mr. Whitfill&#146;s resignation from the Board effective as of May 9, 2025, Dr. Graff will serve as Chair of the Nominating and Corporate Governance Committee. The Board has determined that each member of the Nominating and Corporate
Governance Committee is independent under the Nasdaq listing standards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Specific responsibilities of our Nominating and Corporate Governance Committee
include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing the Company&#146;s corporate governance functions, including reviewing the adequacy of the
Company&#146;s certificate of incorporation and bylaws; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing and making recommendations to our Board regarding corporate governance guidelines and matters,
including developments in corporate governance; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">identifying and evaluating candidates, including the nomination of incumbent directors for reelection and
nominees recommended by stockholders, to serve on our Board; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">considering and making recommendations to our Board regarding the structure, composition and chairmanship of the
committees of our Board; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing periodic evaluations of the Board&#146;s performance, including committees of the Board;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">instituting plans or programs for the continuing education of our Board and orientation of new directors;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing stockholder proposals submitted for inclusion in our proxy statement; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing, evaluating and recommending to our Board succession plans for our executive officers.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board determines the appropriate characteristics, skills and experience for the Board as a whole and for its individual members.
The Board considers recommendation for nominees from the Nominating and Corporate Governance Committee. The Board, and in turn the Nominating and Corporate Governance Committee, consider the minimum general criteria below, and may add any specific
additional criteria with respect to specific searches, in selecting candidates and existing directors for serving on the Board. An acceptable candidate may not fully satisfy all of the criteria but is expected to satisfy nearly all of them. The
Board believes that candidates for director should have certain minimum qualifications, including the highest personal integrity and ethics, the ability to read and understand basic financial statements, ability to understand our industry and being
older than 21. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In considering candidates recommended by the Nominating and Corporate Governance Committee, the Board
intends to consider other factors, such as: (i)&nbsp;possessing relevant expertise upon which to be able to offer advice and guidance to management; (ii)&nbsp;having sufficient time to devote to the affairs of the Company; (iii)&nbsp;demonstrating
excellence in his or her field; (iv)&nbsp;having the ability to exercise sound business judgment; (v)&nbsp;experience as a board member or executive officer of another publicly held company; (vi)&nbsp;having a diverse personal background,
perspective and experience; and (vii)&nbsp;having the commitment to rigorously represent the long-term interests of our stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board and the
Nominating and Corporate Governance Committee reviews candidates for director nomination in the context of the current composition of the Board, our operating requirements, and the long-term interests of our stockholders. In conducting this
assessment, the Board and the Nominating and Corporate Governance Committee consider diversity (including, among other factors, diversity of gender, ethnic background and country of origin), age, skills and other factors that it deems appropriate to
maintain a balance of knowledge, experience, and capability on the Board. For incumbent directors, the Board reviews those directors&#146; overall service to the Company during their term, including the number of meetings attended, level of
participation, quality of performance, and any other relationships and transactions that might impair the directors&#146; independence. In the case of new director candidates, the Board also determines whether the nominee must be independent for
Nasdaq purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Generally, our Nominating and Corporate Governance Committee identifies candidates for director nominees in consultation with
management, using search firms or other advisors, through the recommendations submitted by stockholders or through such other methods as the Nominating and Corporate Governance Committee deems to be helpful to identify candidates. The Nominating and
Corporate Governance Committee conducts any appropriate and necessary inquiries into the backgrounds and qualifications of possible candidates after considering the function and needs of the Board. The Nominating and Corporate Governance Committee
meets to discuss and consider the candidates&#146; qualifications and then selects a nominee for recommendation to the Board by majority vote. The Nominating and Corporate Governance Committee may gather information about the candidates through
interviews, questionnaires, background checks or any other means that the Nominating and Corporate Governance Committee deems to be appropriate in the evaluation process. Our Nominating and Corporate Governance Committee&#146;s priority in selecting
board members is identification of persons who will further the interests of the Company through his or her established record of professional accomplishment, the ability to contribute positively to the collaborative culture among board members, and
professional and personal experiences and expertise relevant to our growth strategy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance Committee will consider
director candidates recommended by stockholders. The Nominating and Corporate Governance Committee does not intend to alter the manner in which it evaluates candidates, including the minimum criteria set forth above, based on whether or not the
candidate was recommended by a stockholder. Stockholders who wish to recommend individuals for consideration by the Nominating and Corporate Governance Committee to become nominees for election to the Board may do so by providing timely notice in
writing to our Secretary at c/o IN8bio, Inc., 350 5th Avenue, Suite 5330, New York, New York 10118. To be timely, we must receive the notice not less than 90 days nor more than 120 days prior to the anniversary of the prior year&#146;s annual
meeting of stockholders, subject to certain exceptions as set forth in our Bylaws. Submissions must include the specific information required in Section&nbsp;5 of our Bylaws. For additional information about our director nomination requirements,
please see our Bylaws. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Science and Technology Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has also established the Science and Technology Committee, which consists of Corinne Epperly, Jeremy Graff and Travis Whitfill, with Dr.&nbsp;Graff
serving as Chair. Mr. Whitfill has resigned from the Board and the Science and Technology Committee effective as of May&nbsp;9, 2025. The Science and Technology Committee assists with the Board&#146;s oversight of the strategic direction of our
research and development activities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Code of Business Conduct and Ethics </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have adopted a Code of Business Conduct and Ethics (&#147;<B><I>Code of Conduct</I></B>&#148;) that applies to all our employees, officers and directors.
This includes our principal executive officer, principal financial officer and principal accounting officer or controller, or persons performing similar functions. The full text of our Code of Conduct is posted on our website at
<I>investors.in8bio.com</I>. If we ever were to amend or waive any provision of our Code of Conduct that applies to our principal executive officer, principal financial officer, principal accounting officer or any person performing similar
functions, we intend to satisfy our disclosure obligations, if any, with respect to any such waiver or amendment by posting such information on our website set forth above rather than by filing a Current Report on Form
<FONT STYLE="white-space:nowrap">8-K.</FONT> In the case of a waiver for an executive officer or a director, the disclosure required under applicable Nasdaq listing standards also will be made available on our website. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Governance Guidelines </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has adopted
Corporate Governance Guidelines to assure that the Board will have the necessary authority and practices in place to review and evaluate our business operations as needed and to make decisions that are independent of our management. The guidelines
are also intended to align the interests of directors and management with those of our stockholders. The Corporate Governance Guidelines set forth the practices the Board intends to follow with respect to, among other things, board composition and
selection including diversity, Board meetings and involvement of senior management, Chief Executive Officer performance evaluation and succession planning, and Board committees and compensation. The Corporate Governance Guidelines are posted on our
website at <I>investors.in8bio.com</I>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stockholder Communications with the Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholders wishing to communicate with the Board or an individual director may send a written communication to the Board or such director addressed to the
Secretary of IN8bio, Inc. at 350 5th Avenue Suite 5330 New York, New York 10118. The Secretary will review each communication and will forward such communication to the Board or to any individual director to whom the communication is addressed
unless the communication contains advertisements or solicitations or is unduly hostile, threatening or similarly inappropriate, in which case the Secretary shall discard the communication or inform the proper authorities, as may be appropriate. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Insider Trading Policy </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have adopted an Insider
Trading Policy governing the purchase, sale, and/or other dispositions of our securities by directors, officers, employees and designated consultants that is designed to promote compliance with insider trading laws, rules and regulations, as well as
procedures designed to further the foregoing purposes. A copy of our Insider Trading Policy is filed as an exhibit to our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for our fiscal year ended December&nbsp;31, 2024. In
addition, it is our intent to comply with applicable laws and regulations relating to insider trading. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Policy on Hedging and Pledging </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under our Insider Trading Policy, our directors, executive officers, employees and designated consultants may not hedge their ownership of our stock, including
but not limited to trading in options, puts, calls, or other derivative instruments related to our stock. Additionally, directors, executive officers, employees and designated consultants may not purchase our stock on margin, borrow against our
stock held in a margin account, or pledge our stock as collateral for a loan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc888198_5"></A>PROPOSAL 2: RATIFICATION OF THE SELECTION OF THE INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee has selected CohnReznick LLP (&#147;<B><I>CohnReznick</I></B>&#148;) as our independent registered public
accounting firm for the fiscal year ending December&nbsp;31, 2025 and has further directed that management submit the selection of its independent registered public accounting firm for ratification by the stockholders at the Annual Meeting.
CohnReznick has audited the Company&#146;s financial statements since 2017. Representatives of CohnReznick are expected to be available during the Annual Meeting. They will have an opportunity to make a statement if they so desire and will be
available to respond to appropriate questions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither our organizational documents nor law require that the stockholders ratify the selection of
CohnReznick as our independent registered public accounting firm. However, the Audit Committee is submitting the selection of CohnReznick to the stockholders for ratification as a matter of good corporate practice. If the stockholders fail to ratify
the selection, the Audit Committee will reconsider whether or not to retain that firm. Even if the selection is ratified, the Audit Committee in its discretion may direct the appointment of different independent auditors at any time during the year
if they determine that such a change would be in the best interests of the Company and its stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Independent Registered Public Accounting Firm
Fees </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table represents the aggregate fees billed to the Company for the fiscal years ended December&nbsp;31, 2024 and December&nbsp;31,
2023 by CohnReznick. All fees described below were <FONT STYLE="white-space:nowrap">pre-approved</FONT> by the Audit Committee. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fiscal Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Fees<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">382,217</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">315,457</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit-related fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All other fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Fees</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>382,217</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>315,457</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Audit fees are fees related to the annual audit of our consolidated financial statements, the review of our
quarterly condensed consolidated financial statements and services performed in connection with registration statements or other regulatory filings with the SEC, including comfort letters and consents. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Pre-Approval</FONT> Policies and Procedures </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Audit Committee approves all audit and <FONT STYLE="white-space:nowrap">pre-approves</FONT> all <FONT STYLE="white-space:nowrap">non-audit</FONT> services
provided by CohnReznick before it is engaged by us to render <FONT STYLE="white-space:nowrap">non-audit</FONT> services to ensure that the provision of these services does not impair the auditor&#146;s independence. These services may include
audit-related services, tax services and other <FONT STYLE="white-space:nowrap">non-audit</FONT> services. The <FONT STYLE="white-space:nowrap">pre-approval</FONT> of services may be delegated to one or more of the Audit Committee&#146;s members,
but the decision must be reported to the full Audit Committee at its next scheduled meeting. The <FONT STYLE="white-space:nowrap">pre-approval</FONT> requirement does not apply with respect to <FONT STYLE="white-space:nowrap">non-audit</FONT>
services if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all such services do not, in the aggregate, amount to more than 5% of the total fees paid by us to CohnReznick
during the fiscal year in which the services are provided; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">such services were not recognized as <FONT STYLE="white-space:nowrap">non-audit</FONT> services at the time of
the relevant engagement; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">such services are promptly brought to the attention of and approved by the Audit Committee (or its delegate)
prior to the completion of the annual audit. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;For&#148; votes from the holders of a majority of the voting power of the shares present by remote communication or represented by proxy at the meeting
and voting affirmatively or negatively (excluding abstentions and broker <FONT STYLE="white-space:nowrap">non-votes)</FONT> will be required to ratify the selection of CohnReznick. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Recommendation </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD
UNANIMOUSLY RECOMMENDS A VOTE FOR THE RATIFICATION OF COHNREZNICK LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (PROPOSAL 2 ON YOUR NOTICE OF INTERNET AVAILABILITY) </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc888198_6"></A>PROPOSAL 3: APPROVAL OF A SERIES OF ALTERNATE AMENDMENTS TO OUR AMENDED AND
RESTATED CERTIFICATE OF INCORPORATION TO EFFECT A REVERSE STOCK SPLIT OF OUR COMMON STOCK </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Background </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board has unanimously approved a series of alternate amendments to our amended and restated certificate of incorporation that would effect a reverse stock
split (&#147;<B><I>Reverse Stock Split</I></B>&#148;) of all issued and outstanding shares of our common stock, at a ratio ranging from <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-15</FONT></FONT> to <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-30,</FONT></FONT> inclusive. The text of the proposed form of amendment to our certificate of incorporation, which we refer to as the Certificate of Amendment, is attached hereto as
Appendix A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accordingly, effecting a Reverse Stock Split would reduce the number of outstanding shares of our common stock. The effectiveness of any one
of these amendments and the abandonment of the other amendments, or the abandonment of all of these amendments, will be determined by our Board following the Annual Meeting and prior to the <FONT STYLE="white-space:nowrap">one-year</FONT>
anniversary of the Annual Meeting, or May&nbsp;8, 2026. Our Board has recommended that these proposed amendments be presented to our stockholders for approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our stockholders are being asked to approve these proposed amendments pursuant to Proposal 3, and to grant authorization to our Board to determine, at its
option, whether to implement a Reverse Stock Split, including its specific timing and ratio. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Should we receive the required stockholder approval for
Proposal 3, our Board will have the sole authority to elect, at any time on or prior to the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the Annual Meeting and without the need for any further action on the part of our
stockholders, whether to effect a Reverse Stock Split and the number of whole shares of our common stock, between and including fifteen (15)&nbsp;and thirty (30), that will be combined into one share of our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding approval of Proposal 3 by our stockholders, our Board may, at its sole option, abandon the proposed amendments and determine prior to the
effectiveness of any filing with the Secretary of State of the State of Delaware not to effect any Reverse Stock Split, as permitted under Section&nbsp;242(c) of the General Corporation Law of the State of Delaware. If our Board does not implement a
Reverse Stock Split on or prior to the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the Annual Meeting, stockholder approval would again be required prior to implementing any Reverse Stock Split. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By approving Proposal 3, our stockholders will: (a)&nbsp;approve a series of alternate amendments to our amended and restated certificate of incorporation
pursuant to which any whole number of outstanding shares of common stock between and including fifteen (15)&nbsp;and thirty (30)&nbsp;could be combined into one share of common stock; and (b)&nbsp;authorize our Board to file only one such amendment,
as determined by the Board at its sole option, and to abandon each amendment not selected by the Board. Our Board may also elect not to undertake any Reverse Stock Split and therefore abandon all amendments.</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Discretion to Implement the Reverse Stock Split </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We
are proposing that our Board have the discretion to select the Reverse Stock Split ratio from within a range between and including <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-15</FONT></FONT> to <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-30,</FONT></FONT> rather than proposing that stockholders approve a specific ratio at this time, in order to give our Board the flexibility to implement a Reverse Stock Split at a
ratio that reflects the Board&#146;s then-current assessment of the factors described below under &#147;Criteria to be Used for Determining Whether to Implement the Reverse Stock Split.&#148; If the Board decides to implement a Reverse Stock Split,
we will file the Certificate of Amendment with the Secretary of State of the State of Delaware and the Reverse Stock Split will be effective at the time set forth in the Certificate of Amendment. Except for adjustments that may result from the
treatment of fractional shares as described below, each of our stockholders will hold the same percentage of our outstanding common stock immediately following the Reverse Stock Split as such stockholder holds immediately prior to the Reverse Stock
Split. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Reasons for Reverse Stock Split </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>To maintain our listing on the Nasdaq Capital Market.</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On
August&nbsp;6, 2024, we were notified by Nasdaq that the bid price for our common stock had closed below $1.00&nbsp;per share for 30 consecutive business days and, as a result, we no longer satisfied the minimum bid price requirement applicable to
Nasdaq Global Market issuers (the &#147;<B><I>Minimum Bid Price Requirement</I></B>&#148;). Pursuant to Nasdaq rules, we were automatically afforded an initial <FONT STYLE="white-space:nowrap">180-calendar</FONT> day grace period, through
February&nbsp;3, 2025, to regain compliance with the minimum bid price requirement. To obtain a second <FONT STYLE="white-space:nowrap">180-day</FONT> grace period, we applied to transfer the listing of our common stock to the Nasdaq Capital Market.
On February&nbsp;7, 2025, we transferred to The Nasdaq Capital Market, and we were afforded an additional 180 calendar day compliance period, or until August&nbsp;4, 2025 (the &#147;<B><I>Compliance Date</I></B>&#148;), to regain compliance with the
Minimum Bid Price Requirement. Our failure to regain compliance prior to the Compliance Date could result in delisting. To regain compliance with the Minimum Bid Price Requirement, we must evidence a closing bid price of at least
$1.00&nbsp;per&nbsp;share for a minimum of 10 consecutive business days. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has considered the potential harm to us and our stockholders should
Nasdaq delist our common stock from the Nasdaq Capital Market. If our common stock were delisted from the Nasdaq Capital Market, the Board believes that such delisting would adversely affect the market liquidity of our common stock, decrease the
market price of our common stock, adversely affect our ability to obtain financing for the continuation of our operations and result in the loss of confidence in our company. In the event that our stockholders fail to approve this proposal, the
Company could be prevented in the future from complying with the Minimum Bid Price Requirement or other Nasdaq listing requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that
maintaining listing on the Nasdaq Capital Market will provide us with a market for the common stock that is more accessible than if the common stock were traded on the OTC Bulletin Board or in the &#147;pink sheets&#148; maintained by the OTC
Markets Group, Inc.&nbsp;An investor likely would find it less convenient to sell, or to obtain accurate quotations in seeking to buy, our common stock on an
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market. Many investors likely would not buy or sell our common stock due to difficulty in accessing <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> markets, policies preventing them from trading in securities not listed on a national exchange or for other reasons. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board believes that the proposed Reverse Stock Split is a potentially effective means for us to maintain compliance with the Minimum Bid Price Requirement
and to avoid, or at least mitigate, the likely adverse consequences of our common stock being delisted from Nasdaq by producing the immediate effect of increasing the bid price of our common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>To potentially improve the marketability and liquidity of our common stock. </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board believes that the increased market price of our common stock expected as a result of implementing a Reverse Stock Split could improve the
marketability and liquidity of our common stock and encourage interest and trading in our common stock. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Investor Stock Price Requirements</I>: We understand that many brokerage houses, institutional investors and
funds have internal policies and practices that either prohibit them from investing in <FONT STYLE="white-space:nowrap">low-priced</FONT> stocks or tend to discourage individual brokers from recommending
<FONT STYLE="white-space:nowrap">low-priced</FONT> stocks to their customers or by restricting or limiting the ability to purchase such stocks on margin. Additionally, a Reverse Stock Split could help increase analyst and broker interest in our
common stock as their internal policies might discourage them from following or recommending companies with low stock prices. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Stock Price Volatility</I>: Because of the trading volatility often associated with <FONT
STYLE="white-space:nowrap">low-priced</FONT> stocks, many brokerage houses and institutional investors have internal policies and practices that either prohibit them from investing in <FONT STYLE="white-space:nowrap">low-priced</FONT> stocks or tend
to discourage individual brokers from recommending <FONT STYLE="white-space:nowrap">low-priced</FONT> stocks to their customers. Some of those policies and practices may make the processing of trades in
<FONT STYLE="white-space:nowrap">low-priced</FONT> stocks economically unattractive to brokers. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Transaction Costs</I>: Investors may be dissuaded from purchasing stocks below certain prices because
brokers&#146; commissions, as a percentage of the total transaction value, can be higher for <FONT STYLE="white-space:nowrap">low-priced</FONT> stocks. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Criteria to be Used for Determining Whether to Implement Reverse Stock Split </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In determining whether to implement the Reverse Stock Split and which Reverse Stock Split ratio to implement, if any, following receipt of stockholder approval
of Proposal 3, our Board may consider, among other things, various factors such as: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the historical trading price and trading volume of our common stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the then-prevailing trading price and trading volume of our common stock and the expected impact of the Reverse
Stock Split on the trading market for our common stock in the short and long term; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to maintain our listing on the Nasdaq Capital Market; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">which Reverse Stock Split ratio would result in the least administrative cost to us; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prevailing general market and economic conditions; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether and when our Board desires to have the additional authorized but unissued shares of common stock that
will result from the implementation of a Reverse Stock Split available for issuance. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain Risks and Potential Disadvantages
Associated with Reverse Stock Split </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>We cannot assure you that the proposed Reverse Stock Split will increase our stock price for a sustained period
or have the desired effect of maintaining compliance with Nasdaq Marketplace Rules. </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We expect that the Reverse Stock Split will increase the market
price of our common stock. However, the effect of the Reverse Stock Split upon the market price of our common stock cannot be predicted with any certainty, and the history of similar reverse stock splits for companies in like circumstances is
varied, particularly since some investors may view a reverse stock split negatively. It is possible that the per share price of our common stock after the Reverse Stock Split will not rise in proportion to the reduction in the number of shares of
our common stock outstanding resulting from the Reverse Stock Split, and the Reverse Stock Split may not result in a per share price that would attract brokers and investors who do not trade in lower priced stocks. In addition, although we believe
the Reverse Stock Split may enhance the desirability of our common stock to certain potential investors, we cannot assure you that, if implemented, our common stock will be more attractive to institutional and other long-term investors. Even if we
implement the Reverse Stock Split, the market price of our common stock may decrease due to factors unrelated to the Reverse Stock Split. In any case, the market price of our common stock may also be based on other factors which may be unrelated to
the number of shares outstanding, including our future performance. If the Reverse Stock Split is consummated and the trading price of the common stock declines, the percentage decline as an absolute number and as a percentage of our overall market
capitalization may be greater than would occur in the absence of the Reverse Stock Split. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We cannot assure you that our common stock will regain
compliance with the Minimum Bid Price Requirement by the Compliance Date. Even if the market price per post-Reverse Stock Split share of our common stock remains in excess of $1.00 per share, we may be delisted due to a failure to meet other
continued listing requirements, including Nasdaq requirements related to the minimum number of shares that must be in the public float, the minimum market value of the public float and the minimum number of &#147;round lot&#148; holders. If we are
unable to satisfy the Nasdaq criteria for continued listing, our common stock would be subject to delisting. A delisting of our common stock could negatively impact us by, among other things, (i)&nbsp;reducing the liquidity and market price of our
common stock; (ii)&nbsp;reducing the number of investors willing to hold or acquire our common stock, which could negatively impact our ability to raise equity financing; (iii)&nbsp;decreasing the amount of news and analyst coverage of us;
(iv)&nbsp;limiting our ability to issue additional securities or obtain additional financing in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the future; (v)&nbsp;limiting our ability to use a registration statement to offer and sell freely tradable securities, thereby preventing us from accessing the public capital markets; and
(iv)&nbsp;impairing our ability to provide equity incentives to our employees. In addition, delisting from Nasdaq may negatively impact our reputation and, consequently, our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The proposed Reverse Stock Split may decrease the liquidity of our common stock and result in higher transaction costs. </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The liquidity of our common stock may be negatively impacted by a Reverse Stock Split, given the reduced number of shares that would be outstanding after the
Reverse Stock Split. In addition, if a Reverse Stock Split is implemented, it will increase the number of our stockholders who own &#147;odd lots&#148; of fewer than 100 shares of common stock. Brokerage commission and other costs of transactions in
odd lots are generally higher than the costs of transactions of more than 100 shares of common stock. Accordingly, a Reverse Stock Split may not achieve the desired results of increasing marketability and liquidity of our common stock described
above. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The effective increase in the authorized number of shares of our common stock as a result of the Reverse Stock Split could have anti-takeover
implications. </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The implementation of a Reverse Stock Split will result in an effective increase in the authorized number of shares of our common stock,
which could, under certain circumstances, have anti-takeover implications. The additional shares of common stock that would become available for issuance if this Proposal 3 is approved and a Reverse Stock Split is implemented could be used by us to
oppose a hostile takeover attempt or to delay or prevent changes in control or our management. While the Board has not adopted a stockholder rights plan which, under certain circumstances related to an acquisition of our securities that is not
approved by the Board, would give certain holders the right to acquire additional shares of our common stock at a low price, the Board may elect to adopt a rights plan in the future. The Board also could strategically sell shares of common stock in
a private transaction to purchasers who would oppose a takeover or favor the current Board. Although this Proposal 3 has been prompted by business and financial considerations and not by the threat of any hostile takeover attempt (nor is the Board
currently aware of any such attempts directed at us), stockholders should be aware that approval of this Proposal 3 could facilitate future efforts by us to deter or prevent changes in control, including transactions in which the stockholders might
otherwise receive a premium for their shares over then current market prices. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Effects of Reverse Stock Split </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After the effective date of any Reverse Stock Split that our Board elects to implement, each stockholder will own a reduced number of shares of common stock.
However, any Reverse Stock Split will affect all of our stockholders uniformly and will not affect any stockholder&#146;s percentage ownership interests in the Company, except to the extent that the Reverse Stock Split results in any of our
stockholders owning a fractional share as described below. Voting rights and other rights and preferences of the holders of our common stock will not be affected by a Reverse Stock Split (other than as a result of the payment of cash in lieu of
fractional shares). For example, a holder of 2% of the voting power of the outstanding shares of our common stock immediately prior to a Reverse Stock Split would continue to hold 2% (assuming there is no impact as a result of the payment of cash in
lieu of issuing fractional shares) of the voting power of the outstanding shares of our common stock immediately after such Reverse Stock Split. The number of stockholders of record will not be affected by a Reverse Stock Split (except to the extent
that any stockholder holds only a fractional share interest and receives cash for such interest after such Reverse Stock Split). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The principal effects of
a Reverse Stock Split will be that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">depending on the Reverse Stock Split ratio selected by the Board, each fifteen (15)&nbsp;to thirty
(30)&nbsp;shares of our common stock owned by a stockholder will be combined into one new share of our common stock; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no fractional shares of common stock will be issued in connection with any Reverse Stock Split; instead, holders
of common stock who would otherwise receive a fractional share of common stock pursuant to the Reverse Stock Split will receive cash in lieu of the fractional share as explained more fully below; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the total number of authorized shares of our common stock will not be reduced proportionally to the Reverse Stock
Split and, therefore, the Reverse Stock Split will result in an effective increase in the authorized number of shares of our common stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">based upon the Reverse Stock Split ratio selected by the Board, proportionate adjustments will be made to the per
share exercise price and/or the number of shares issuable upon the exercise or vesting of all then outstanding stock options and warrants, which will result in a proportional decrease in the number of shares of our common stock reserved for issuance
upon exercise or vesting of such stock options and warrants and a proportional increase in the exercise price of all such stock options and warrants; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of shares then reserved for issuance under our equity compensation plans will be reduced
proportionately based upon the Reverse Stock Split ratio selected by the Board. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table contains approximate
information, based on share information as of March 12, 2025, relating to our outstanding common stock based on the proposed Reverse Stock Split ratios (without giving effect to the treatment of fractional shares): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:26pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:26pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:26pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:26pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:27pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:27pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:29pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:29pt"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Status</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Shares of</B><br><B>Common&nbsp;Stock</B><br><B>Authorized</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Shares of</B><br><B>Common&nbsp;Stock</B><br><B>Issued and</B><br><B>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of</B><br><B>Shares of</B><br><B>Common&nbsp;Stock</B><br><B>Reserved for</B><br><B>Future&nbsp;Issuance</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Shares of</B><br><B>Common&nbsp;Stock</B><br><B>Authorized</B><br><B>but&nbsp;Unissued&nbsp;and</B><br><B>Unreserved</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Pre-Reverse</FONT> Stock Split</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">490,000,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81,258,763</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">79,589,015</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">329,152,222</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Post-Reverse Stock Split 1:15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">490,000,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,417,250</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,305,934</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">479,276,816</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Post-Reverse Stock Split 1:16</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">490,000,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,078,672</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,974,313</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">479,947,015</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Post-Reverse Stock Split 1:17</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">490,000,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,779,927</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,681,706</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">480,538,367</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Post-Reverse Stock Split 1:18</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">490,000,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,514,375</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,421,611</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">481,064,014</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Post-Reverse Stock Split 1:19</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">490,000,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,276,777</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,188,895</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">481,534,328</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Post-Reverse Stock Split 1:20</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">490,000,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,062,938</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,979,450</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">481,957,612</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Post-Reverse Stock Split 1:21</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">490,000,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,869,464</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,789,953</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">482,340,583</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Post-Reverse Stock Split 1:22</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">490,000,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,693,580</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,617,682</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">482,688,738</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Post-Reverse Stock Split 1:23</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">490,000,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,532,989</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,460,391</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">483,006,620</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Post-Reverse Stock Split 1:24</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">490,000,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,385,781</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,316,208</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">483,298,011</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Post-Reverse Stock Split 1:25</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">490,000,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,250,350</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,183,560</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">483,566,090</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Post-Reverse Stock Split 1:26</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">490,000,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,125,337</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,061,115</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">483,813,548</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Post-Reverse Stock Split 1:27</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">490,000,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,009,583</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,947,741</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">484,042,676</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Post-Reverse Stock Split 1:28</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">490,000,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,902,098</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,842,464</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">484,255,438</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Post-Reverse Stock Split 1:29</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">490,000,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,802,026</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,744,448</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">484,453,526</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Post-Reverse Stock Split 1:30</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">490,000,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,708,625</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,652,967</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">484,638,408</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After the effective date of any Reverse Stock Split that our Board elects to implement, our common stock would have a new
Committee on Uniform Securities Identification Procedures (CUSIP) number, a number used to identify our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common stock is currently
registered under Section&nbsp;12(b) of the Exchange Act, and we are subject to the periodic reporting and other requirements of the Exchange Act. The implementation of any proposed Reverse Stock Split will not affect the registration of our common
stock under the Exchange Act. Our common stock would continue to be listed on the Nasdaq Capital Market under the symbol &#147;INAB&#148; immediately following the Reverse Stock Split, although Nasdaq will add the letter &#147;D&#148; to the end of
the trading symbol for a period of 20 trading days after the effective date of the Reverse Stock Split to indicate that a reverse stock split has occurred. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Effective Time </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The proposed Reverse Stock Split would become effective at 5:00 p.m., Eastern Time, on date of filing of a Certificate of Amendment with the office of the
Secretary of State of the State of Delaware, or such later date or other time as is set forth in the Certificate of Amendment, which date and time we refer to in this Proposal 3 as the &#147;Effective Time.&#148; Except as explained below with
respect to fractional shares, effective as of the Effective Time, shares of common stock issued and outstanding immediately prior thereto will be combined, automatically and without any action on the part of us or our stockholders, into a fewer
number of new shares of our common stock in accordance with the Reverse Stock Split ratio determined by our Board within the limits set forth in this Proposal 3. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cash Payment In Lieu of Fractional Shares </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No fractional
shares of common stock will be issued as a result of any Reverse Stock Split. Instead, in lieu of any fractional shares to which a stockholder of record would otherwise be entitled as a result of the Reverse Stock Split, we will pay cash (without
interest) equal to such fraction multiplied by the average of the closing sales prices of the common stock on the Nasdaq Capital Market during regular trading hours for the five consecutive trading days immediately preceding the Effective Time (with
such average closing sales prices being adjusted to give effect to the Reverse Stock Split). After the Reverse Stock Split, a stockholder otherwise entitled to a fractional interest will not have any voting, dividend or other rights with respect to
such fractional interest except to receive payment as described above. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of March 12, 2025, there were 38 stockholders of record of our common
stock. Upon stockholder approval of this Proposal 3, if our Board elects to implement the proposed Reverse Stock Split, stockholders owning, prior to the Reverse Stock Split, less than the number of whole shares of common stock that will be combined
into one share of common stock in the Reverse Stock Split would no longer be stockholders. Holders of as many as 15 shares (if we were to implement the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-15</FONT></FONT> Reverse
Stock Split) of common stock would be eliminated as a result of the cash payment in lieu of any issuance of fractional shares or interests in connection with the Reverse Stock Split. The exact number by which the number of holders of the common
stock would be reduced will depend on the number of stockholders that hold less than 15 shares as of the effective date of the Reverse Stock Split. As of the Record Date, there were 38 holders of record of the common stock, none of which was a
holder of fewer than 15 shares of common stock. As a result of the Reverse Stock Split, assuming a Reverse Stock Split ratio of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-15,</FONT></FONT> we estimate that cashing out
fractional stockholders would not reduce the number of stockholders of record. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we do not intend for this transaction to be the first
step in a series of plans or proposals of a &#147;going private transaction&#148; within the meaning of Rule <FONT STYLE="white-space:nowrap">13e-3</FONT> of the Exchange Act. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Record and Beneficial Stockholders </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If this Proposal 3 is
approved by our stockholders and our Board elects to implement a Reverse Stock Split, stockholders of record holding all of their shares of our common stock electronically in book-entry form under the direct registration system for securities will
be automatically exchanged by the exchange agent and will receive a transaction statement at their address of record indicating the number of new post-split shares of our common stock they hold after the Reverse Stock Split along with payment in
lieu of any fractional shares. <FONT STYLE="white-space:nowrap">Non-registered</FONT> stockholders holding common stock through a bank, broker or other nominee should note that such banks, brokers or other nominees may have different procedures for
processing the Reverse Stock Split and making payment for fractional shares than those that would be put in place by us for registered stockholders. If you hold your shares with such a bank, broker or other nominee and if you have questions in this
regard, you are encouraged to contact your nominee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If this Proposal 3 is approved by our stockholders and our Board elects to implement a Reverse Stock
Split, stockholders of record holding some or all of their shares in certificate form will receive a letter of transmittal </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
from us or our exchange agent, as soon as practicable after the effective date of the Reverse Stock Split. Our transfer agent is expected to act as &#147;exchange agent&#148; for the purpose of
implementing the exchange of stock certificates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Accounting Consequences </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The par value per share of our common stock would remain unchanged at $0.0001 per share after any Reverse Stock Split. As a result, on the Effective Time, the
stated capital on our balance sheet attributable to the common stock would be reduced proportionally, based on the actual Reverse Stock Split ratio, from its present amount, and the additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital
account would be credited with the amount by which the stated capital would be reduced. The net income or loss per share of common stock would be increased because there would be fewer shares of common stock outstanding. The Reverse Stock Split
would be reflected retrospectively in our financial statements. We do not anticipate that any other accounting consequences would arise as a result of any Reverse Stock Split. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Appraisal Rights </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our stockholders are not entitled to
dissenters&#146; or appraisal rights under the General Corporation Law of the State of Delaware with respect to the proposed alternate amendments to our certificate of incorporation to allow for a Reverse Stock Split. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Material U.S. Federal Income Tax Consequences </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
following is a summary of the material U.S. federal income tax consequences of a Reverse Stock Split that are generally expected to be applicable to U.S. Holders (as defined below) who hold their common stock as capital assets within the meaning of
Section&nbsp;1221 of Internal Revenue Code of 1986, as amended (the &#147;Code&#148;) (generally property held for investment). This summary is based on provisions of the Code, applicable Treasury Regulations promulgated thereunder, judicial
authority and current administrative rulings and practices as in effect on the date of this proxy statement. Changes to these laws could alter the tax consequences described below, possibly with retroactive effect, which may result in the U.S.
federal income tax consequences of the Reverse Stock Split differing substantially from the consequences summarized below. We have not sought and will not seek an opinion of counsel or a ruling from the Internal Revenue Service regarding the federal
income tax consequences of a Reverse Stock Split. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This discussion is for general information only and does not purport to consider all aspects of U.S.
federal income taxation that might be relevant to a U.S. Holder. This discussion does not address the tax consequences which may apply to stockholders subject to special rules, such as financial institutions, insurance companies, <FONT
STYLE="white-space:nowrap">tax-exempt</FONT> organizations, dealers in securities, real estate investment trusts, regulated investment companies, stockholders who hold their <FONT STYLE="white-space:nowrap">pre-reverse</FONT> split shares through
individual retirement or other <FONT STYLE="white-space:nowrap">tax-deferred</FONT> accounts, stockholders who are not U.S. Holders, stockholders who have a functional currency other than the U.S. dollar, partnerships or other entities classified as
partnerships or disregarded entities for U.S. federal income tax purposes (or persons holding our common stock through such entities), stockholders who hold the <FONT STYLE="white-space:nowrap">pre-reverse</FONT> split shares as part of a straddle,
hedge, or conversion transaction, stockholders who hold the <FONT STYLE="white-space:nowrap">pre-reverse</FONT> split shares as qualified small business stock within the meaning of Section&nbsp;1202 of the Code or Section&nbsp;1244 stock for
purposes of Section&nbsp;1244 of the Code, stockholders who acquired their stock in a transaction subject to the gain rollover provisions of Section&nbsp;1045 of the Code, or stockholders who acquired their
<FONT STYLE="white-space:nowrap">pre-reverse</FONT> split shares pursuant to the exercise of employee stock options or otherwise as compensation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
addition, this summary does not address: (a)&nbsp;the tax consequences of transactions effectuated before, after or at the same time as the Reverse Stock Split, whether or not they are in connection with the Reverse Stock Split; (b)&nbsp;any U.S.
federal <FONT STYLE="white-space:nowrap">non-income</FONT> tax consequences of the Reverse Stock Split, including estate, gift or other tax consequences; (c)&nbsp;any state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax consequences
of the Reverse Stock Split; (d)&nbsp;the alternative </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
minimum tax, the Medicare contribution tax on net investment income, or special tax accounting rules under Section 451(b) of the Code, or (e)&nbsp;tax consequences to holders of options, warrants
or similar rights to acquire our common stock. Stockholders are urged to consult their own tax advisors to determine the particular consequences to them. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this discussion, a &#147;U.S. Holder&#148; means a beneficial owner of shares of our common stock that is any of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an individual who is a citizen or resident of the United States or treated as a U.S. citizen or resident for U.S.
federal income tax purposes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created or
organized in or under the laws of the United States, any state thereof, or the District of Columbia; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an estate, the income of which is subject to U.S. federal income taxation regardless of its source; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust if (i)&nbsp;a U.S. court can exercise primary supervision over the trust&#146;s administration and one or
more &#147;United States persons&#148; (within the meaning of Section&nbsp;7701(a)(30) of the Code) are authorized or have the authority to control all substantial decisions of the trust or (ii)&nbsp;it has a valid election in effect under
applicable U.S. Treasury Regulations to be treated as a United States person for U.S. federal income tax purposes.</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Reverse Stock
Split should constitute a &#147;recapitalization&#148; for U.S. federal income tax purposes. In general, the federal income tax consequences of a Reverse Stock Split will vary depending upon whether a U.S. Holder receives cash for fractional shares
or solely a reduced number of shares of common stock in exchange for their old shares of common stock. A U.S. Holder who receives solely a reduced number of shares of common stock should generally not recognize gain or loss in the Reverse Stock
Split. Such U.S. Holder&#146;s aggregate tax basis in the reduced number of shares of common stock should equal the U.S. Holder&#146;s aggregate tax basis in its old shares of common stock and such U.S. Holder&#146;s holding period in the reduced
number of shares of common stock will include the holding period in its old shares of common stock exchanged. Treasury Regulations provide detailed rules for allocating the tax basis and holding period of the shares of common stock surrendered to
the shares of common stock received in a recapitalization pursuant to the Reverse Stock Split. U.S. Holders should consult their tax advisors as to application of the foregoing rules where shares of common stock were acquired at different times or
at different prices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A U.S. Holder who receives cash in lieu of a fractional share as a result of the Reverse Stock Split should generally recognize gain
or loss equal to the difference, if any, between the amount of cash received and the portion of the U.S. Holder&#146;s basis in the common stock surrendered that is allocated to the fractional share. Such gain or loss will be a capital gain or loss
and will be long-term capital gain or loss if the U.S. Holder&#146;s holding period for such shares was more than one year at the time of the Reverse Stock Split. Long-term capital gains of <FONT STYLE="white-space:nowrap">non-corporate</FONT> U.S.
Holders are generally subject to preferential tax rates. There are limitations on the deductibility of capital losses under the Code. Such U.S. Holder&#146;s aggregate tax basis in the reduced number of shares of common stock should equal the U.S.
Holder&#146;s aggregate tax basis in its old shares of common stock decreased by the basis allocated to the fractional share for which such U.S. Holder is entitled to receive cash, and the holding period of the reduced number of shares received will
include the holding period of the old shares exchanged. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholders may be subject to information reporting with respect to any cash received in
exchange for a fractional share interest in a new share in the Reverse Stock Split. Stockholders who are subject to information reporting and who do not provide a correct taxpayer identification number and other required information (such as by
submitting a properly completed IRS Form <FONT STYLE="white-space:nowrap">W-9)</FONT> may also be subject to backup withholding, at the applicable rate. Any amount withheld under such rules is not an additional tax and may be refunded or credited
against the stockholder&#146;s U.S. federal income tax liability, provided that the required information is properly furnished in a timely manner to the IRS. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The preceding discussion is intended only as a summary of certain material U.S. federal income tax
consequences of the Reverse Stock Split. It is not a complete analysis or discussion of all potential tax effects that may be important to a particular holder. All holders of our common stock should consult their own tax advisors as to the specific
tax consequences of the Reverse Stock Split to them, including record retention and <FONT STYLE="white-space:nowrap">tax-reporting</FONT> requirements, and the applicability and effect of any federal, state, local and
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax laws. </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Recommendation </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD UNANIMOUSLY RECOMMENDS A VOTE FOR APPROVAL OF A SERIES OF ALTERNATE AMENDMENTS TO OUR AMENDED AND RESTATED CERTIFICATE OF
INCORPORATION TO EFFECT A REVERSE STOCK SPLIT OF OUR COMMON STOCK </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(PROPOSAL 3 ON YOUR NOTICE OF INTERNET AVAILABILITY) </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc888198_7"></A>EXECUTIVE OFFICERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding our executive officers as of March&nbsp;14, 2025: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="68%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Position(s)</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William Ho</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President, Chief Executive Officer, Director and
<FONT STYLE="white-space:nowrap">Co-Founder</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lawrence Lamb, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Executive Vice President, Chief Scientific Officer, and
<FONT STYLE="white-space:nowrap">Co-Founder</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Patrick McCall</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Financial Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kate Rochlin, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Operating Officer</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Biographical information for Mr.&nbsp;Ho is included above with the director biographies under the caption &#147;Information
Regarding Director Nominees and Continuing Directors.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Lawrence Lamb</I></B>, Ph.D., is our <FONT STYLE="white-space:nowrap">co-founder</FONT>
and has served as our Executive Vice President and Chief Scientific Officer since November 2018 and as the Chair of our Scientific Advisory Board since December 2017. From April 2004 to December 2018, Dr.&nbsp;Lamb was a Professor of Medicine at the
University of Alabama at Birmingham (&#147;<B><I>UAB</I></B>&#148;) specializing in transplantation immunology and also served as the Director of the UAB Cell Therapy Laboratory in the Bone Marrow Transplant and Cellular Therapy department. Prior to
that, from 1995 to 2004, he served as faculty (Assistant and Associate Professor) at the University of South Carolina School of Medicine. Dr.&nbsp;Lamb received two postdoctoral fellowships, one from University of South Carolina-Columbia and another
from South Carolina Cancer Center. He also received a Ph.D. and an M.S. from University of South Carolina-Columbia and a B.S. from Medical College of Georgia. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Patrick McCall</I></B> has served as our Chief Financial Officer since February 2021. Prior to joining us, Mr.&nbsp;McCall was Vice President of Finance
at Turnstone Biologics Corp., a public clinical-stage biotechnology company, focused on cancer immunotherapies. There he assisted in raising several rounds of financing, a large collaboration with a global pharmaceutical company, an acquisition in
the immunotherapy space and led the build out of the company&#146;s finance and accounting functions. Prior to that Mr.&nbsp;McCall was the Corporate Controller at Catalyst Biosciences, a publicly traded, clinical stage biopharmaceutical company
focused on developing hemophilia treatments. While at Catalyst Biosciences, Mr.&nbsp;McCall was part of the team that successfully completed the company&#146;s initial public offering and he was responsible for leading the firm&#146;s SEC reporting,
accounting, financial planning&nbsp;&amp; analysis and procurement functions. Previously, he spent 11 years in a variety of finance, accounting, and operational roles at companies such as Apple, Chubb and the accounting firm Deloitte.
Mr.&nbsp;McCall is an active Certified Public Accountant and holds an MBA from Cornell University and a B.S. in Accounting from Drexel University. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Kate Rochlin</I></B>, PhD., has served as our Chief Operating Officer since December 2021. She previously served as our Vice President of Operations and
Innovation from December 2020 until December 2021 and as our Associate Vice President of Operations and Innovation from August 2020 until December 2020. Since February 2013, Dr.&nbsp;Rochlin has served as a Project Principle and since October 2019
on the board of directors of the Solution Lab, Inc., a nonprofit organization that provides Ph.D. and MBA students real-world consulting experiences. From March 2020 until August 2020, Dr.&nbsp;Rochlin served as the Chief Business Officer of
Curadigm SAS, a private nanotechnology company. Previously, she served as Curadigm&#146;s Director of Business Development from March 2019 to August 2020. Prior to that, Dr.&nbsp;Rochlin Served as Director of Scientific Affairs for Filament
BioSolutions Inc., a private biotechnology company, from March 2016 until April 2019. From September 2012 to January 2017, she was a <FONT STYLE="white-space:nowrap">Co-founder</FONT> and the Chief Scientific Officer of Immunovent, LLC, a
biotechnology company focused on commercialization of technologies for diagnosing allergies, and then served as a Scientific and Business Advisor to Immunovent, LLC from January 2017 until March 2019. Dr.&nbsp;Rochlin received a Ph.D. in Cell and
Developmental Biology from Weill Cornell University and a B.A. with double majors in Molecular Biology and History and Sociology of Science (HSSC) from the University of Pennsylvania. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc888198_8"></A>EXECUTIVE OFFICER AND DIRECTOR COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Officer Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Summary
Compensation Table </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information for each of the last two completed fiscal years regarding compensation awarded to or
earned by our Chief Executive Officer and the two other most highly compensated executive officers, or collectively, the named executive officers, during the fiscal years indicated: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="55%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name and Principal Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary<BR>($)<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option</B><br><B>Awards<BR>($)<SUP STYLE="font-size:75%; vertical-align:top">(2)(3)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-Equity</FONT></B><br><B>Incentive
Plan</B><br><B>Compensation<BR>($)<SUP STYLE="font-size:75%; vertical-align:top">(4)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other</B><br><B>Compensation</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William Ho</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">552,840</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">888,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,453,512</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>President and Chief Executive Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">572,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">984,166</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">286,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,854,166</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kate Rochlin, Ph.D.<SUP STYLE="font-size:75%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">457,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">329,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">790,083</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Chief Operating Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Patrick McCall</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">438,317</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">330,060</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">780,377</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Chief Financial Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">412,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">323,571</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">167,272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">914,843</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Salary amounts represent actual amounts earned during the applicable year. See &#147;&#151;Narrative to the
Summary Compensation Table&#151;Annual Base Salary&#148; below. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Amounts represent the aggregate grant date fair value of the option awards granted to our named executive
officers during the years indicated as computed in accordance with Accounting Standards Codification Topic 718 (&#147;ASC 718&#148;). See Note 2 to Consolidated Financial Statements in our Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for a discussion of assumptions made by us in determining the aggregate grant date fair value of our option awards. Note that the amounts reported in this column reflect the accounting cost for these
stock options and do not reflect the actual economic value that may be realized by the named executive officers. For additional information on these awards, please see &#147;&#151;Outstanding Equity Awards at Fiscal
<FONT STYLE="white-space:nowrap">Year-End.&#148;</FONT> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">See &#147;&#151;Narrative Disclosure to Summary Compensation Table&#151;Equity-Based Incentive Awards&#148;
below for a description of the material terms of the program pursuant to which this compensation was awarded. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">The amounts reported in this column represent annual performance-based bonuses earned based on the achievement
of company and individual performance goals and other factors deemed relevant by our Board and Compensation Committee. For additional information, see &#147;&#151;Narrative Disclosure to Summary Compensation Table &#150; <FONT
STYLE="white-space:nowrap">Non-Equity</FONT> Incentive Plan Compensation.&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Amount represents (i) $3,000 of employer matching contribution under the 401(k) plan and (ii) $9,000 of medical
waiver contributions. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Dr.&nbsp;Rochlin was not an NEO for the fiscal year 2023, and as such, we have provided information solely with
respect to fiscal year 2024. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Amount represents employer matching contribution under the 401(k) plan. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Narrative to the Summary Compensation Table </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Annual Base Salary </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our named executive officers receive a
base salary to compensate them for services rendered to us. The base salary payable to each named executive officer is intended to provide a fixed component of compensation reflecting the executive&#146;s skillset, experience, role and
responsibilities. None of our named executive officers is currently party to an employment agreement or other agreement or arrangement that provides for automatic or scheduled increases in base salary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;4, 2024, we announced that, to reduce costs while continuing to pursue our revised strategic plan, the Board approved, and management
implemented, a workforce reduction (the &#147;<B><I>Workforce</I></B> <B><I>Reduction</I></B>&#148;). In connection with the Workforce Reduction, the executive management team and the Board agreed to an 11% reduction in their cash compensation,
effective as of September&nbsp;1, 2024 (&#147;<B><I>2024 Salary Reductions</I></B>&#148;). Mr.&nbsp;Ho, Dr.&nbsp;Rochlin and Mr.&nbsp;McCall&#146;s annual base salaries were reduced from $612,000, $475,000 and $455,000 to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
$544,680, $404,950 and $422,750, respectively. In addition, Mr.&nbsp;Ho&#146;s annual base salary was further reduced from $544,680 to $397,800 in connection with the 2024 Private Placement,
which reduction will remain in effect until December&nbsp;31, 2025. Dr.&nbsp;Rochlin and Mr.&nbsp;McCall&#146;s salary reductions are expected to be effective until December&nbsp;31, 2025, unless otherwise determined by the Board or a committee of
the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See &#147;&#151;Employment Arrangements&#148; for additional information. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Equity-Based Incentive Awards </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I><U>Annual Awards</U> </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our equity
award program is the primary vehicle for offering long-term incentives to our executives. We believe that equity awards provide our executives with a strong link to our long-term performance, create an ownership culture and help to align the
interests of our executives and our stockholders. We have historically used stock option grants for this purpose because we believe they are an effective means by which to align the long-term interests of our executive officers with those of our
stockholders. The use of options also can provide tax and other advantages to our executive officers relative to other forms of equity compensation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We
award equity grants broadly to our employees, including to our <FONT STYLE="white-space:nowrap">non-executive</FONT> employees. Grants to our executives and other employees are made at the discretion of the Board and are generally made upon
commencement of employment, promotion or annually during the first quarter of each year. We believe that our equity awards are an important retention tool for our executive officers, as well as for our other employees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with our annual grant process, in February 2024, the Board granted each of Mr.&nbsp;Ho, Dr.&nbsp;Rochlin and Mr.&nbsp;McCall a stock option to
purchase 502,000 shares, 186,000 shares and 189,000 shares of our common stock, respectively, at an exercise price of $1.22 per share under the Amended and Restated 2023 Equity Incentive Plan (&#147;<B><I>2023 Plan</I></B>&#148;). Each option award
vests <FONT STYLE="white-space:nowrap">one-fourth</FONT> (1/4<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) on the first anniversary of the grant date with the remainder of the award vesting in 36 equal monthly installments thereafter,
subject to the executive&#146;s continuous service with us through each vesting date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I><U>Retention and Other Awards</U>
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In September 2024, to enhance motivation and address retention concerns as a result of a Workforce Reduction implemented to reduce costs while
continuing to pursue the Company&#146;s revised strategic plan, the Compensation Committee granted retention awards to our employees, including our named executive officers, in the form of stock option awards (the &#147;<B><I>Retention
Awards</I></B>&#148;). Each of Mr.&nbsp;Ho, Dr.&nbsp;Rochlin and Mr.&nbsp;McCall received a stock option to purchase 500,000 shares, 250,000 shares and 250,000 shares of our common stock, respectively, at an exercise price of $0.47 per share under
the 2023 Plan. Each option award vests <FONT STYLE="white-space:nowrap">one-fourth</FONT> (1/4<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) on the <FONT STYLE="white-space:nowrap">six-month</FONT> anniversary of the grant date, <FONT
STYLE="white-space:nowrap">one-fourth</FONT> (1/4<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) on the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the grant date, and the remaining
<FONT STYLE="white-space:nowrap">one-half</FONT> (1/2) on the eighteen-month anniversary of the grant date, subject to the executive&#146;s continuous service with us through each vesting date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2024, our Board considered the recent salary reductions and determined it would be in the best interest of the Company and our stockholders to
grant each of Mr.&nbsp;Ho, Dr.&nbsp;Rochlin and Mr.&nbsp;McCall a stock option award. Each of Mr.&nbsp;Ho, Dr.&nbsp;Rochlin and Mr.&nbsp;McCall received an option to purchase 1,188,282 shares, 302,839&nbsp;shares and 290,085 shares of our common
stock, respectively, at an exercise price of $0.24 per share under the 2023 Plan. Each option award vests on the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the grant date, subject to the executive&#146;s continuous service with
us through each vesting date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Annual Performance-Based Bonus </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We develop a performance-based bonus program annually. Under the annual performance bonus program, each named executive officer was eligible to be considered
for an annual performance bonus based on (1)&nbsp;the individual&#146;s target bonus, as a percentage of base salary, (2)&nbsp;the percentage attainment of our corporate goals established by our Board in its sole discretion and communicated to each
officer, and (3)&nbsp;the percentage </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
attainment of individual performance goals established by the Board in its sole discretion and communicated to each officer. Mr.&nbsp;Ho&#146;s bonus is based 100% on corporate performance, and
each of Dr.&nbsp;Rochlin&#146;s and Mr.&nbsp;McCall&#146;s bonus is based 90% on corporate performance and 10% on individual performance. For 2024, as part of our cost-saving measures, the named executive officers agreed to forego their annual
performance-based bonuses as reflected in the column of the Summary Compensation Table above entitled <FONT STYLE="white-space:nowrap">&#147;Non-Equity</FONT> Incentive Plan Compensation.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Outstanding Equity Awards at Fiscal <FONT STYLE="white-space:nowrap">Year-End</FONT></I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides information regarding equity awards held by the named executive officers that were outstanding as of December&nbsp;31, 2024. Prior
to the 2020 Equity Incentive Plan (the &#147;2020 Plan&#148;) becoming effective on July&nbsp;29, 2021, all equity awards were granted pursuant to our 2018 Equity Incentive Plan. The 2023 Plan succeeds the 2020 Plan and was approved at the 2023
Annual Meeting. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Securities</B><br><B>Underlying</B><br><B>Unexercised</B><br><B>Options</B><br><B>(#)</B><br><B>Exercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Securities</B><br><B>Underlying</B><br><B>Unexercised</B><br><B>Options</B><br><B>(#)</B><br><B>Unexercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option</B><br><B>Exercise</B><br><B>Price</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option</B><br><B>Expiration</B><br><B>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William Ho</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10/5/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">182,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10/4/2030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7/29/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">188,343</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32,157</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">07/28/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/15/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">180,270</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74,230</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/14/2032</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10/21/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55,510</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27,755</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10/21/2032</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4/14/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">164,145</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">229,805</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4/14/2033</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6/21/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">147,730</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">246,220</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6/21/2033</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/7/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">502,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/7/2034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9/4/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9/4/2034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12/19/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,188,282</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12/19/2034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kate Rochlin, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10/5/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46,984</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10/5/2030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/1/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39,882</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,734</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/1/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7/29/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29,895</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,105</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7/29/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/15/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/15/2032</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10/21/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40,370</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,185</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10/21/2032</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4/14/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">116,667</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4/14/2033</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6/21/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,375</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6/21/2033</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/7/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">186,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/7/2034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9/4/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9/4/2034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12/19/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">302,839</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12/19/2034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Patrick McCall</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/1/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">180,948</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,868</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1/31/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7/29/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34,166</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,834</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7/28/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/15/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59,854</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24,646</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/14/2032</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10/21/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39,864</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,932</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10/21/2032</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4/14/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">116,667</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4/14/2033</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6/21/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32,680</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54,470</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6/21/2033</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/7/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">189,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/7/2034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9/4/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9/4/2034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12/19/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">290,085</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12/19/2034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">The shares underlying this option vest in 48 equal monthly installments commencing on August&nbsp;29, 2021,
subject to the executive officer&#146;s continuous service. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Of the shares underlying this option, 25% vested on the first anniversary of the Grant Date and the remaining
shares vest in 36 equal monthly installments thereafter, subject to the executive officer&#146;s continuous service. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">The shares underlying this option vest in three equal annual installments commencing on October&nbsp;21, 2023,
subject to the executive officer&#146;s continuous service. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Of the shares underlying this option, 25% vest on the six month anniversary of the grant date, 25% vest on the
one year anniversary of the grant date, and the remaining 50% vest on the 18 month anniversary of the grant date, subject to the executive&#146;s continuous service. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">The shares underlying this option vest on the one year anniversary of the grant date, subject to the
executive&#146;s continuous service. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employment Arrangements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Below are descriptions of our employment agreements and arrangements with our named executive officers. The agreements generally provide for <FONT
STYLE="white-space:nowrap">at-will</FONT> employment without any specific term and set forth the named executive officer&#146;s initial base salary and annual target bonus. Each named executive officer is also eligible to participate in all employee
benefit plans that are generally available to our employees. Furthermore, each of our named executive officers has executed our standard employee confidential information and invention assignment agreement, which includes, among other things, <FONT
STYLE="white-space:nowrap">non-solicitation</FONT> and <FONT STYLE="white-space:nowrap">non-competition</FONT> provisions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>William Ho </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2020, we entered into an amended and restated employment agreement with William Ho, our President and Chief Executive Officer, which we further
amended in August 2024 to provide for, among other things, a reduced salary to $544,680 per annum, effective September 1, 2024. In addition, as discussed above, Mr. Ho&#146;s annual base salary was further reduced from $544,680 to $397,800 in
connection with the 2024 Private Placement, and the reduction will remain in effect until December 31, 2025. Prior to such reductions, Mr.&nbsp;Ho&#146;s annual base salary was increased to $612,000 and his target annual performance achievement was
increased to 55% of his annual base salary, each of which were effective as of January 1, 2024. For 2025, Mr.&nbsp;Ho&#146;s current annual base salary is $397,800 and his target annual performance achievement is 55% of his annual base salary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we terminate Mr.&nbsp;Ho&#146;s employment with us without &#147;cause&#148; or he terminates his employment for &#147;good reason&#148; (each as defined
in his amended employment agreement), he will receive the following severance payments and benefits if he timely executes and does not revoke a release of claims in our favor and complies with certain restrictive covenants and continuing
obligations: (i)&nbsp;a lump sum severance payment equal to the greater of 18 months of his base salary prior to the 2024 Salary Reduction or 18 months of his then-current annual base salary and (ii)&nbsp;accelerated vesting of the then-unvested
portion of each of his outstanding time-based equity awards that would have become vested had he remained employed by us for an additional 18 months following his termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If Mr.&nbsp;Ho&#146;s employment is terminated without cause or he terminates his employment for good reason within three months prior to or 12 months after a
&#147;change in control,&#148; as defined in his employment agreement, he is instead entitled to (a)&nbsp;a lump sum severance payment equal to the greater of 18 months of his base salary prior to the 2024 Salary Reduction or 18 months of his
then-current annual base salary and 150% of his annual current target performance bonus in effect as of the change in control, (b)&nbsp;full accelerated vesting on all of his unvested equity awards and (c)&nbsp;payment on his behalf of up to 18
months of health insurance benefits continuation. If Mr.&nbsp;Ho&#146;s employment is terminated without cause or he terminates his employment for good reason between 12 months and 18 months after a &#147;change in control,&#148; as defined in his
employment agreement, he is instead entitled to (a)&nbsp;a lump sum severance payment equal to the greater of 18 months of his base salary prior to the 2024 Salary Reduction or 18 months of his then-current annual base salary, (b) 150% of his annual
current target performance bonus in effect as of the change in control and (c)&nbsp;payment on his behalf of up to 18 months of health insurance benefits continuation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Kate Rochlin, Ph.D. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March 2024, we entered
into an employment agreement with Kate Rochlin, our Chief Operating Officer, which we amended in August 2024 to provide for, among other things, a reduced salary to $422,750 per annum, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
effective September 1, 2024, pursuant to the 2024 Salary Reduction. Prior to such reduction, Dr.&nbsp;Rochlin&#146;s annual base salary was $475,000 and her target annual performance bonus was
40% of her annual base salary. For 2025, Dr.&nbsp;Rochlin&#146;s current annual base salary is $422,750 and her target annual performance achievement is 40% of her annual base salary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we terminate Dr.&nbsp;Rochlin&#146;s employment with us without &#147;cause&#148; or she terminates her employment for &#147;good reason&#148; (each as
defined in her employment agreement), she will receive: (i)&nbsp;a lump sum severance payment equal to the greater of 12 months of her base salary prior to the 2024 Salary Reduction or the sum of 12 months of her then-current annual base salary for
12 months; (ii)&nbsp;to the extent Dr.&nbsp;Rochlin achieved any of the performance goals for such calendar year, a prorated bonus, subject to her timely execution and <FONT STYLE="white-space:nowrap">non-revocation</FONT> of a release of claims in
our favor and compliance with certain restrictive covenants and continuing obligations; and (iii)&nbsp;payment on her behalf of up to 12 months of health insurance benefits continuation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If Dr.&nbsp;Rochlin&#146;s employment is terminated without cause or she terminates her employment for good reason within three months prior to or 12 months
after a &#147;change in control,&#148; as defined in her employment agreement, she is instead entitled to (a)&nbsp;a lump sum severance payment equal to the greater of 12 months of her base salary prior to the 2024 Salary Reduction or 12 months of
her then-current annual base salary (b) 100% of her annual current target performance bonus in effect as of the change in control, (c)&nbsp;full accelerated vesting on all of her unvested equity awards and (d)&nbsp;payment on her behalf of up to 12
months of health insurance benefits continuation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Patrick McCall </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In January 2021, we entered into an employment agreement with Patrick McCall, our Chief Financial Officer, which we amended in August 2024 to provide for,
among other things, a reduced salary to $404,950 per annum, effective September 1, 2024, pursuant to the 2024 Salary Reduction. Prior to such reduction, Mr.&nbsp;McCall&#146;s annual base salary was increased to $455,000 with a target annual
performance achievement of 40%, each of which were effective as of January 1, 2024. For 2025, Mr. McCall&#146;s current annual base salary is $404,950 and his target annual performance achievement is 40% of his annual base salary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we terminate Mr.&nbsp;McCall&#146;s employment with us without &#147;cause&#148; or he terminates his employment for &#147;good reason&#148; (each as
defined in his employment agreement), he will receive: (i)&nbsp;a lump sum severance payment equal to the greater of 12 months of his base salary prior to the 2024 Salary Reduction or 12 months of his then-current annual base salary; (ii)&nbsp;to
the extent Mr.&nbsp;McCall achieved any of the performance goals for such calendar year, a prorated bonus, subject to his timely execution and <FONT STYLE="white-space:nowrap">non-revocation</FONT> of a release of claims in our favor and compliance
with certain restrictive covenants and continuing obligations; and (iii)&nbsp;payment on his behalf of up to 12 months of health insurance benefits continuation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If Mr.&nbsp;McCall&#146;s employment is terminated without cause or he terminates his employment for good reason within three months prior to or 12 months
after a &#147;change in control,&#148; as defined in his employment agreement, he is instead entitled to (a)&nbsp;a lump sum severance payment equal to the greater of 12 months of his base salary prior to the 2024 Salary Reduction or 12 months of
his then-current annual base salary, (b) 100% of his annual current target performance bonus in effect as of the change in control, (c)&nbsp;full accelerated vesting on all of his unvested equity awards and (d)&nbsp;payment on his behalf of up to 12
months of health insurance benefits continuation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Potential Payments and Benefits Upon Termination or Change in Control </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The employment agreements for our named executive officers provide for severance and change in control benefits as described above under &#147;&#151;Employment
Arrangements.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Health and Welfare and Retirement Benefits; Perquisites </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All of our current named executive officers are eligible to participate in our employee benefit plans, including our medical, dental, vision, disability and
life insurance plans, in each case on the same basis as all of our other employees. We generally do not provide perquisites or personal benefits to our named executive officers, except in limited circumstances. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>401(k) Plan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our named executive officers are
eligible to participate in a defined contribution retirement plan that provides eligible U.S. employees with an opportunity to save for retirement on a tax advantaged basis. Eligible employees may defer eligible compensation on a <FONT
STYLE="white-space:nowrap">pre-tax</FONT> or <FONT STYLE="white-space:nowrap">after-tax</FONT> (Roth) basis, up to the statutorily prescribed annual limits on contributions under the Code. Contributions are allocated to each participant&#146;s
individual account and are then invested in selected investment alternatives according to the participants&#146; directions. We make matching contributions into the 401(k) plan on behalf of participants equal to 100% on participant contributions up
to $3,000 of their compensation. Participants are immediately and fully vested on all contributions. The 401(k) plan is intended to be qualified under Section&nbsp;401(a) of the Code with the 401(k) plan&#146;s related trust intended to be tax
exempt under Section&nbsp;501(a) of the Code. As a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> retirement plan, contributions to the 401(k) plan (except for Roth contributions) and earnings on those contributions are not taxable to the
employees until distributed from the 401(k) plan. Our Board may elect to adopt qualified or nonqualified benefit plans in the future, if it determines that doing so is in our best interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To further reduce costs while continuing to pursue our revised strategic plan, the Company temporarily paused its matching contributions for the 401(k) plan,
beginning January&nbsp;1, 2025. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Clawback Policy </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
October 2023, the Compensation Committee adopted our Incentive Compensation Recoupment Policy (the &#147;<B><I>Clawback Policy</I></B>&#148;), designed to comply with Rule <FONT STYLE="white-space:nowrap">10D-1</FONT> of the Exchange Act and Nasdaq
Listing Rule 5608, which provides for recoupment of incentive compensation in the event of an accounting restatement resulting from material noncompliance with financial reporting requirements under the relevant securities laws. The Clawback Policy
applies to our current and former executive officers. Compensation that is granted, earned or vested based wholly or in part upon attainment of a Financial Reporting Measure (as defined in the Clawback Policy) is subject to recoupment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Policies and Practices Related to the Grant of Certain Equity Awards Close in Time to the Release of Material Nonpublic Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From time to time, the Company grants stock options to its employees, including our named executive officers. Historically, the Company has granted <FONT
STYLE="white-space:nowrap">new-hire</FONT> option awards on or soon after a new hire&#146;s employment start date and annual refresh employee option grants in the first quarter of each fiscal year, which refresh grants are typically approved at the
regularly scheduled meeting of the Compensation Committee occurring in such quarter. Also, <FONT STYLE="white-space:nowrap">non-employee</FONT> directors receive automatic grants of initial and annual stock option awards, at the time of a
director&#146;s initial appointment or election to the board and at the time of each annual meeting of the Company&#146;s stockholders, respectively, pursuant to the <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation policy,
as further described under the heading, &#147;Director Compensation&#151;Cash and Equity Compensation&#148; below. The Company does not otherwise maintain any written policies on the timing of awards of stock options, stock appreciation rights, or
similar instruments with option-like features. The Compensation Committee considers whether there is any material nonpublic information (&#147;<B><I>MNPI</I></B>&#148;) about the Company when determining the timing of stock option grants and does
not seek to time the award of stock options in relation to the Company&#146;s public disclosure of MNPI. The Company has not timed the release of MNPI for the purpose of affecting the value of executive compensation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table is being provided pursuant to Item 402(x)(2) of Regulation <FONT
STYLE="white-space:nowrap">S-K:</FONT> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Name</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(a)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant&nbsp;date</B><br><B>(b)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of</B><br><B>securities<BR>underlying<BR>the&nbsp;award</B><br><B>(c)<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercise&nbsp;price&nbsp;of&nbsp;the<BR>award ($/Sh)</B><br><B>(d)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant&nbsp;date&nbsp;fair<BR>value of the<BR>award</B><br><B>(e)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage&nbsp;change&nbsp;in&nbsp;the&nbsp;closing<BR>market price of the securities<BR>underlying the award between<BR>the trading day
ending<BR>immediately prior to the<BR>disclosure of material nonpublic<BR>information and the trading day<BR>beginning&nbsp;immediately&nbsp;following<BR>the disclosure of material<BR>nonpublic information</B><br><B>(f)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William Ho</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9/4/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">193,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(48.4</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kate Rochlin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9/4/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">96,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(48.4</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Patrick McCall</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9/4/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">96,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(48.4</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Awards represent the Retention Awards granted in connection with the Workforce Reduction implemented on
September&nbsp;4, 2024. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash and Equity Compensation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our <FONT
STYLE="white-space:nowrap">non-employee</FONT> director compensation policy, as amended from time to time, is intended to provide a total compensation package that enables us to attract and retain qualified and experienced individuals to serve as
directors and to align our directors&#146; interests with those of our stockholders. Under this policy, we pay each of our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors a cash retainer for service on the Board and for service on
each committee on which the director is a member. The chairperson of each committee will receive a higher retainer for such service. These retainers are payable in arrears in four equal quarterly installments on the last day of each quarter,
provided that the amount of such payment will be prorated for any portion of such quarter that the director is not serving on our Board or the applicable committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the Workforce Reduction, the Board agreed to an 11% reduction in their cash compensation, effective as of September&nbsp;1, 2024. The
following table reflects the retainers to be paid to <FONT STYLE="white-space:nowrap">non-employee</FONT> directors for service on the Board and for service on each committee of the Board on which the director is a member, effective
September&nbsp;1, 2024: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:9pt; font-family:Times New Roman; "><B>Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Annual&nbsp;Service</B><br><B>Retainer</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Chairperson</B><br><B>Additional&nbsp;Retainer</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Board of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,850</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Science and Technology Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,675</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compensation Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nominating and Corporate Governance Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,560</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to September&nbsp;1, 2024, the retainers paid to <FONT STYLE="white-space:nowrap">non-employee</FONT>
directors for service on the Board and for service on each committee of the Board on which the director is a member were as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:9pt; font-family:Times New Roman; "><B>Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Annual&nbsp;Service</B><br><B>Retainer</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Chairperson</B><br><B>Additional&nbsp;Retainer</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Board of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Science and Technology Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compensation Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nominating and Corporate Governance Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Effective as of February&nbsp;5, 2024, the annual service retainer paid to each member of the Audit Committee
was increased from $7,500 to $10,000. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each <FONT STYLE="white-space:nowrap">non-employee</FONT> director elected to our Board was
entitled to receive an option to purchase 67,300 shares of our common stock (the &#147;<B><I>Initial Grant</I></B>&#148;). Further, on the date of each annual meeting of stockholders, each <FONT STYLE="white-space:nowrap">non-employee</FONT>
director that continued to serve as a <FONT STYLE="white-space:nowrap">non-employee</FONT> director received an option to purchase 33,650&nbsp;shares of our common stock (the &#147;<B><I>Annual Grant</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares subject to the Initial Grant will vest monthly over a three-year period, subject to the director&#146;s continued service as a director. The shares
subject to each Annual Grant will vest in equal monthly installments over the 12 months following the date of grant and, notwithstanding the foregoing, will be fully vested on the date of Company&#146;s next annual stockholder meeting, subject to
the director&#146;s continued service as a director. The exercise price per share of these options will equal the fair market value of our common stock on the date of grant. All options granted under this policy will vest in full upon the occurrence
of a change in control (as defined in the 2023 Plan) prior to the termination of the director&#146;s continuous service. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each <FONT
STYLE="white-space:nowrap">non-employee</FONT> director may elect to convert his or her cash compensation into an award of restricted stock units, which we refer to as the retainer grant. If a <FONT STYLE="white-space:nowrap">non-employee</FONT>
director timely makes this election, each such retainer grant will be automatically granted on the first business day following the date the corresponding cash compensation otherwise would be paid under the policy and will cover a number of shares
of our common stock equal to (A)&nbsp;the aggregate amount of the corresponding cash compensation otherwise payable to the <FONT STYLE="white-space:nowrap">non-employee</FONT> director divided by (B)&nbsp;the closing sales price per share of our
common stock on the date the corresponding cash compensation otherwise would be paid (or, if such date is not a business day, on the first&nbsp;business day thereafter), rounded down to the nearest whole share. In addition, each retainer grant will
be fully vested on the grant date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, any member of our Board that is entitled to the above compensation may elect to forego
all or a portion of such compensation from time to time by giving notice to the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Director Compensation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding the compensation earned for service on the Board by our
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors during the year ended December&nbsp;31, 2024. Mr.&nbsp;Ho is a member of our Board, but he did not receive any additional compensation for service as a director. Mr.&nbsp;Ho&#146;s
compensation as a named executive officer is set forth above under &#147;&#151;Summary Compensation Table.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees&nbsp;Earned&nbsp;or</B><br><B>Paid in Cash</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option</B><br><B>Awards<SUP STYLE="font-size:75%; vertical-align:top">(1)(2)</SUP></B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alan S. Roemer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">122,850</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">53,102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">175,952</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Peter Brandt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,205</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45,187</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">110,392</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corrine Epperly</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49,613</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">104,207</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Emily Fairbairn</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41,580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41,943</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83,523</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jeremy Graff</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62,843</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">107,705</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Luba Greenwood</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44,371</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">95,346</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Travis Whitfill<SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56,644</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43,954</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100,599</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">The amounts reported in this column reflect the aggregate grant date fair value of the stock and option awards
granted to our directors as computed in accordance with ASC Topic 718. Note that the amounts reported in this column reflect the accounting cost for these awards and do not reflect the actual economic value that may be realized by the directors.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">The following table provides information regarding the aggregate number of option awards granted to our <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors that were outstanding as of December&nbsp;31, 2024: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option</B><br><B>Awards</B><br><B>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alan S. Roemer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">548,029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Peter Brandt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">264,361</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corrine Epperly</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">138,605</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Emily Fairbairn</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">184,709</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jeremy Graff</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">193,347</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Luba Greenwood</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">192,599</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Travis Whitfill</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">198,101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Mr. Whitfill has resigned from the Board and all committees effective as of May 9, 2025. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc888198_9"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information known to us regarding the beneficial ownership of shares of our common stock as of February&nbsp;16, 2025,
by: (i)&nbsp;each of our named executive officers; (ii)&nbsp;each of our directors; (iii)&nbsp;all of our executive officers and directors as a group; and (iv)&nbsp;each person, or group of affiliated persons, known by us to beneficially own more
than 5% of any class of our voting securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Information with respect to beneficial ownership is based on information furnished to us by each director
or executive officer. Information about our 5% or greater stockholders, other than percentages of beneficial ownership, is based solely on Schedules 13G or 13D filed with the SEC. Beneficial ownership is determined according to the rules of the SEC
and generally means that a person has beneficial ownership of a security if he or she possesses sole or shared voting or investment power of that security and includes options and warrants that are currently exercisable within 60 days of
February&nbsp;16, 2025. Options to purchase shares of our common stock that are exercisable within 60 days of February&nbsp;16, 2025, are deemed to be beneficially owned by the persons holding these options for the purpose of computing percentage
ownership of that person but are not treated as outstanding for the purpose of computing any other person&#146;s ownership percentage. Except as indicated in the footnotes below, each of the beneficial owners named in the table below has, to our
knowledge, sole voting and investment power with respect to all shares of common stock listed as beneficially owned by him or her, except for shares owned jointly with that person&#146;s spouse. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have based our calculation of beneficial ownership on 81,258,763 shares of our common stock outstanding as of February&nbsp;16, 2025. Unless otherwise
indicated, the address for each of the stockholders in the table below is c/o IN8bio, Inc., 350 5th Avenue, Suite 5330, New York, New York 10118. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address of Beneficial Owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of</B><br><B>Shares</B><br><B>Beneficially</B><br><B>Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent&nbsp;of</B><br><B>Shares</B><br><B>Beneficially</B><br><B>Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B></B><B><I>5% and Greater Stockholders:</I></B><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Bios Equity Partners,
LP<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,600,001</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with AIGH Capital Management,
LLC<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,188,932</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alyeska Master Fund, L.P.<SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,457,291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Franklin
Biotechnology<SUP STYLE="font-size:75%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,696,202</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B></B><B><I>Directors and Named Executive Officers:</I></B><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William Ho<SUP STYLE="font-size:75%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,159,537</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Patrick McCall<SUP STYLE="font-size:75%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">731,392</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kate Rochlin<SUP STYLE="font-size:75%; vertical-align:top">(7)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">600,611</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Peter Brandt<SUP STYLE="font-size:75%; vertical-align:top">(8)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,254,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corrine Epperly<SUP STYLE="font-size:75%; vertical-align:top">(9)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">312,502</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Emily Fairbairn<SUP STYLE="font-size:75%; vertical-align:top">(10)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,254,192</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jeremy Graff<SUP STYLE="font-size:75%; vertical-align:top">(11)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">146,047</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Luba Greenwood<SUP STYLE="font-size:75%; vertical-align:top">(12)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">160,538</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alan S. Roemer<SUP STYLE="font-size:75%; vertical-align:top">(13)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,086,154</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Travis Whitfill<SUP STYLE="font-size:75%; vertical-align:top">(14)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61,984</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current directors and executive officers as a group (11 people)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,672,985</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Represents beneficial ownership of less than 1%. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Consists of (a) 251,211 shares of common stock held by Bios Fund II NT, LP (&#147;<B><I>Bios</I></B> <B><I>Fund
II NT</I></B>&#148;), (b) 1,876,624 shares of common stock held by Bios Fund II QP, LP (&#147;<B><I>Bios</I></B> <B><I>Fund II QP</I></B>&#148;), (c) 574,432 shares of common stock held by Bios Fund II, LP (&#147;<B><I>Bios Fund II</I></B>&#148;),
(d) 570,724 shares of common stock held by Bios Fund III, LP (&#147;<B><I>Bios</I></B> <B><I>Fund III</I></B>&#148;), (e)&nbsp;601,980 shares of common stock held by Bios Fund III NT, L.P. (&#147;<B><I>Bios</I></B> <B><I>Fund III NT</I></B>&#148;),
(f) 3,727,597 shares of common stock held by Bios Fund III QP, L.P. (&#147;<B><I>Bios</I></B> <B><I>Fund III QP</I></B>&#148;), (g) 997,433 shares of common stock held by Bios </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Incysus <FONT STYLE="white-space:nowrap">Co-Invest</FONT> I, LP (&#147;<B><I>Bios Incysus</I></B>&#148;) and (i) 93,441 shares underlying outstanding options that are immediately exercisable or
will be immediately exercisable within 60 days of February&nbsp;16, 2025 held by Travis Whitfill. Excludes a total of 3,140,803 shares issuable upon the exercise of the warrants held by Bios Clinical Opportunity Fund, LP (&#147;<B><I>Bios
COF</I></B> <B><I>Fund</I></B>&#148;), which warrants may not be exercised if immediately prior to or as a result of such exercise would result in beneficial ownership by a holder, together with that of its affiliates and any member of a
Section&nbsp;13(d) group, of more than 9.99%. The holders of the warrants may increase or decrease such beneficial ownership limitation percentage not in excess of 19.99% by providing us with at least 61 days&#146; prior notice of any increase. Bios
Equity Partners II, LP (&#147;<B><I>Bios</I></B> <B><I>Equity II</I></B>&#148;) is the general partner of Bios Fund II NT, Bios Fund II QP, Bios Fund II and Bios Incysus. Bios Equity Partners III, LP (&#147;<B><I>Bios</I></B> <B><I>Equity
III</I></B>&#148;) is the general partner of Fund III NT, Fund III QP and Fund III. Cavu Management, LP and Bios Capital Management, LP (&#147;<B><I>Bios Management</I></B>&#148;) are the general partners of Bios Equity I, Bios Equity II and Bios
Equity III. Cavu Advisors, LLC (&#147;<B><I>Cavu Advisors</I></B>&#148;) is the general partner of Cavu Management LP. Bios Management is the general partner Bios Equity COF, LP (&#147;<B><I>Bios Equity COF</I></B>&#148;), and Bios Equity COF is the
general partner of Bios COF Fund. Bios Advisors GP, LLC (&#147;<B><I>Bios Advisors</I></B>&#148;) is the general partner of Bios Capital Management, LP. Leslie Kreis, Jr. is the sole manager of Cavu Advisors, a
<FONT STYLE="white-space:nowrap">co-manager</FONT> of each of Bios Fund II, Bios Fund II QP, Bios Fund II NT, Bios Fund III, Bios Fund III QP, Bios Fund III NT and Bios Directors. Aaron Fletcher is the sole manager of Bios Advisors and Bios COF Fund
and a <FONT STYLE="white-space:nowrap">co-manager</FONT> of each of Bios Fund II, Bios Fund II QP, Bios Fund II NT, Bios Fund III, Bios Fund III QP, Bios Fund III NT and Bios Directors. Mr.&nbsp;Kreis and Dr.&nbsp;Fletcher have shared voting and
investment power over the shares described in this footnote 1. Mr.&nbsp;Whitfill, a director of the Company, was a partner at Bios Equity Partners, LP (&#147;<B><I>Bios</I></B> <B><I>Equity I</I></B>&#148;) through June&nbsp;30, 2023 but does not
have voting or investment power over the shares described in this footnote. Pursuant to an agreement with BP Directors, LP (&#147;<B><I>Bios Directors</I></B>&#148;), Mr.&nbsp;Whitfill has agreed that he will hold certain equity-based awards granted
to him on or prior to June&nbsp;30, 2023 in connection with his services as a director as a nominee for Bios Directors. Bios Equity I is the general partner of Bios Directors. The principal business address of these entities and persons is 1751
River Run, Suite 400, Fort Worth, Texas 76107. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Consists of (a) 6,737,932 shares and (b) 1,451,000 shares issuable upon exercise of warrants within 60 days of
February&nbsp;16, 2025. Excludes a total of 11,809,016 shares issuable upon the exercise of the warrants, which warrants may not be exercised if immediately prior to or as a result of such exercise would result in beneficial ownership by a holder,
together with that of its affiliates and any member of a Section&nbsp;13(d) group, of more than 9.99%. The holders of the warrants may increase or decrease such beneficial ownership limitation percentage not in excess of 19.99% by providing us with
at least 61 days&#146; prior notice of any increase. AIGH Capital Management, LLC (&#147;<B><I>AIGH Management</I></B>&#148;) is as an advisor or <FONT STYLE="white-space:nowrap">sub-advisor</FONT> with respect to the shares held by AIGH Investment
Partners, LP and WVP Emerging Manager Onshore Fund, LLC &#150; AIGH Series. Orin Hirschman is the Managing Member of AIGH Management and president of AIGH LLC. The principal office and business address of these entities and persons is 6006 Berkeley
Avenue, Baltimore, MD 21209. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Consists of (a) 5,063,291 shares and (b) 3,394,000 shares issuable upon exercise of warrants within 60 days of
February&nbsp;16, 2025. Excludes a total of 6,702,635 shares issuable upon the exercise of the warrants, which warrants may not be exercised if immediately prior to or as a result of such exercise would result in beneficial ownership by a holder,
together with that of its affiliates and any member of a Section&nbsp;13(d) group, of more than 9.99%. The holders of the warrants may increase or decrease such beneficial ownership limitation percentage not in excess of 19.99% by providing us with
at least 61 days&#146; prior notice of any increase. Alyeska Fund GP, LLC, is the General Partner and control person of Alyeska Master Fund, L.P. Jason Bragg is the Chief Financial Officer of Alyeska Fund GP, LLC. The address of this entity is 77 W.
Wacker St., Suite 700, Chicago, IL 60601. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Consists of (a) 3,606,002 shares held by Franklin Templeton Investment Funds &#150; Franklin Biotechnology
Discovery Fund (&#147;<B><I>FTIF</I></B>&#148;) and (b) 2,090,200 shares held by Franklin Strategic Series &#150; Franklin Biotechnology Discovery Fund (&#147;<B><I>FSS</I></B>&#148;). Excludes an aggregate of 3,322,519 shares issuable within 60
days of February&nbsp;16, 2025 upon exercise of warrants held by FTIF and FSS, which warrants may not be exercised if immediately prior to or as a result of such exercise would result in beneficial ownership by a holder, together with that of its
affiliates and any member of a Section&nbsp;13(d) group, of more than 4.99%. The holders of the warrants may increase or decrease such beneficial ownership limitation percentage not in excess of 19.99% by providing us with at least 61 days&#146;
prior notice of any increase. Evan McCulloch is the portfolio manager for both Franklin Strategic and Franklin Templeton. Mr.&nbsp;McCulloch may be deemed to have voting and investment power over the common stock held by Franklin Strategic and
Franklin Templeton. The address of FSS is c/o Franklin Advisers, Inc., One Franklin Parkway, San Mateo, CA 94403. The address of FTIF is 8A Rue Albert Borschette, 1246 Kirchberg, Luxembourg. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Consists of (a) 2,548,144 shares held directly by Mr.&nbsp;Ho, (b) 145,999 shares held by Mr.&nbsp;Ho&#146;s
children, (c)&nbsp;109,500&nbsp;shares held by other relatives of Mr.&nbsp;Ho over which Mr.&nbsp;Ho has voting power pursuant to a voting proxy and (c)&nbsp;1,355,894&nbsp;shares underlying outstanding options that are immediately exercisable or
will be immediately exercisable </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
within 60 days of February&nbsp;16, 2025. Excludes a total of 290,516 shares issuable upon the exercise of the warrants held directly by Mr.&nbsp;Ho, which warrants may not be exercised if
immediately prior to or as a result of such exercise would result in beneficial ownership by a holder, together with that of its affiliates and any member of a Section&nbsp;13(d) group, of more than 4.99%. The holders of the warrants may increase or
decrease such beneficial ownership limitation percentage not in excess of 19.99% by providing us with at least 61 days&#146; prior notice of any increase. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Consists of (a) 52,071 shares, (b) 66,300 shares underlying outstanding warrants that are immediately
exercisable and (c)&nbsp;613,021 shares underlying outstanding options that are immediately exercisable or will be immediately exercisable within 60 days of February&nbsp;16, 2025. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Consists of (a) 42,874 shares, (b) 49,906 shares underlying outstanding warrants that are immediately
exercisable and (c)&nbsp;507,831 shares underlying outstanding options that are immediately exercisable or will be immediately exercisable within 60 days of February&nbsp;16, 2025. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Consists of (a) 517,604 shares, (b) 105,290 shares held by The Peter C. Brandt
<FONT STYLE="white-space:nowrap">2020-4</FONT> GRAT (the &#147;<B><I>GRAT</I></B>&#148;), (c)&nbsp;417,098&nbsp;shares underlying outstanding warrants that are immediately exercisable, and (d) 214,871 shares underlying outstanding options that are
immediately exercisable or will be immediately exercisable within 60 days of February&nbsp;16, 2025. Mr.&nbsp;Brandt is the trustee of the GRAT and, as such, has voting and investment power over the shares held by the GRAT. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Consists of (a) 81,967 shares, (b) 163,934 shares underlying outstanding warrants that are immediately
exercisable, and (c) 66,601 shares underlying outstanding options that are immediately exercisable or will be immediately exercisable within 60 days of February&nbsp;16, 2025. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Consists of (a) 27,706 shares held by Ms.&nbsp;Fairbairn through an individual retirement account
(&#147;<B><I>Roth IRA</I></B>&#148;), (b)&nbsp;91,336&nbsp;shares held by Valley High Limited Partnership (&#147;<B><I>Valley High</I></B>&#148;), (c) 3,982,000 shares underlying outstanding warrants held by the Malcolm and Emily Charitable
Remainder Unitrust 2010 (the &#147;CRUT&#148;) that are immediately exercisable and (d) 153,150 shares underlying outstanding options that are immediately exercisable or will be immediately exercisable within 60 days of February&nbsp;16, 2025.
Excludes a total of 2,095,486 shares issuable upon the exercise of the warrants held directly by Mr.&nbsp;Ho, which warrants may not be exercised if immediately prior to or as a result of such exercise would result in beneficial ownership by a
holder, together with that of its affiliates and any member of a Section&nbsp;13(d) group, of more than 4.99%. The holders of the warrants may increase or decrease such beneficial ownership limitation percentage not in excess of 19.99% by providing
us with at least 61 days&#146; prior notice of any increase. Ms.&nbsp;Fairbairn exercises control over the Roth IRA and, as such, has voting and investment power over the shares held by the Roth IRA. Ms.&nbsp;Fairbairn&#146;s spouse is the sole
managing partner of Valley High and has voting and investment power over the shares held by Valley High. Ms.&nbsp;Fairbairn and her spouse both exercise control over the CRUT and, as such, have voting and investment power over the shares held by the
CRUT. Ms.&nbsp;Fairbairn disclaims beneficial ownership of the shares held by Valley High except to the extent of her pecuniary interest therein. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Consists of (a) 4,549 shares, (b) 4,098 shares underlying outstanding warrants that are immediately exercisable,
and (c)&nbsp;137,400&nbsp;shares underlying outstanding options that are immediately exercisable or will be immediately exercisable within 60 days of February&nbsp;16, 2025. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Consists of (a) 7,826 shares and (b) 152,712 shares underlying outstanding options that are immediately
exercisable or will be immediately exercisable within 60 days of February&nbsp;16, 2025. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Consists of (a) 285,030 shares, (b) 14,837 shares held by Christiana Trust a Division of Wilmington Savings Fund
Society FSB TR Alan S. Roemer 2015 Family Trust (the &#147;<B><I>Family Trust</I></B>&#148;), (c) 331,500 shares underlying outstanding warrants that are immediately exercisable, and (d) 454,787 shares underlying outstanding options that are
immediately exercisable or will be immediately exercisable within 60 days of February&nbsp;16, 2025. Mr.&nbsp;Roemer disclaims beneficial ownership of the shares held by the Family Trust except to the extent of his pecuniary interest therein, if
any. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Consists of 61,984 shares underlying outstanding options that are immediately exercisable or will be immediately
exercisable within 60 days of February&nbsp;16, 2025. As described in footnote 1, Mr.&nbsp;Whitfill has agreed that he will hold certain equity-based awards granted to him on or prior to June&nbsp;30, 2023 in connection with his services as a
director. Mr.&nbsp;Whitfill disclaims beneficial ownership of the shares held by Bios except to the extent of his pecuniary interest therein. Mr. Whitfill has resigned from the Board effective as of May&nbsp;9, 2025. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc888198_10"></A>EQUITY COMPENSATION PLAN INFORMATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides certain information with respect to all of our equity compensation plans in effect as of December&nbsp;31, 2024.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD style="width:29pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:29pt"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD style="width:31pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:31pt"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD style="width:33pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:33pt"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Plan Category</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>securities&nbsp;to&nbsp;be</B><br><B>issued upon</B><br><B>exercise
of</B><br><B>outstanding</B><br><B>options,&nbsp;warrants</B><br><B>and rights</B><br><B>(a)(#)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Weighted-average</FONT></B><br><B>exercise price of</B><br><B>outstanding</B><br><B>options, warrants</B><br><B>and
rights</B><br><B>(b)($)<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>securities</B><br><B>remaining&nbsp;available</B><br><B>for issuance under</B><br><B>equity</B><br><B>compensation
plans</B><br><B>(excluding</B><br><B>securities reflected</B><br><B>in column (a))</B><br><B>(c)(#)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans approved by security holders:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2018 Equity Incentive Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,355,568</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.51</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top"> (2)</SUP>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020 Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,289,914</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.26</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top"> (2)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023 Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,449,923</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.86</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,679,014</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020 Employee Stock Purchase Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">787,812</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(4)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans not approved by security holders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,095,405</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,466,826</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">The weighted average exercise price is calculated based solely on outstanding stock options.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Following the adoption of the 2020 Plan, no additional stock awards have been or will be granted under the 2018
Equity Incentive Plan (&#147;<B><I>2018 Plan</I></B>&#148;). Following adoption of the 2023 Plan, no additional stock awards have been or will be granted under the 2020 Plan. Any shares becoming available under the 2018 Plan or 2020 Plan by
repurchase, forfeiture, expiration or cancellation will become available for grant under the 2023 Plan. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">The number of shares of common stock reserved for issuance under the 2023 Plan will automatically increase on
January&nbsp;1 of each year by 5% of the total number of shares of our capital stock outstanding on December&nbsp;31 of the preceding calendar year, or a lesser number of shares determined by our Board (which may be zero). On December&nbsp;3, 2024,
the Compensation Committee determined that there would be no increase to the share reserve under the 2023 Plan on January&nbsp;1, 2025. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">The number of shares of common stock reserved for issuance under the ESPP will automatically increase on
January&nbsp;1 of each year by the lesser of (i) 1% of the outstanding number of shares of common stock on the immediately preceding December&nbsp;31 and (ii) 400,000, or such lesser number of shares as determined by our Board. On December&nbsp;3,
2024, the Compensation Committee determined that there would be no increase to the share reserve under the ESPP on January&nbsp;1, 2025. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc888198_11"></A>TRANSACTIONS WITH RELATED PERSONS AND INDEMNIFICATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Policies and Procedures for Transactions with Related Persons </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have adopted a written related party transaction policy in which all proposed related party transactions must be approved by either (i)&nbsp;our full Board
in the case of executive officers and directors or (ii)&nbsp;with respect to all other related parties, our Nominating and Corporate Governance Committee. This review covers any transaction, arrangement or relationship, or any series of similar
transactions, arrangements or relationships, in which we and any &#147;related person&#148; were or are participants involving an amount that exceeds or will exceed $120,000 or, during such time as we qualify as a &#147;smaller reporting
company,&#148; the lesser of (a) $120,000 or (b) 1% of the average of our total assets for the last two completed fiscal years, and in which any related person had or will have a direct or indirect material interest. Transactions involving
compensation for services provided to us as an employee, director, consultant or similar capacity by a related person are not covered by this policy. A &#147;related party&#148; is any person who is or was one of our executive officers, directors or
director nominees or is a holder of more than 5% of our common stock, or their immediate family members or any entity owned or controlled by any of the foregoing persons. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Transactions involving compensation for services, including equity awards, provided to us as an employee, consultant or director will not be considered
related person transactions under this policy. For more information regarding our compensation arrangements and equity awards granted to our directors and named executive officers, see the sections titled &#147;Executive Officer and Director
Compensation&#151;Executive Compensation&#148; and &#147;Executive Officer and Director Compensation&#151;Director Compensation.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A related person
is any executive officer, director, nominee to become a director or a holder of more than 5% of any class of our voting securities (including the common stock), including any of their immediate family members and affiliates, including entities owned
or controlled by such persons. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain Related Person Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than compensation arrangements for our directors and executive officers, below we describe transactions since January&nbsp;1, 2023 to which we were a
party or will be a party, in which: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amounts involved exceeded or will exceed $120,000; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any of our directors, executive officers or holders of more than 5% of our capital stock, or any member of the
immediate family of, or person sharing the household with, the foregoing persons, had or will have a direct or indirect material interest. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Participation in 2024 Private Placement </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
September 2024, we entered into a securities purchase agreement (the &#147;<B><I>2024 Purchase Agreement</I></B>&#148;) with multiple investors (the &#147;<B><I>2024</I></B> <B><I>Private Placement</I></B>&#148;), pursuant to which we issued and
sold an aggregate of 31,406,448 units comprising (i)&nbsp;(a) one share of common stock or (b)&nbsp;one <FONT STYLE="white-space:nowrap">pre-funded</FONT> warrant to purchase one&nbsp;share of common stock (&#147;<B><I>PFWs</I></B>&#148;), and, in
each case, (ii)&nbsp;one Series C ordinary warrant to purchase one share of common stock (&#147;<B><I>Series C Warrants</I></B>&#148;). In connection with the 2024 Private Placement, we issued an aggregate of 25,696,305 shares of common stock,
5,646,853 PFWs and 31,343,158 Series C Warrants. The PFWs have an exercise price of $0.0001 per share, are exercisable immediately and are exercisable until the PFW is exercised in full. The Series C Warrants have an exercise price of $0.27 per
share, are exercisable immediately and will expire on October&nbsp;4, 2027. The units were sold at a purchase price of $0.3950 per unit (or $0.3949 per unit with respect to units that include PFWs in lieu of Common Stock), for an aggregate initial
net proceeds of $11.2&nbsp;million, after deducting private placement fees and expenses. The closing of the 2024 Private Placement occurred on October&nbsp;4, 2024. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The table below sets forth the aggregate number of shares of our common stock and warrants purchased by our
directors and officers and the holders of more than 5% of our common stock and affiliates in the 2024 Private Placement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Warrant</B><br><B>Shares</B><br><B>Underlying</B><br><B><FONT STYLE="white-space:nowrap">Pre-Funded</FONT></B><br><B>Warrants</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Warrant</B><br><B>Shares</B><br><B>Underlying</B><br><B>Series C</B><br><B>Ordinary</B><br><B>Warrants</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate</B><br><B>Purchase&nbsp;Price</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AIGH Investment Partners, LP<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,804,542</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,804,542</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,502,794</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">WVP Emerging Manager Onshore Fund, LLC &#150; AIGH Series<SUP
STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">988,914</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">988,914</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">390,621</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">WVP Emerging Manager Onshore Fund, LLC &#150; Optimized Equity Series<SUP
STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">269,838</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">269,838</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">106,586</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Hewlett Fund LP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,012,658</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,012,658</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">400,000</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alyeska Master Fund, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,063,291</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,063,291</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,000,000</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bios Clinical Opportunity Fund,
LP<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">709,040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">709,040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">280,000</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Malcolm and Emily Charitable Remainder Unitrust
2010<SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,038,743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,038,743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Peter Brandt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">253,164</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">253,164</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William Ho</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">126,582</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">126,582</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Patrick McCall</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,316</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,316</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kate Rochlin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,316</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,316</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alan S. Roemer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">126,582</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">126,582</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>11,696,203</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>3,743,783</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>15,443,986</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>6,100,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">AIGH Investment Partners, LP, WVP Emerging Manager Onshore Fund, LLC &#150; AIGH Series, and WVP Emerging
Manager Onshore Fund, LLC &#150; Optimized Equity Series are affiliates of AIGH Capital Management, LLC. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Bios Clinical Opportunity Fund, LP is an affiliate of Bios Equity Partners, LP. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Emily Fairbairn, a member of the Board, is a trustee of the Malcolm and Emily Charitable Remainder Unitrust
2010. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Also in September 2024, we entered into a registration rights agreement (&#147;<B><I>2024 Registration Rights
Agreement</I></B>&#148;) with the investors party to the 2024 Purchase Agreement pursuant to which we agreed to register for resale the shares of common stock issued pursuant to the 2024 Purchase Agreement and the common stock underlying the PFWs
and Series C Warrants (the &#147;<B><I>2024</I></B> <B><I>Registrable Securities</I></B>&#148;). Under the 2024 Registration Rights Agreement, we agreed to file a registration statement covering the resale of the 2024 Registrable Securities no later
than 30 days following the closing of the 2024 Private Placement, which we filed in November 2024. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Amended Series A Warrants </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the closing of the 2024 Private Placement, we amended certain of our outstanding Series A Warrants (as defined below), representing
approximately 11,714,076 shares of our Common Stock (the &#147;Amended Series A Warrants&#148;), including (i) 299,180 Series A Warrants held by our directors and officers and (ii) 6,291,946 Series A Warrants held by holders of more than 5% of our
common stock and affiliates, to (a)&nbsp;reduce the exercise price from $1.25 to $0.45 per share and (b)&nbsp;extend the termination date of such Amended Series A warrants to October&nbsp;4, 2025. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Reduction in Salary of Chief Executive Officer </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Also, in connection with the closing of the 2024 Private Placement, Mr.&nbsp;Ho agreed to a further reduction in his annual base salary from $544,680 to
$397,800, which will remain in effect until December&nbsp;31, 2025. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Participation in 2023 Private Placement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2023, we entered into a securities purchase agreement (the &#147;<B><I>2023 Purchase Agreement</I></B>&#148;) with multiple investors (the
&#147;<B><I>2023</I></B> <B><I>Private Placement</I></B>&#148;), pursuant to which we issued and sold an aggregate of 11,823,829 units comprising (i)&nbsp;(a) one share of common stock or (b)&nbsp;one
<FONT STYLE="white-space:nowrap">pre-funded</FONT> warrant to purchase one share of common stock (&#147;<B><I><FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants</I></B>&#148;), and, in each case, (ii)&nbsp;one Series A ordinary warrant to
purchase one share of common stock (&#147;<B><I>Series A Warrants</I></B>&#148;) and (iii)&nbsp;one Series B ordinary warrant to purchase one share of common stock (&#147;<B><I>Series B Warrants</I></B>&#148;). In connection with the 2023 Private
Placement, we issued an aggregate of 11,249,588 shares of common stock, 574,241 <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants, 11,823,829 Series A Warrants and 11,823,829 Series B Warrants. The
<FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants have an exercise price of $0.0001 per share, are exercisable immediately and are exercisable until the <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrant is exercised in full. The
Series A Warrants had an initial exercise price of $1.25 per share, are exercisable immediately and were set to expire on June&nbsp;13, 2025. In connection with the closing of the 2024 Private Placement, we also issued the Amended Series A Warrants.
The Series B Warrants have an exercise price of $1.50 per share, are exercisable immediately and will expire on December&nbsp;13, 2028. The units were sold at a purchase price of $1.22 per unit, for an aggregate initial net proceeds of
$13.5&nbsp;million, after deducting private placement fees and expenses. The closing of the 2023 Private Placement occurred on December&nbsp;13, 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The table below sets forth the aggregate number of shares of our common stock and warrants purchased by our directors and officers and the holders of more
than 5% of our common stock and affiliates in the 2023 Private Placement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Warrant</B><br><B>Shares</B><br><B>Underlying</B><br><B><FONT STYLE="white-space:nowrap">Pre-Funded</FONT></B><br><B>Warrants</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Warrant</B><br><B>Shares</B><br><B>Underlying</B><br><B>Series A</B><br><B>Ordinary</B><br><B>Warrants</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Warrant</B><br><B>Shares</B><br><B>Underlying</B><br><B>Series B</B><br><B>Ordinary</B><br><B>Warrants</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate</B><br><B>Purchase Price</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AIGH Investment Partners, LP<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,079,496</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,079,496</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,079,496</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,756,985.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">WVP Emerging Manager Onshore Fund, LLC &#150; AIGH Series<SUP
STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">800,452</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">800,452</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">800,452</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">976,551.44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">WVP Emerging Manager Onshore Fund, LLC &#150; Optimized Equity Series<SUP
STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">218,413</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">218,413</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">218,413</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">266,463.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Hewlett Fund LP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">819,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">819,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">819,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">999,999.84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alyeska Master Fund, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">819,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">819,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">819,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">999,999.84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bios Clinical Opportunity Fund,
LP<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">574,241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">574,241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">574,241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">700,516.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Peter Brandt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99,999.74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corinne Epperly</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99,999.74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trishna Goswami</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,098</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,098</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,098</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,999.56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jeremy Graff</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,049</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,049</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,049</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,499.78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William Ho</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99,999.74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lawrence Lamb</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,639</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,639</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,639</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,999.58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Patrick McCall</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,492</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,492</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,492</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,000.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kate Rochlin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,999.90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alan S. Roemer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">102,459</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">102,459</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">102,459</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">124,999.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>6,126,638</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>574,241</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>6,700,879</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>6,700,879</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>8,175,015</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">AIGH Investment Partners, LP, WVP Emerging Manager Onshore Fund, LLC &#150; AIGH Series, and WVP Emerging
Manager Onshore Fund, LLC &#150; Optimized Equity Series are affiliates of AIGH Capital Management, LLC. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Bios Clinical Opportunity Fund, LP is an affiliate of Bios Equity Partners, LP. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Also in December 2023, we entered into a registration rights agreement (&#147;<B><I>2023 Registration Rights Agreement</I></B>&#148;) with the investors party
to the 2023 Purchase Agreement pursuant to which we agreed to register for resale the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shares of common stock issued pursuant to the 2023 Purchase Agreement and the common stock underlying the <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants, Series A Warrants and Series
B Warrants (the &#147;<B><I>2023</I></B> <B><I>Registrable Securities</I></B>&#148;). Under the 2023 Registration Rights Agreement, we agreed to file a registration statement covering the resale of the 2023 Registrable Securities no later than 30
days following the closing of the 2023 Private Placement, which we filed in January 2024. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Indemnification Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have entered or intend to enter, and intend to continue to enter, into separate indemnification agreements with our directors and certain of our executive
officers, in addition to the indemnification provided for in our certificate of incorporation and bylaws. These indemnification agreements provide our directors and executive officers with contractual rights to indemnification and, in some cases,
expense advancement in any action or proceeding arising out of their services as one of our directors or executive officers or as a director or executive officer of any other company or enterprise to which the person provides services at our
request. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc888198_12"></A>OTHER INFORMATION FOR STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stockholder Proposals for the 2026 Annual Meeting of Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our amended and restated bylaws (&#147;<B><I>Bylaws</I></B>&#148;) provide that, for stockholder director nominations or other proposals to be considered at an
annual meeting, the stockholder must give timely notice thereof in writing to our Secretary at IN8bio, Inc., 350 5th Avenue, Suite 5330, New York, New York 10118. To be timely for the 2026 Annual Meeting of Stockholders, a stockholder&#146;s notice
must be delivered to or mailed and received by our Secretary at our principal executive offices between January&nbsp;8, 2026 and February&nbsp;7, 2026; <I>provided,</I> that if the date of that annual meeting of stockholders is more than 30 days
prior to or more than 60 days after the anniversary of the immediately preceding year&#146;s annual meeting, we must receive the required notice no earlier than the close of business on the 120th day prior to the meeting date and not later than the
close of business on the 90th day prior to the meeting date or, if later than the 90th day prior to such meeting date, the 10th day following the day on which public disclosure of that meeting date is first made. A stockholder&#146;s notice to the
Secretary must also set forth the information required by our Bylaws. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholder proposals submitted pursuant to Rule
<FONT STYLE="white-space:nowrap">14a-8</FONT> under the Securities Exchange Act of 1934, as amended (the &#147;<B><I>Exchange Act</I></B>&#148;), and intended to be presented at the 2026 Annual Meeting of Stockholders must be received by us not
later than November 17, 2025 in order to be considered for inclusion in our proxy materials for that meeting. In addition, stockholders who intend to solicit proxies in support of director nominees other than our nominees must also comply with the
additional requirements of Rule <FONT STYLE="white-space:nowrap">14a-19(b)</FONT> under the Exchange Act. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Householding of Proxy Materials
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for Notices of Internet
Availability of Proxy Materials or other Annual Meeting materials with respect to two or more stockholders sharing the same address by delivering a single Notice of Internet Availability of Proxy Materials or other Annual Meeting materials addressed
to those stockholders. This process, which is commonly referred to as &#147;householding,&#148; potentially means extra convenience for stockholders and cost savings for companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This year, a number of brokers with account holders who are our stockholders will be &#147;householding&#148; our Proxy Materials. A single Notice of Internet
Availability of Proxy Materials will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker that they will be
&#147;householding&#148; communications to your address, &#147;householding&#148; will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in &#147;householding&#148; and
would prefer to receive a separate Notice of Internet Availability of Proxy Materials, please notify your broker or IN8bio, Inc. Direct your written request to IN8bio, Inc., 350 5th Avenue, Suite 5330, New York, New York 10118, Attn: Patrick McCall,
Secretary, or email ir@IN8bio.com. Stockholders who currently receive multiple copies of the Notices of Internet Availability of Proxy Materials at their addresses and would like to request &#147;householding&#148; of their communications should
contact their brokers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc888198_13"></A>OTHER MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board knows of no business to be brought before the Annual Meeting which is not referred to in the accompanying Notice of Annual Meeting. Should any such
matters be presented, the persons named in the proxy shall have the authority to take such action in regard to such matters as in their judgment seems advisable. If you hold shares through a broker, bank or other nominee as described above, they
will not be able to vote your shares on any other business that comes before the Annual Meeting unless they receive instructions from you with respect to such matter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">By Order of the Board of Directors </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g888198g03g03.jpg" ALT="LOGO" STYLE="width:0.77975in;height:0.511482in;">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Patrick McCall </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><I>Corporate Secretary </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March 17, 2025 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>A copy of our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2024 is available free of charge at the SEC&#146;s web site at </B><B><I>www.sec.gov</I></B><B>. Stockholders can also access this proxy statement and our Annual
Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> at </B><B><I>investors.in8bio.com</I></B><B>. A copy of our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2024 is also
available without charge upon written request to our Secretary at IN8bio, Inc., 350 5th Avenue, Suite 5330, New York, New York 10118 or via email at ir@in8bio.com. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Appendix I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF AMENDMENT OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IN8BIO, INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Pursuant to
Section&nbsp;242 of the General Corporation Law of the State of Delaware) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN8bio, Inc. (the &#147;Corporation&#148;), a corporation organized and
existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the &#147;General Corporation Law&#148;), </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DOES
HEREBY CERTIFY: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&#8195;The name of this Corporation is IN8bio, Inc. The original name of this corporation was Incysus Therapeutics,
Inc., and the date of filing the original Certificate of Incorporation of this corporation with the Secretary of State of the State of Delaware was&nbsp;May 7, 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&#8195;A resolution was duly adopted by the Board of Directors of the Corporation pursuant to Sections 141 and 242 of the General
Corporation Law proposing this amendment of the Corporation&#146;s Amended and Restated Certificate of Incorporation and declaring the advisability of this amendment of the Amended and Restated Certificate of Incorporation, which resolution setting
forth the proposed amendment is as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">RESOLVED, that Article IV of the Amended and Restated Certificate of Incorporation be amended
by inserting into Article IV immediately following Section C the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>D.</B>&#8195;Effective as of the effective time of [5:00]
p.m., Eastern Time, on [Date] (the &#147;Effective Time&#148;), each [fifteen (15) / sixteen (16) / seventeen (17) / eighteen (18) / nineteen (19) / twenty (20) / <FONT STYLE="white-space:nowrap">twenty-one</FONT> (21) / <FONT
STYLE="white-space:nowrap">twenty-two</FONT> (22) / twenty-three (23) / twenty-four (24) / twenty-five (25) / <FONT STYLE="white-space:nowrap">twenty-six</FONT> (26) / twenty-seven (27) / twenty-eight (28) / twenty-nine (29) / thirty (30)]<SUP
STYLE="font-size:75%; vertical-align:top">1</SUP> shares of Common Stock issued and outstanding immediately prior to the Effective Time shall, automatically and without any action on the part of the Corporation or the respective holders thereof, be
combined into one (1)&nbsp;share of Common Stock without increasing or decreasing the par value of each share of Common Stock or the authorized number of shares of Common Stock (the &#147;Reverse Split&#148;); provided, however, that no fractional
shares of Common Stock shall be issued as a result of the Reverse Split and, in lieu thereof, upon receipt after the Effective Time by the exchange agent selected by the Corporation of a properly completed and duly executed transmittal letter and,
where shares are held in certificated form, the surrender of the stock certificate(s) formerly representing shares of <FONT STYLE="white-space:nowrap">pre-Reverse</FONT> Split Common Stock, any stockholder who would otherwise be entitled to a
fractional share of post-Reverse Split Common Stock as a result of the Reverse Split, following the Effective Time (after taking into account all fractional shares of post-Reverse Split Common Stock otherwise issuable to such stockholder), shall be
entitled to receive a cash payment (without interest) equal to the fractional share of post-Reverse Split Common Stock to which such stockholder would otherwise be entitled multiplied by the average of the closing sales prices of a share of the
Corporation&#146;s Common Stock (as adjusted to give effect to the Reverse Split) on the Nasdaq Capital Market during regular trading hours for the five (5)&nbsp;consecutive trading days immediately preceding the Effective Time. Each stock
certificate that, immediately prior to the Effective Time, represented shares of <FONT STYLE="white-space:nowrap">pre-Reverse</FONT> Split Common Stock shall, from </P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These amendments approve the combination of any whole number of shares of Common Stock between and including
fifteen&nbsp;(15)&nbsp;and thirty (30)&nbsp;into one&nbsp;(1) share of Common Stock. By these amendments, the stockholders would approve each of the alternate amendments proposed by the Corporation&#146;s Board of Directors. If the reverse stock
split proposal is approved by stockholders, the Certificate of Amendment filed with the Secretary of State of the State of Delaware will include only that reverse stock split ratio determined by the Corporation&#146;s Board of Directors to be in the
best interests of the Corporation and its stockholders. The other amendments will be abandoned pursuant to Section&nbsp;242(c) of the General Corporation Law of the State of Delaware. The Corporation&#146;s Board of Directors may also elect not to
effect any reverse stock split, in which case all proposed alternate amendments will be abandoned. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
and after the Effective Time, automatically and without any action on the part of the Corporation or the respective holders thereof, represent that number of whole shares of post-Reverse Split
Common Stock into which the shares of <FONT STYLE="white-space:nowrap">pre-Reverse</FONT> Split Common Stock represented by such certificate shall have been combined (as well as the right to receive cash in lieu of any fractional shares of
post-Reverse Split Common Stock as set forth above; provided, however, that each holder of record of a certificate that represented shares of <FONT STYLE="white-space:nowrap">pre-Reverse</FONT> Split Common Stock shall receive, upon surrender of
such certificate, a new certificate representing the number of whole shares of post-Reverse Split Common Stock into which the shares of <FONT STYLE="white-space:nowrap">pre-Reverse</FONT> Split Common Stock represented by such certificate shall have
been combined pursuant to the Reverse Split, as well as any cash in lieu of fractional shares of post-Reverse Split Common Stock to which such holder may be entitled as set forth above. The Reverse Split shall be effected on a record <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">holder-by-record</FONT></FONT> holder basis, such that any fractional shares of post-Reverse Split Common Stock resulting from the Reverse Split and held by a single record holder shall be
aggregated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&#8195;Thereafter, pursuant to a resolution of the Board of Directors, this Certificate of Amendment was submitted to the
stockholders of the Corporation for their approval and was duly adopted at an annual meeting of the stockholders of the Corporation, in accordance with the provisions of Section&nbsp;242 of the General Corporation Law of the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the Corporation has caused this Certificate of Amendment to be signed by its duly authorized officer this &#8195;&#8195;&#8195; day
of &#8195;&#8195;&#8195;&#8195;&#8195; 202&#8195;. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="40%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="padding-bottom:12pt ;"><B>IN8BIO,&nbsp;INC.</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By:<U> &#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt">&#8194;


<IMG SRC="g888198g55g55.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:6pt; font-family:Times New Roman">P.O. BOX 8016, CARY, NC 27512-9903</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g888198g55g01.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="52%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#86ba56"><B>IN8bio, Inc.</B></FONT></P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#86ba56"><B>Internet:</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="middle" ROWSPAN="3" ALIGN="center" STYLE="BORDER-BOTTOM:3.50pt solid #0a6085" BGCOLOR="#86ba56"><FONT STYLE="font-size:14pt" COLOR="#FFFFFF"><B>Annual Meeting of Stockholders</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="4">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="4" ALIGN="right">


<IMG SRC="g888198g55g02.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#0a6085"><B>www.proxypush.com/INAB</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:7pt; font-family:Times New Roman">&#9679;&#8194;&#8201;&#8201;Cast your vote online</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:7pt; font-family:Times New Roman"><B></B>&#9679;<B></B><B>&#8194;&#8201;&#8201;Have your Proxy Card ready</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:7pt; font-family:Times New Roman">&#9679;&#8194;&#8201;&#8201;Follow the simple instructions to record your vote</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="5" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center">For Stockholders of record as of March&nbsp;12, 2025</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#86ba56"><B>Thursday, May&nbsp;8, 2025 9:00 AM, Eastern Time</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#86ba56"><B>Annual Meeting to be held live via the internet&#151;please visit</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#86ba56"><B>www.proxydocs.com/INAB for more details</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#86ba56"><B>Phone:</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="3" ALIGN="right">


<IMG SRC="g888198g55g03.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#0a6085"><B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-866-601-1589</FONT></FONT></FONT></B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:7pt; font-family:Times New Roman">&#9679;&#8194;&#8201;&#8201;Use any touch-tone telephone</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:7pt; font-family:Times New Roman"><B></B>&#9679;<B></B><B>&#8194;&#8201;&#8201;Have your Proxy Card ready</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:7pt; font-family:Times New Roman">&#9679;&#8194;&#8201;&#8201;Follow the simple recorded instructions</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #86ba56"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="3" ALIGN="right">


<IMG SRC="g888198g55g04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#86ba56"><B>Mail:</B></FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:7pt; font-family:Times New Roman">&#9679;&#8194;&#8201;&#8201;Mark, sign and date your Proxy Card</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>YOUR VOTE IS IMPORTANT!</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PLEASE VOTE BY: 9:00 AM, Eastern Time, May&nbsp;8, 2025.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:7pt; font-family:Times New Roman">&#9679;&#8194;&#8201;&#8201;Fold and return your Proxy Card in the postage-paid envelope
provided</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ROWSPAN="4">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="4"> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="right">


<IMG SRC="g888198g55g05.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#86ba56"><B>&#147;Alexa, Vote My Proxy&#148;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:7pt; font-family:Times New Roman">&#9679;&#8194;&#8201;&#8201;Open Alexa app and browse skills</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:7pt; font-family:Times New Roman">&#9679;&#8194;&#8201;&#8201;Search &#147;Vote my Proxy&#148;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt" COLOR="#86ba56"><B>This proxy is being solicited on behalf of the Board of Directors</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:7pt; font-family:Times New Roman">&#9679;&#8194;&#8201;&#8201;Enable skill</P></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">The undersigned hereby appoints Alan Roemer and William Ho (the &#147;Named Proxies&#148;), and each or either of them, as the
true and lawful attorneys of the undersigned, with full power of substitution and revocation, and authorizes them, and each of them, to vote all the shares of capital stock of IN8bio, Inc. which the undersigned is entitled to vote at said meeting
and any adjournment thereof upon the matters specified and upon such other matters as may be properly brought before the meeting or any adjournment thereof, conferring authority upon such true and lawful attorneys to vote in their discretion on such
other matters as may properly come before the meeting and revoking any proxy heretofore given. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">THE SHARES REPRESENTED BY THIS PROXY WILL BE VOTED AS
DIRECTED OR, IF NO DIRECTION IS GIVEN, SHARES WILL BE VOTED FOR ALL NOMINEES FOR DIRECTOR IN PROPOSAL 1 AND FOR EACH OF PROPOSAL 2 AND PROPOSAL 3. This proxy, when properly executed, will be voted in the manner directed herein. In their discretion,
the Named Proxies are authorized to vote upon such other matters that may properly come before the meeting or any adjournment or postponement thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">You
are encouraged to specify your choice by marking the appropriate box (SEE REVERSE SIDE) but you need not mark any box if you wish to vote in accordance with the Board of Directors&#146; recommendation. The Named Proxies cannot vote your shares
unless you sign (on the reverse side) and return this card. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">PLEASE BE
SURE TO SIGN AND DATE THIS PROXY CARD AND MARK ON THE REVERSE SIDE </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Copyright <SUP STYLE="font-size:75%; vertical-align:top">&copy;</SUP>
2025 BetaNXT, Inc. or its affiliates. All Rights Reserved </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g888198g55g55.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#86ba56"><B>IN8bio, Inc. Annual Meeting of Stockholders</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"><FONT STYLE="font-size:8pt"><B>Please&nbsp;make&nbsp;your&nbsp;marks&nbsp;like&nbsp;this:</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">


<IMG SRC="g888198g56g01.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">THE BOARD OF DIRECTORS RECOMMENDS A VOTE <B>FOR</B> ALL NOMINEES FOR DIRECTOR IN PROPOSAL 1 AND <B>FOR</B> EACH OF
PROPOSAL 2 AND PROPOSAL 3 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:6pt" ALIGN="center">


<TR>

<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6pt">
<TD VALIGN="bottom" BGCOLOR="#cccccc"></TD>
<TD VALIGN="bottom" BGCOLOR="#cccccc">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#cccccc"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6pt; font-family:Times New Roman"><B>PROPOSAL</B></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#cccccc">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" STYLE="BORDER-RIGHT:1px solid #585858" BGCOLOR="#cccccc" ALIGN="center"><B>YOUR VOTE</B> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6pt; font-family:Times New Roman" ALIGN="center"><B>BOARD OF DIRECTORS RECOMMENDS</B></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6pt">
<TD VALIGN="top"><FONT STYLE="font-size:8pt">1.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">To elect the three Class&nbsp;I directors named in the attached proxy statement, each to serve until our 2028 Annual Meeting of
Stockholders.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>FOR</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>WITHHOLD</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #585858"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g888198g56g02.jpg" ALT="LOGO">
</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">1.01 Emily Fairbairn</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #585858"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>FOR</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #585858">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">1.02 Jeremy Graff</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #585858"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>FOR</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #585858">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">1.03 Luba Greenwood</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #585858"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>FOR</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #585858">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>FOR</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>AGAINST</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #585858"><B>ABSTAIN</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" NOWRAP>2.&#8194;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">To ratify the selection of CohnReznick LLP as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2025.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #585858">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>FOR</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #585858">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" NOWRAP>3.&#8194;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">To approve a series of alternate amendments to our Amended and Restated Certificate of Incorporation to effect, at the option of our Board of Directors, a reverse stock split of our common stock at a ratio in the range of <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-15</FONT></FONT> to <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-30,</FONT></FONT> inclusive, with such ratio to be determined by our Board of Directors in
its sole discretion.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #585858">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>FOR</B></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; margin-right:5%; font-size:8pt; font-family:Times New Roman"><B>You must register to
attend the meeting online and/or participate at www.proxydocs.com/INAB </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; margin-right:5%; font-size:8pt; font-family:Times New Roman">Authorized Signatures - Must be completed for
your instructions to be executed. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; margin-right:5%; font-size:8pt; font-family:Times New Roman">Please sign exactly as your name(s) appears on your account. If held in joint tenancy,
all persons should sign. Trustees, administrators, etc., should include title and authority. Corporations should provide full name of corporation and title of authorized officer signing the Proxy/Vote Form. </P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="7%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1.50pt solid #000000">Signature (and Title if applicable)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.50pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right" STYLE="BORDER-TOP:1.50pt solid #000000">Date&#8195;&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8199;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.50pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1.50pt solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:-0.80em; font-size:8pt; font-family:Times New Roman">Signature (if held jointly)</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.50pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right" STYLE="BORDER-TOP:1.50pt solid #000000">Date&#8195;&#8195;&#8195;</TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g888198g01r16.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g888198g01r16.jpg
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M*"@H*"@H_\  $0@ )P : P$B  (1 0,1 ?_$ !D  0$! 0$!
M  < " 0%!O_$ "X0  $#!  %  D%          $" P0 !081!Q(A06$($Q0B
M,3)Q<I$6,U%BHO_$ !8! 0$!                   ! O_$ !41 0$
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H%,ITN)C,#3;>^R?%*5KX(9=+ML22AF*E#S*' %/IV 1OK^:JJ)7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g888198g01x16.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g888198g01x16.jpg
M_]C_X  02D9)1@ ! 0 #YP/G  #_X<.%:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 V+C M8S P,B W.2XQ
M-C0U,3DL(#(P,C O,#@O,C4M,3<Z-30Z,# @(" @(" @("(^"B @(#QR9&8Z
M4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O
M9&,O96QE;65N=',O,2XQ+R(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(@H@(" @(" @(" @("!X;6QN<SIX
M;7!'26UG/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O9R]I;6<O(@H@
M(" @(" @(" @("!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+VUM+R(*(" @(" @(" @(" @>&UL;G,Z<W12968](FAT=' Z+R]N
M<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B"B @(" @
M(" @(" @('AM;&YS.G-T179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q
M+C O<U1Y<&4O4F5S;W5R8V5%=F5N=",B"B @(" @(" @(" @('AM;&YS.FEL
M;'5S=')A=&]R/2)H='1P.B\O;G,N861O8F4N8V]M+VEL;'5S=')A=&]R+S$N
M,"\B"B @(" @(" @(" @('AM;&YS.GAM<%109STB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+W0O<&<O(@H@(" @(" @(" @("!X;6QN<SIS=$1I;3TB
M:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+T1I;65N<VEO;G,C
M(@H@(" @(" @(" @("!X;6QN<SIX;7!'/2)H='1P.B\O;G,N861O8F4N8V]M
M+WAA<"\Q+C O9R\B"B @(" @(" @(" @('AM;&YS.G!D9CTB:'1T<#HO+VYS
M+F%D;V)E+F-O;2]P9&8O,2XS+R(^"B @(" @(" @(#QD8SIF;W)M870^87!P
M;&EC871I;VXO<&]S='-C<FEP=#PO9&,Z9F]R;6%T/@H@(" @(" @(" \9&,Z
M=&ET;&4^"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \
M<F1F.FQI('AM;#IL86YG/2)X+61E9F%U;'0B/F<P,6$Q-CPO<F1F.FQI/@H@
M(" @(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO9&,Z=&ET;&4^"B @
M(" @(" @(#QD8SID97-C<FEP=&EO;CX*(" @(" @(" @(" @/')D9CI!;'0^
M"B @(" @(" @(" @(" @(#QR9&8Z;&D@>&UL.FQA;F<](G@M<F5P86ER(CY&
M:6QE($YA;64Z(" @(" @(" @(" @(" @9S Q83$V+F%I)B-X03M5<V5R;F%M
M93H@(" @(" @(" @(" @($1E;'1A)B-X03M,;V-A;"!4:6UE.B @(" @(" @
M(" @(" R,RU!<'(M,C R-" P.#HQ,SHP.28C>$$[15-4(%1I;64Z(" @(" @
M(" @(" @(" R,BU!<'(M,C R-" R,CHT,SHP.28C>$$[4V-R:7!T(%9E<G-I
M;VXZ(" @(" @(" @,BXV)B-X03M);&QU<W1R871O<B!697)S:6]N.B @(" Q
M-BXP+C F(WA!.T=R87!H:6,@='EP93H@(" @(" @(" @07)T=V]R:R8C>$$[
M)B-X03OB@*(@,B!B;&%C:R!R=6QE<R!C:&%N9V5D('1O(&]V97)P<FEN="XF
M(WA!.R8C>$$[5&AE(&9O;&QO=VEN9R!C;VQO<G,@87)E('!R97-E;G0@:6X@
M=&AE(&1O8W5M96YT.B8C>$$[(" @(" @(" @($)L86-K)B-X03LF(WA!.RTM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+28C>$$[1FEL92!.86UE.B @(" @(" @(" @(" @(&<P,6$Q-BYA:28C>$$[
M57-E<FYA;64Z(" @(" @(" @(" @("!R<C@S,3 P,B8C>$$[3&]C86P@5&EM
M93H@(" @(" @(" @(" @,C@M1F5B+3(P,C4@,34Z,3,Z,3<F(WA!.T535"!4
M:6UE.B @(" @(" @(" @(" @,C@M1F5B+3(P,C4@,#4Z-#,Z,3<F(WA!.U-C
M<FEP="!697)S:6]N.B @(" @(" @(#(N-B8C>$$[26QL=7-T<F%T;W(@5F5R
M<VEO;CH@(" @,C4N,"XP)B-X03M'<F%P:&EC('1Y<&4Z(" @(" @(" @($)A
M<B!#:&%R="8C>$$[)B-X03LJ*BI4:&4@<')E9FQI9VAT(&-H96-K(&ES(&-O
M;7!L971E+B!0;&5A<V4@96YS=7)E(&UA;G5A;"!C:&5C:W,@87)E(&-O;7!L
M971E9"!P97(@<')O8V5S<RXJ*BHF(WA!.R8C>$$[5&AE(&9O;&QO=VEN9R!C
M;VQO<G,@87)E('!R97-E;G0@:6X@=&AE(&1O8W5M96YT.B8C>$$[(" @(" @
M(" @($)L86-K)B-X03LF(WA!.RTM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+28C>$$[/"]R9&8Z;&D^"B @(" @(" @
M(" @(#PO<F1F.D%L=#X*(" @(" @(" @/"]D8SID97-C<FEP=&EO;CX*(" @
M(" @(" @/'AM<#I-971A9&%T841A=&4^,C R-2TP,BTR.%0Q-3HQ,SHS,BLP
M-3HS,#PO>&UP.DUE=&%D871A1&%T93X*(" @(" @(" @/'AM<#I-;V1I9GE$
M871E/C(P,C4M,#(M,CA4,34Z,3,Z,S(K,#4Z,S \+WAM<#I-;V1I9GE$871E
M/@H@(" @(" @(" \>&UP.D-R96%T941A=&4^,C R-2TP,BTR.%0Q-3HQ,SHS
M,BLP-3HS,#PO>&UP.D-R96%T941A=&4^"B @(" @(" @(#QX;7 Z0W)E871O
M<E1O;VP^061O8F4@26QL=7-T<F%T;W(@,C4N," H5VEN9&]W<RD\+WAM<#I#
M<F5A=&]R5&]O;#X*(" @(" @(" @/'AM<#I4:'5M8FYA:6QS/@H@(" @(" @
M(" @(" \<F1F.D%L=#X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QX;7!'26UG
M.G=I9'1H/C(S-CPO>&UP1TEM9SIW:61T:#X*(" @(" @(" @(" @(" @(" @
M/'AM<$=);6<Z:&5I9VAT/C(U-CPO>&UP1TEM9SIH96EG:'0^"B @(" @(" @
M(" @(" @(" @(#QX;7!'26UG.F9O<FUA=#Y*4$5'/"]X;7!'26UG.F9O<FUA
M=#X*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z:6UA9V4^+SEJ+S1!05%3
M:UI*4F=!0D%G14%304))04%$+S=107-51VAV9$<Y>F%'.7=)1$UU34%!-%%K
M;$Y!*S!!04%!04%"04%304%!04%%028C>$$[05%"24%!04%!44%"+RLT041K
M1FMB,DIL04=404%!04%!9B]B04E104)G445"055%0F=51D)G:T="45E*0W=G
M1T)G9TQ$06]+0W=O2R8C>$$[1$)!341!=TU$07=11$$T4$5!.$]$0DU41D)1
M5$5X=V)'>'-C2'@X9DAX.&9(>#AF2'=%2$)W8TY$03!914)!64=H55)&4F]F
M2'@X9B8C>$$[2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF
M2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF+SA!04519T)!041S07=%4B8C>$$[
M04%)4D%135)!9B]%06%)04%!04A!445"05%%04%!04%!04%!04%11D%W24=!
M44%(0T%K2T-W14%!9TE$05%%0D%114%!04%!04%!028C>$$[05%!0T%W449"
M9V-)0U%O3$5!04-!44U$06=10T)G8T1"04E'06Y-0D%G35)"04%&25))>%%6
M14=%,D5I8UE%54UP1VA">%=X46E00B8C>$$[571(:$UX6FDX0U)Y9W9%;%%Z
M4E1K<4MY63-00TY546YK-D]Z3FAD55I(5$0P=4E)2F]-2D-H9UIH2E)&4G%3
M,%9T3E9+0G)Y-"]0128C>$$[,4]4,%I85T9L85<Q>&18;#E76C)H<&%M='-B
M5S5V63-2,61N9#1E6' W9D@Q*V8S3T5H66%(:4EM2VDT>4YJ;RM#:S535FQP
M95EM6B8C>$$[<6)N2C)E;C5+:G!+5VUP-FEP<7%U<W)A-G9O4D%!24-!44E$
M0E%514)1645#04U$8E%%04%H141"0T53355%1E523FA)9UIX9UI%>28C>$$[
M;V)(=T9-2%(T4TY#1E9*:6-V17I*1%)$9VAA4U5Y5VE9-TQ#0C-04TYE2D5G
M>&15:W=G2D-H9UI*:EI&1VED:V1&53,X<4]Z=WEG<"8C>$$[,"M0>FA*4VMT
M3515-5!2;&195U9P8EA&,658,5)L6FUD;V%7<')B1S%U8C)2,61N9#1E6' W
M9D@Q*V8S3T5H66%(:4EM2VDT>4YJ;R8C>$$[*T1L2E=7;#5I6FUP=6-N6C9F
M:W%/:W!A86YQ2VUQ<39Y=')Q*W8O84%!=T1!44%#15%-4D%$.$$X+S1S;EEQ
M-T9867$W1EA9<3=&6"8C>$$[67$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ
M-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6#(O=T0K=3-F*T-D+S-A.%50
M:41&3"8C>$$[<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S
M5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<C=F+W=$6"8C>$$[
M8G8X07=4=BLW6&EH.%%9<&1I<4PP<E-T4C%F55E.3C R0G)Q*W5M-%<Y=6Q/
M5'13=$)7;FAI<DQV*U9)9FUX+S%,3C4Y>68X,5EO="8C>$$[,R]+:U!Z62\V
M;&TX*S50*V%S5G0S+TMK4'I9+S9L;3@K-5 K87-6=#,O2VM0>EDO-FQM."LU
M4"MA<U9T,R]+:U!Z62\V;&TX*S50*R8C>$$[87-6=#,O2VM0>EDO-FQM."LU
M4"MA<U9T,R]+:U!Z62\V;&TX*S50*V%S5G0S+TMK4'I9+S9L;3@K-5 K87-6
M=#,O2VM0>EDO-FQM."8C>$$[*S50*V%S5G0S+TMK4'I9+S9L;3@K-5 K87-6
M=#,O2VM0>EDO-FQM."LU4"MA<U9T,R]+:U!Z62\V;&TX*S50*V%S5G0S+TMK
M4'I9+R8C>$$[-FQM."LU4"MA<U9T,R]+:U!Z62\V;&TX*S50*V%S5G0S+TMK
M4'I9+S9L;3@K-5 K87-6=#,O2VM0>EDO-FQM."LU4"MA<U9T,R]+:R8C>$$[
M4'I9+S9L;3@K-5 K87-6=#,O2VM0>EDO-FQM."LU4"MA<U9T,R]+:U!Z62\V
M;&TX*S50*V%S5G0S+TMK4'I9+S9L;3@K-5 K87-6="8C>$$[,R]+:U!Z62\V
M;&TX*S50*V%S5G0S+TMK4'I9+S9L;3@K-5 K87-6=#,O2VM0>EDO-FQM."LU
M4"MA<U9T:DAM1'DU<FYL-U5$<#)T5R8C>$$[8VQJ9D)&:TYV3%1L>&8W2C)*
M-C1P4S-&6%EQ*S,O.$$Q,C<O04U%-R]U,31O9D5'2UA9<7IN.&M0+TIS95=F
M*UEW9CA18D9"9F5'2R8C>$$[2%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9
M<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EAX<"]Z;$XO-4YE8B]!2F=R
M8B]I2B8C>$$[>%-(:T]+6%EQ*S,O05 Q,C<O=U1V*S=8:6@X45EP9&ER3V9Y
M42\X04IS95=F*UEW9CA18D9"9F5'2TA9<3=&6%EQ-T9867$W1EA9<28C>$$[
M-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EAX<"]W0354
M9CA!:S$U=BM92S(O=T-);D9)95$T<&1I<C=F+W=$6"8C>$$[8G8X07=4=BLW
M6&EH.%%9<&1I<D]F>5$O.&UX-5HO-6I"+WA"<U5&.319;V1I<G-69&ER<U9D
M:7)S5F1I<G-69&ER<U9D:7)S5F1I<B8C>$$[<U9D:7)S5F1I<G-69&ER<U9D
M:7)S5F9';B]/53,O:S$U=CA!;4-T=BM);D9)95$T<&1I<C=F.$$O6&)V+T)/
M+S=T94M(>$)I;#)+<R8C>$$[-2]*1"]W06UX-5HO-6I"+WA"<U5&.319;V1I
M<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I
M<G-69"8C>$$[:7)S5F9';B]!1&Q.+W=#5%AM+S5G<F(O04EI8U5H-41I;#)+
M=G0O+T%.9'4O=T1"3R\W=&5+2'A":6PR2W-T+TMF5CE.,&(X>'1",28C>$$[
M5%4U>&)71G!C:5,T;EE%:$8T<TMK2T-C5DPV.2]W0U8Y+VQ$+W="5$I"+WE,
M;B\V<#1S6&8X<C<O2T@O04MM4T0O:UA0+S%4>%8S+R8C>$$[04-V=CAO9BMP
M:V<O-49Z+T%05E!&6&8X<C<O2T@O<5I)4#A!:UA0+T%.53A69"]Y=G8X04M(
M+W%:25 K4F,O+T%&5'A6,R]+*R]Y:"8C>$$[+W=#<&MG+S5&>B\Y53A69"]W
M07(W+TM(+W%:25 K4F,O=T0Q5'A6,R]+*R]Y:"\V;5-$+T%*1GHO=T164$98
M9CAR-R]!0V@O-FU31"8C>$$[+VM84"]W0E4X5F0O>79V.&]F.$%Q6DE0*U)C
M+R]64$989CA!2RLO>6@O-FU31"]K6% X03E5.%9D+WEV=CAO9BMP:V<O=T-2
M8R\X028C>$$[,51X5C,O2RLO=T%O9BMP:V<O-49Z+SA!5E!&6&8X<C<O2T@O
M04MM4T0O:UA0+S%4>%8S+T%#=G8X;V8K<&MG+S5&>B]!4%901EAF."8C>$$[
M<C<O2T@O<5I)4#A!:UA0+T%.53A69"]Y=G8X04M(+W%:25 K4F,O+T%&5'A6
M,R]+*R]Y:"]W0W!K9R\U1GHO.54X5F0O=T%R-R]+2"8C>$$[+W%:25 K4F,O
M=T0Q5'A6,R]+*R]Y:"\V;5-$+T%*1GHO=T164$989CAR-R]!0V@O-FU31"]K
M6% O=T)5.%9D+WEV=CAO9CA!<5I)4"8C>$$[*U)C+R]64$989CA!2RLO>6@O
M-FU31"]K6% X03E5.%9F3"\O041K1C5N,$AZ3"M9<W5P-DAE3&971%=S15EN
M44UO-4E$>49(0VYB1B8C>$$[265A-'!D:7(W9CA!+UAB=B]"3R\W=&5+2'A"
M:6PR2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU
M>%8R2R8C>$$[=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8Y=B\X07)T,R]!24HS
M+V1R>%$K24U5=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=28C>$$[
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=G0O.$$Y
M9'4O.$4W+T%,=&5+2'A":6PR2W!P-5DX=3,O04IJ,28C>$$[*WDP4%1Z1W0W
M9GEE;$%:5TMP>6]4.%)!66IP-%EQ.50O=T-H5"]Z42]W0BLV6B\P:U-F.55S
M55<W+V]5+W=$3D0O9G5M9CA!4U)*+R8C>$$[,5-X5S-F.$%1<"\U;V8W.3!Z
M+W!):R\V<%ER8G8K:%0O=T$P4#DK-EHO,&M39CA!5DQ&8F0O,$MF*V%(*R]D
M32]W0VMI5"]Q;&ET=28C>$$[+W=#:%0O>E$O=T(K-EHO,&M39CE5<U9T,R]1
M<"]W0V%(*R]D32\V4TI0.$%Q;&ET=2\V1E O3D0O9G5M9CE*16XO5DQ&8F0O
M,$MF*R8C>$$[84@K+V1-+S932E K<5=+,C<O;U4O=T1.1"]F=6UF.$%34DHO
M,5-X5S-F.$%1<"\U;V8W.3!Z+W!):R\V<%ER8G8K:%0O=T$P4#DK-B8C>$$[
M6B\P:U-F.$%63$9B9"\P2V8K84@K+V1-+W=#:VE4+W%L:71U+W=#:%0O>E$O
M=T(K-EHO,&M39CE5<U9T,R]1<"]W0V%(*R]D32\V4R8C>$$[2E X07%L:71U
M+S9&4"].1"]F=6UF.4I%;B]63$9B9"\P2V8K84@K+V1-+S932E K<5=+,C<O
M;U4O=T1.1"]F=6UF.$%34DHO,5-X5R8C>$$[,V8X05%P+S5O9C<Y,'HO<$EK
M+S9P67)B=BMH5"]W03!0.2LV6B\P:U-F.$%63$9B9"\P2V8K84@K+V1-+W=#
M:VE4+W%L:71U+W=#:"8C>$$[5"]Z42]W0BLV6B\P:U-F.55S5G0S+U%P+W=#
M84@K+V1-+S932E X07%L:71V3V904&MF5V9*979.;VUS3D,Q-G-35$4R-T8P
M-'E62R8C>$$[-W-Q8C=E1TM74%EQ-T98,B]W1"MU,V8K0V0O,V$X55!I1$9,
M<U9:>BM32"]!2DYJ>7HO>D=$+VE$66],-W=X43=&6%EQ-T9867$W1B8C>$$[
M6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<2M.
M4#A!;DMB+T%-;79.+WI"5S,O151I:U!)8U5U>%8Y=B8C>$$[+W=$<G0S+V=N
M9CA!9')X42M)355U>%9N4#5)9BM463AS+SA!35E0*TE.:6=V=D1&1'-69&ER
M<U9D:7)S5F1I<G-69&ER<U9D:7)S5B8C>$$[9&ER<U9D:7)S5F1I<G-69&ER
M<U9D:7)S5F1I<C0P+S5Y;2\X;79.+WI"5S,O151I:U!)8U5U>%8Y=CA!+W)T
M,R]G;F8Y,G9&1#1G>"8C>$$[4S=&5V,O:V@O=T-463AS+SAX9R\T9S)+0RLX
M355/>%8X>B]N1BMF;C5G*U9F>D<Q9E%.2FQT5C K>BMR*V=*64$W+W9B5TM6
M<7189B8C>$$[-'!$:6UM1V8Y1%1F;78X03<K<W8K:UIF-C1R5$EF>3DO=T-C
M:2]Z2C$S>GAO96HS.#%O8DLO=DEO3&=*8FA72T\Q1%)Q-UER5#9Q>"8C>$$[
M43=&6&I8+T]26#5P*V)0268K2"]!4$0W=W K:W9R;C%N,31H3%@P4%$T8V%K
M52]V5WA303A:+S9';2].9B]F,6PO,&I,+UA&860O,"8C>$$[3DXK82]W1'8V
M>2\V4FPO<FET4')N>3%F6$=O95A.2W8W:V<S1C-:,C@X>%552$]72EAA9S=B
M;D9#6EEQ=S,X-'9.3W)E5F9Y-3%F6"8C>$$[.4I:1C%#>BMR*V=:5C5P*SEU
M;V]M<79F-%I$:7(U;2\V1VTO3F8X03,Y6F8Y27DO,7A45'8K:'!V>E@O04XO
M5U@O4TUV.6-6<#E$+R8C>$$[04I%965.93@U*U(R,6I7,FIE.48U3D%$0V=J
M6&=I;U(X27(O041(1D0P5$9867$K3E X06]A8C@Q+SA!9C%L+S!J3"]!1GA4
M5'8X028C>$$[;V%B.#$O.$%F,6PO,&I,+T%&>%=N<6XO041J-2MC4&Y0>GHU
M:C%+=S$V4S-E,W1B4#$T:$1%27IZ.595,TE*-TYI<$0S9D9$<U9F1R8C>$$[
M;B]/53,O:S$U=CA!;4-T=BM);D9)95$T<&1I<C=F.$$O6&)V+T)/+S=T94M(
M>$)I;#)+<S4O2D0O=T%M>#5:+S5J0B]X0G-51CDT628C>$$[;V1I<C1H+S5Y
M4#A!+TIZ*UEF.$%O>B\V9UE-5U%E85EQ>D@X;G8X07EA6&QB+W1O,B\X07A-
M67%8,WAI>&1I<C5R+S5Z2R\V6D0O="8C>$$[-"\X05ER:6M0;7)&3'-69F]F
M-4HO=T-533!$+T%,6C%P+WE95$9I;E=+=DYF*V-J+W=$>51(;4@O;WHO04]O
M-D1&269%1TM867$K>"8C>$$[9BMC578O2E=V+S(P8FHO:45E3$5V6DU69&ER
M.#%S5U1S5F4Y+W=$3TE(+TM:-C,O04YS-&8X;C!X45@Q9&EH,DMV:E0O;DMB
M+W=!;28C>$$[=DXO>D)7,R]!0D4T<$1Y2$9,<U9F8B\O04LW9"]W0T-D+S-A
M.%50:41&3'-66GHK4T@O:S)03% O35E0*TE.:6=V=D1&1'-69D50+R8C>$$[
M041K9B]W0U1N.'<O.4=F+T%&07=9<V<X,'A6;5 U4&8K5%,X<F8X06)2="\K
M2FI&4RLK35=,<U9F3F8O041M5B]W0DUH+S(X9BMX6"8C>$$[1DEF3E=+6%EQ
M+U$O>50O>6AM9V8Y<S8P+W=#5$-9<U4V>%8U<B]Z:V8O-4IJ>D0O04Y'9B]5
M9$)I:U!I1$9,<U9F678O3TM8+VMR6"8C>$$[+W=#,FIC9CA1:GA9;#=*:7)S
M5F9M=&EY9&ER,W8O;D5$+VQ-.6(O-UIW+S50<&EG=G$W1D1S5F9';B]/53,O
M:S$U=BM92S(O-&EC528C>$$[:#5$:6PR2W9T+SA!.61U+SA%-R]!3'1E2TAX
M0FEL,DMS-2]*1"]Y8DAL;B]!2FI"+W=!46)&0F9E1TM(67$W1EA9<3=&6%EQ
M-T98628C>$$[<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ
M-T98>' O>FQ.+S5.96(O;4-T=BM);D9)95$T<&1I<C=F+SA!6&)V+R8C>$$[
M04%4=BLW6&EH.%%9<&1I<D]F>5$O=T1*<V579BM9=V8X46)&0F9E1TM(67$W
M1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1B8C>$$[6%EQ-T9867$W
M1EA9<3=&6%EQ-T98>' O>FQ.+S5.96(O;4-T=BM);D9)95$T<&1I<C=F+T%0
M6&)V+T)/+W=#-UAI:#A167!D:7)/9B8C>$$[>5$O.&UX-5HO=T-9=V8X045'
M>%%8,VAI:#)+=DIF4%@O3U(O;&)Y9#5Q=G9,;#EP;#EC6%9J-EAQ5%%#2# R
M.6%&2FAX-4]P,D5G2"8C>$$[5$9.2D0O,$XY-4DO-G,R<"]D8B]!4%941F%4
M4'EX+WIK+S52.'<K6610,$\Q,')527)J55HP=#1P6E)$=U9P1%%&=4UH3E!O
M>%)4,B8C>$$[6$9867%W4#@P=GIF,%0X=78P6BML3$LU=2\P<#8O;R]6=E0K
M2#9V-F9,;'I:3W9R0VQ-5EE(+S!..35)+W=#<DYQ9C-7+SA!,55X5"8C>$$[
M5'8X06]B-WE2+S%:=%0K-C,O-G%9<E0R-U-D4FDQ4%-R3%59;%I)<C)#2S1J
M4G%C9W-Q0G=$5&%O1%EO4E=+<$0U-C@T5U!K-WER9B8C>$$[95DW-D=7-'1B
M2#!V56AG-"MO,W)42D-/4$EQ3FI)1#%X5C5,+W="1&9E4U K<DYQ9C-7+R]6
M5$9.3R\V1RLX:V8Y5V)5+W5T+W=$<28C>$$[<&ET4%50>34O34149E!F;#0V
M-7 Q=$YA,C1N93,Y2S0T8RM5655K+T%71E!I.&-536]X5C)+=D(O=T1O8C=Y
M4B]W0E=B52]U="\X028C>$$[<7!I;6YF.$%1,S-K:B]Q>F%N.3%V+S%5>%=M
M62]L:BME2&PO.'=D5G4Y3S!Y=W4W4U<P9RMS3SEZ-F9%<GI#54A",TYA=&EH
M-E!I<B8C>$$[<U9F1VXO3U4S+VLQ-78X06U#='8K26Y&2651-'!D:7(W9CA!
M+UAB=B]"3R\W=&5+2'A":6PR2W,U+TI$+W=!;7@U6B\U:D(O>$)S528C>$$[
M1CDT66]D:7(T:"\U>5 X02]*>BM99CA!;WHO-F=935=196%9<7I(.&YV.$%Y
M85AL8B]T;S(O.$%X35EQ6#-X:7AD:7(U<B\U>DLO-B8C>$$[6D0O=#0O.$%9
M<FEK4&UR1DQS5F9O9C5*+W=#54TP1"]!3%HQ<"]Y651&:6Y72W9.9BMC:B]W
M1'E42&U(+V]Z+T%/;S9$1DEF14=+6"8C>$$[67$K>&8K8U5V+TI7=B\R,&)J
M+VE%94Q%=EI-5F1I<C@Q<U=4<U9E.2]W1$])2"]+6C8S+T%.<S1F.&XP>%%8
M,61I:#)+=FI4+VY+8B8C>$$[+W=!;79.+WI"5S,O04)%-'!$>4A&3'-69F(O
M+T%+-V0O=T-#9"\S83A54&E$1DQS5EIZ*U-(+VLR4$Q0+TU94"M)3FEG=G9$
M1D1S5B8C>$$[9D50+T%$:V8O=T-4;CAW+SE'9B]!1D%W67-G.#!X5FU0-5!F
M*U13.')F.$%B4G0O*TIJ1E,K*TU73'-69DYF+T%$;58O=T)-:"\R."8C>$$[
M9BMX6$9)9DY72UA9<2]1+WE4+WEH;6=F.7,V,"]W0U1#67-5-GA6-7(O>FMF
M+S5*:GI$+T%.1V8O561":6M0:41&3'-69EEV+T]+6"8C>$$[+VMR6"]W0S)J
M8V8X46IX66PW2FER<U9F;71I>61I<C-V+VY%1"]L33EB+S=:=R\U4'!I9W9Q
M-T9$<U9F1VXO3U4S+VLQ-78K64LR+R8C>$$[-&EC56@U1&EL,DMV="\X03ED
M=2\X13<O04QT94M(>$)I;#)+<S4O2D0O>6)(;&XO04IJ0B]W05%B1D)F94=+
M2%EQ.#8X,F9K2BM8=B8C>$$[;7)Z0F1A.7$X1GDK;UAN<"MU,&,W27 Y2TY9
M;&]O1S-W;TU64VHO;U9V.$%+9CA!-5IR>B]P2V8K;4LR:CE"+S5X,B],6%$Y
M6G-T628C>$$[<TE,<&(R=VQ793-:-VAM54]H<4MQ4G9I<C S1EA9<7A(>CDK
M5G9L4'HS.5$O=T%14GI39F\W,69Q,V]Y;4MN<CA/9&%D9C=P8U99:B8C>$$[
M+W="0W0O;% O=T%S,34O,&Q0.$$P>%<S9CE#="]L4"]!37,Q-2\P;% O5$9B
M97%A9%DR*VXV9F$R1G5#3&4P:6IG:$1'<#122T57<"8C>$$[-S=$1E52:7%5
M96)02S)K*V%V3#DQ;T]R<3<V9F5E;C8V>'-562ML27-Q,%ED4&E167$X-B]W
M0VA7+WEN+W=#5V$X+S93;B]P:71U+R8C>$$[-D9B+T%#;B]!3U=A."\V4VXO
M<&ET<SDX:RM33D(X;6%-9$@P4DI%<VI+."]'5GI),TYW03-X2"]!1E)I<68T
M<3=&6&MF+U%R9C54+R8C>$$[05!,3F5F.$%352\Y359T,R]1<F8U5"\X<S$U
M+S!L4"]!17A7,E1E4E!Y9CAL*U(Y475,+T%%1TME3S1U;W91;$TP>&M"5&M(
M,D(Y,28C>$$[>%9M,DMU>%8X868X-51F*U18;2\U9W)B+VE*>%-(:T]+6%EQ
M*S,O+T%&,C<O=T%%-R]U,31O9D5'2UA9<7IN.&M0.$%Y8DAL;B]M328C>$$[
M2"]%1WA16#-H:6@R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X
M5C)+=7A6,DMU>%8R2W5X5C)+=7A6.&%F.#549BM46"8C>$$[;2\U9W)B+VE*
M>%-(:T]+6%EQ*S,O=T0Q,C<O=U1V.$%U,31O9D5'2UA9<7IN.&M0+TIS95=F
M.$%M34@O04)"<U5&.319;V1I<5=8=B8C>$$[;6YY>EDS3#)T-W$Y;&$S3610
M56=M=4EO-48U04U+<7I!:6])3TMQ2"M.=DIN+U8O,#<O<$QG+S5R>%95="].
M,VQ3-6YJ=#=B5W)#828C>$$[959G:U559'I#-W-X,D%647A*2GA63G-69&EQ
M0S%,5SE','8P+W="2E@Y=%DK='DY3#9Z3DA$>C0P-6-E6E=T3U%R5$951B]J
M8GE:+R8C>$$[,68X051V.$%P3&<O-7)X5C,K3G9*;B]6+W="3R]W0VMU1"]M
M=D95-&EL:6UI4U=*,6MI:U502$EH1$MY<TMG9VI99VI&5C)+<4XW9B8C>$$[
M5U9J8E!D6'1X2&$R,&1056YM9%DT,35%2TMS>$%&4U%-5E-V+T<S:WHO<2\V
M9"\P;'=F.#$T<3<O1S-K>B]Q+S9D+S!L=V8X,31Q;28C>$$[3FAQ96TV:D(Y
M63 K-VAV24%X47DR.&EY<'E'-4A*0U)89D955&ER<U936"]!0G0U32\V=BMN
M9CE*8T@O0418:7)V.$%',VMZ+W$O-B8C>$$[9"\P;'=F.$%.94MO=E1V34=G
M-FQ+,%=N86QA,W-Q3'IE3S-N:FQ93%=L4T5::4)5-'%J.%9D:7(T,"\U>6TO
M.&UV3B]Z0E<S+T54:28C>$$[:U!)8U5U>%8Y=CA!+W)T,R]G;F8Y,G9&1#1G
M>%,W1E=C+VMH+W=#5%DX<R\X>&<O-&<R2T,K.$U53WA6.%$O.#5(+RM4;CAW
M+W=$4B8C>$$[;B\Q07=9<V<X,'A6;5 U4&8K5%,X<F8Y=$<S+T%/2FI&4RLK
M35=,<U9F3F8O3UI8+U1)9CEV2"]!3$9C56@X,5EP9&ER.40O04-4+R8C>$$[
M04UO6F](+V)/=% K5$-9<U4V>%8U<B]Z:V8X02M363AW+SA!4FXO,4A167!$
M-&=X4S=&6#),+WII;"\U2S$O*S)J8V8X46IX66PW2B8C>$$[:7)S5F9M=&EY
M9&ER,W8X035X02\U5%!7+W=$=&Y$+VLK;4M#*W)S54]X5CAA9CA!3U4S+T%*
M3F5B+VU#='8X06E*>%-(:T]+6%EQ*R8C>$$[,R\X03$R-R]!344W+W4Q-&]F
M14=+6%EQ>FXX:U O2G-E5V8K67=F.%%B1D)F94=+2%EQ*TEF.$%N22\O04UN
M4#5H+S9-+SA!<4)G>"8C>$$[6D(U<&ER369Y92\X;6PU5R]W0S)J8B\X5$=+
M;#DX67-867$K82\X06Y-<B]!2UI$+W0T+SEI=4M1*V%S575X5BMH+VMN+VQ$
M3D$O-R8C>$$[6C%P+WE95$9I;E=+=DYF*V-J+R]!0U1(;4@O;WHO-FIO355H
M.%%9<&1I<C=&+S5X4R\X04I7=B]!3G1'-"\T:$AI>$PR5$9867$O3B8C>$$[
M8D9K-T98=F8O3TE(+TM:-C,O,GIH+WEF5$9"9E8R2TA9<2M.4"MC<'8O2G)Z
M9CA!349B9CA23TM1.&AX4S=&6#(O.$$K=3-F*T-D+R8C>$$[,V$X55!I1$9,
M<U9:>BM32"]K,E!,4#A!>D=$+T%)9S)+0RLX355/>%8X-F9M>B]Z:FXU,S@T
M9FU"<79M3%1,-U1)8DLK*W(K;$AC>28C>$$[,T-Y:C!B84]&=5%30U)F=%)M
M;$<V67!T:5 X03!+3"M:4#A!,6-T1R]W0U(Y,2\R5%ER869E478K8UDO4'9L
M+WIN;S)T,W0O<%5L<"8C>$$[<#$S1F-4<$1.8TY)55)Q:TE'=#!7=GI)>%5L
M.4XT;V1I<GE0."]V>6DX>69M2BMG9C!,8S)D=BMI+W)F,6HV-CAQ8W9R2&\X
M3TAP4B8C>$$[5%9P-DIR5VU+43AI+W=#:%)F>DHO=T-R;&\S+T%#4'5V*WEB
M1F)D+S!+3"M:4#A!,6-T1R]W0U(Y,2\R5%ER8C9P.'4V9DYP=FPO5"8C>$$[
M3D]N6E=N<W)30S-L6D-3:&5+3E59<5-!85988F)&0UE9<7A(.#)F2T=P96-0
M>2\Q6'DW<&MS34XW9F96+U-K=5=D66@V3GI(33-);R8C>$$[<VIF6FI.2TPQ
M>%8X-F8X05%O=C5K+SA!5GDP8B]K9F1F.6LR2V)D+S!+3"M:4#A!,6-T1R]W
M0U(Y,2\R5%ER8C-V.$%*4'E"<E!K6"8C>$$[>5DR:6%V3F)Z,UIU-6)J;F%-
M-W@X2D91059K4TIQ+T0T66]:.6ER<U9F23,O46]V-6LO.5A,4G8K4CDQ+W="
M:S)+8F0O=T)#:2]M5"8C>$$[+W="6$Q2=BM2.3$O,E19<F(P>CAI4'E2.#$O
M;"]W0UE.4C%(5V)U=W5)3'4P*W)X<EIY5$\T9C%&97)#4TM)56]V:FEP93(T
M;V1I<B8C>$$[-# O-7EM+SAM=DXO>D)7,R]%5&EK4$EC575X5CEV.$$O<G0S
M+V=N9CDR=D9$-&=X4S=&5V,O:V@O=T-463AS+SAX9R\T9S)+0RLX328C>$$[
M54]X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R
M2W5X5C)+=7A6,DMV:E0O04IY;2]W1$IR>F8X=U9T+R8C>$$[>$4T<$1Y2$9,
M<U9F8B\X038W9"\T2C,O04AA.%50:41&3'-66GHK4T@O:S)03% O041'1"]I
M1%EO3#=W>%$W1EA9<3=&6%EQ-T98628C>$$[<3=&6%EQ-T9867$W1EA9<3=&
M6%EQ-T9867$W1EA9<3=&6%EQ-T9867$K3E K8W!V+TIR>F8X=U9T+WA%-'!$
M>4A&3'-69F(O05 V-R8C>$$[9"\T2C,O9')X42M)355U>%9&-E9Q=6\V4G%-
M1W!A8D\Q<F97<F,W9313;DI'<%-O<EAX>%9L,R]!0W4O.#)0*W!M=E!V5"]M
M;D9&3R8C>$$[+W=#5C,O;7@O=T)43F5F96XO3D]+,#<O04I89BMB2"]!1DTQ
M-3DV9C@P-')4=CA!;&0O-7-F.$%5>EAN,W O>E1I=$\O=T-6,R]M>"8C>$$[
M+W="5$YE9F5N+TY/2S W+T%*6&8K8D@O049-,34Y-F8X,#1R5'8X06QD+S5S
M9CA!57I8;C-P+WI4:71/+W=#5C,O;7@O=T)43F5F928C>$$[;B].3TLP-R]!
M2EAF*V)(+T%&33$U.39F.# T<E1V.$%L9"\U<V8X055Z6&XS<"]Z5&ET3R]W
M0U8S+VUX+W="5$YE9F5N+TY/2S W+R8C>$$[04I89BMB2"]!1DTQ-3DV9C@P
M-')4=CA!;&0O-7-F.$%5>EAN,W O>E1I=$\O=T-6,R]M>"]W0E1.969E;B].
M3TLP-R]!2EAF*V)(+R8C>$$[049-,34Y-F8X,#1R5'8X06QD+S5S9CA!57I8
M;C-P+WI4:71/+W=#5C,O;7@O=T)43F5F96XO3D]+,#<O04I89BMB2"]!1DTQ
M-3DV9B8C>$$[.# T<E1V.$%L9"\U<V8X055Z6&XS<"]Z5&ET3R]W0U8S+VUX
M+W="5$YE9F5N+TY/2S W+T%*6&8K8D@O049-,34Y-F8X,#1R5'8X028C>$$[
M;&0O-7-F.$%5>EAN,W O>E1I=$\O=T-6,R]M>"]W0E1.969E;B].3TLP>&IZ
M0C5J,7IZ1'%",4A7<GE3*W9I:7AM-&QP>31P.6MB028C>$$[9$U5<&)I<G-6
M9F(O05 V-V0O-$HS+V1R>%$K24U5=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R
M2W5X5C)+=7A6,DMU>%8R2W5X5C)+=28C>$$[>%8R2W5X5C)+=7A6,DMU>%8R
M2W5X5C)+=G0O+T%.9'4O=T1"3R\W=&5+2'A":6PR2W5X5C)+=7A6,DMU>%8R
M2W5X5C)+=7A6,DMU>"8C>$$[5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R
M2W5X5C)+=7A6,DMU>%8Y=B]!4')T,R]G;F8Y,G9&1"\O,E$]/3PO>&UP1TEM
M9SII;6%G93X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(#PO<F1F.D%L=#X*(" @(" @(" @/"]X;7 Z5&AU;6)N86EL<SX*(" @(" @
M(" @/'AM<$U-.DEN<W1A;F-E240^>&UP+FEI9#IB9#,X93<U,BTR8V,P+3DQ
M-#DM83$P9"UB839F93EE,68R.&8\+WAM<$U-.DEN<W1A;F-E240^"B @(" @
M(" @(#QX;7!-33I$;V-U;65N=$E$/GAM<"YD:60Z8F0S.&4W-3(M,F-C,"TY
M,30Y+6$Q,&0M8F$V9F4Y93%F,CAF/"]X;7!-33I$;V-U;65N=$E$/@H@(" @
M(" @(" \>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/G5U:60Z-40R,#@Y,C0Y
M,T)&1$(Q,3DQ-$$X-3DP1#,Q-3 X0S@\+WAM<$U-.D]R:6=I;F%L1&]C=6UE
M;G1)1#X*(" @(" @(" @/'AM<$U-.E)E;F1I=&EO;D-L87-S/F1E9F%U;'0\
M+WAM<$U-.E)E;F1I=&EO;D-L87-S/@H@(" @(" @(" \>&UP34TZ1&5R:79E
M9$9R;VT@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" \
M<W12968Z:6YS=&%N8V5)1#YX;7 N:6ED.C4P-S8T-V%A+3AC8S0M-#(T-"UB
M834S+68Q,#!A-3)D,3-A,CPO<W12968Z:6YS=&%N8V5)1#X*(" @(" @(" @
M(" @/'-T4F5F.F1O8W5M96YT240^>&UP+F1I9#HU,#<V-#=A82TX8V,T+30R
M-#0M8F$U,RUF,3 P834R9#$S83(\+W-T4F5F.F1O8W5M96YT240^"B @(" @
M(" @(" @(#QS=%)E9CIO<FEG:6YA;$1O8W5M96YT240^=75I9#HU1#(P.#DR
M-#DS0D9$0C$Q.3$T03@U.3!$,S$U,#A#.#PO<W12968Z;W)I9VEN86Q$;V-U
M;65N=$E$/@H@(" @(" @(" @(" \<W12968Z<F5N9&ET:6]N0VQA<W,^9&5F
M875L=#PO<W12968Z<F5N9&ET:6]N0VQA<W,^"B @(" @(" @(#PO>&UP34TZ
M1&5R:79E9$9R;VT^"B @(" @(" @(#QX;7!-33I(:7-T;W)Y/@H@(" @(" @
M(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA
M8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#HX-38W-SE".38W,#!%1C$Q0C-"
M0T1$1$4U,C0Y-38P-SPO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @
M(" @(" @/'-T179T.G=H96X^,C R-"TP-"TR,U0P-SHU.#HQ."LP-3HS,#PO
M<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E
M06=E;G0^061O8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S*3PO<W1%=G0Z
M<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG
M960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R
M8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S
M=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC
M94E$/GAM<"YI:60Z8F0S.&4W-3(M,F-C,"TY,30Y+6$Q,&0M8F$V9F4Y93%F
M,CAF/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z=VAE;CXR,#(U+3 R+3(X5#$U.C$S.C,R*S U.C,P/"]S=$5V=#IW:&5N
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B
M92!);&QU<W1R871O<B R-2XP("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!
M9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%
M=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @
M(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!-33I(:7-T;W)Y/@H@(" @
M(" @(" \:6QL=7-T<F%T;W(Z4W1A<G1U<%!R;V9I;&4^4')I;G0\+VEL;'5S
M=')A=&]R.E-T87)T=7!0<F]F:6QE/@H@(" @(" @(" \:6QL=7-T<F%T;W(Z
M0W)E871O<E-U8E1O;VP^061O8F4@26QL=7-T<F%T;W(\+VEL;'5S=')A=&]R
M.D-R96%T;W)3=6)4;V]L/@H@(" @(" @(" \>&UP5%!G.DAA<U9I<VEB;&5/
M=F5R<')I;G0^5')U93PO>&UP5%!G.DAA<U9I<VEB;&5/=F5R<')I;G0^"B @
M(" @(" @(#QX;7!44&<Z2&%S5FES:6)L951R86YS<&%R96YC>3Y&86QS93PO
M>&UP5%!G.DAA<U9I<VEB;&54<F%N<W!A<F5N8WD^"B @(" @(" @(#QX;7!4
M4&<Z3E!A9V5S/C$\+WAM<%109SI.4&%G97,^"B @(" @(" @(#QX;7!44&<Z
M36%X4&%G95-I>F4@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" \<W1$:6TZ=SXW+C0U-S$P,#PO<W1$:6TZ=SX*(" @(" @(" @(" @
M/'-T1&EM.F@^."XQ.3$U,# \+W-T1&EM.F@^"B @(" @(" @(" @(#QS=$1I
M;3IU;FET/E!O:6YT<SPO<W1$:6TZ=6YI=#X*(" @(" @(" @/"]X;7!44&<Z
M36%X4&%G95-I>F4^"B @(" @(" @(#QX;7!44&<Z4&QA=&5.86UE<SX*(" @
M(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D^0FQA
M8VL\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \
M+WAM<%109SI0;&%T94YA;65S/@H@(" @(" @(" \>&UP5%!G.E-W871C:$=R
M;W5P<SX*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" \>&UP1SIG<F]U<$YA;64^1&5F875L="!3=V%T8V@@1W)O=7 \+WAM
M<$<Z9W)O=7!.86UE/@H@(" @(" @(" @(" @(" @(" \>&UP1SIG<F]U<%1Y
M<&4^,#PO>&UP1SIG<F]U<%1Y<&4^"B @(" @(" @(" @(" @(" @(#QX;7!'
M.D-O;&]R86YT<SX*(" @(" @(" @(" @(" @(" @(" @/')D9CI397$^"B @
M(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB
M4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS
M=V%T8VA.86UE/E=H:71E/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\
M+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P
M,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0FQA8VL\+WAM
M<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'
M.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N
M=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,3 P+C P
M,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIS=V%T8VA.86UE/D--64L@4F5D/"]X;7!'.G-W871C:$YA;64^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO
M>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT
M>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C$P,"XP,# P,# \
M+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z>65L;&]W/C$P,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB
M;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @
M(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S
M;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T
M8VA.86UE/D--64L@665L;&]W/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%
M4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N
M=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXQ
M,# N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @
M(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#35E+
M($=R965N/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXQ,# N
M,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.FUA9V5N=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C$P,"XP,# P,# \
M+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @
M(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D--64L@0WEA;CPO>&UP
M1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,3 P+C P,# P,#PO>&UP
M1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E
M;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY96QL;W<^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P
M,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D
M9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.G-W871C:$YA;64^0TU92R!";'5E/"]X;7!'.G-W871C:$YA;64^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO
M>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT
M>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z8WEA;CXQ,# N,# P,# P/"]X;7!'.F-Y86X^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,3 P+C P,# P
M,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB
M;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @
M(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S
M;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T
M8VA.86UE/D--64L@36%G96YT83PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#
M15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XQ,# N,# P,# P/"]X;7!'.FUA
M9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO
M=SXP+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @
M(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STQ
M-2!-/3$P,"!9/3DP($L],3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T53
M4SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIC>6%N/C$U+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIM86=E;G1A/C$P,"XP,# P,# \+WAM<$<Z;6%G
M96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W
M/CDP+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.F)L86-K/C$P+C P,# P,#PO>&UP1SIB;&%C:SX*(" @
M(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @
M(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,]
M,"!-/3DP(%D].#4@2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\
M+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIM86=E;G1A/CDP+C P,# P,#PO>&UP1SIM86=E;G1A
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^.#4N
M,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @
M(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @
M(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3 @33TX
M,"!9/3DU($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'
M.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^
M,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z;6%G96YT83XX,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/CDU+C P,# P
M,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @
M(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @
M/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STP($T]-3 @63TQ
M,# @2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P
M,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM86=E;G1A/C4P+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,3 P+C P,# P,#PO
M>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STP($T],S4@63TX-2!+
M/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P
M/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.FUA9V5N=&$^,S4N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXX-2XP,# P,# \+WAM<$<Z
M>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C
M:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,]-2!-/3 @63TY,"!+/3 \+WAM
M<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C4N,# P,# P/"]X;7!'
M.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N
M=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z>65L;&]W/CDP+C P,# P,#PO>&UP1SIY96QL;W<^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P
M,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D
M9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.G-W871C:$YA;64^0STR,"!-/3 @63TQ,# @2STP/"]X;7!'.G-W
M871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO
M9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXR,"XP,# P,# \+WAM<$<Z8WEA
M;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP
M+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIY96QL;W<^,3 P+C P,# P,#PO>&UP1SIY96QL;W<^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P
M/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL
M:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54
M>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.G-W871C:$YA;64^0STU,"!-/3 @63TQ,# @2STP/"]X;7!'.G-W871C
M:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^
M0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z8WEA;CXU,"XP,# P,# \+WAM<$<Z8WEA;CX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P
M,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIY96QL;W<^,3 P+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X
M;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*
M(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.G-W871C:$YA;64^0STW-2!-/3 @63TQ,# @2STP/"]X;7!'.G-W871C:$YA
M;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU9
M2SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z8WEA;CXW-2XP,# P,# \+WAM<$<Z8WEA;CX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P
M,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIY96QL;W<^,3 P+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'
M.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W
M871C:$YA;64^0STX-2!-/3$P(%D],3 P($L],3 \+WAM<$<Z<W=A=&-H3F%M
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+
M/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIC>6%N/C@U+C P,# P,#PO>&UP1SIC>6%N/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C$P+C P,# P
M,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIY96QL;W<^,3 P+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C$P+C P,# P,#PO>&UP
M1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB
M4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS
M=V%T8VA.86UE/D,].3 @33TS,"!9/3DU($L],S \+WAM<$<Z<W=A=&-H3F%M
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+
M/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIC>6%N/CDP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C,P+C P,# P
M,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIY96QL;W<^.34N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,S N,# P,# P/"]X;7!'
M.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W
M871C:$YA;64^0STW-2!-/3 @63TW-2!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X
M;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y
M<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIC>6%N/C<U+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X
M;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.GEE;&QO=SXW-2XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C
M:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @
M(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R
M8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.
M86UE/D,].# @33TQ,"!9/30U($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z
M;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y0
M4D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F-Y86X^.# N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,3 N,# P,# P/"]X;7!'
M.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE
M;&QO=SXT-2XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*
M(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE
M/D,]-S @33TQ-2!9/3 @2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%
M4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z8WEA;CXW,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XQ-2XP,# P,# \+WAM<$<Z;6%G
M96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W
M/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @
M(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3@U
M($T]-3 @63TP($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X
M;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y
M86X^.#4N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUA9V5N=&$^-3 N,# P,# P/"]X;7!'.FUA9V5N=&$^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P
M,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STQ,# @33TY
M-2!9/34@2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z
M='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXQ
M,# N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.FUA9V5N=&$^.34N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXU+C P,# P
M,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @
M(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @
M/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STQ,# @33TQ,# @
M63TR-2!+/3(U/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z
M='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXQ
M,# N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.FUA9V5N=&$^,3 P+C P,# P,#PO>&UP1SIM86=E;G1A/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,C4N,# P
M,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z8FQA8VL^,C4N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STW-2!-/3$P
M,"!9/3 @2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z
M='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXW
M-2XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z;6%G96YT83XQ,# N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P
M,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @
M(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @
M/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STU,"!-/3$P,"!9
M/3 @2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXU,"XP
M,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z;6%G96YT83XQ,# N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO
M>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STS-2!-/3$P,"!9/3,U
M($L],3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C,U+C P
M,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM86=E;G1A/C$P,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C,U+C P,# P,#PO
M>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.F)L86-K/C$P+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @
M(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],3 @33TQ,# @63TU
M,"!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C$P+C P
M,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM86=E;G1A/C$P,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C4P+C P,# P,#PO
M>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STP($T].34@63TR,"!+
M/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P
M/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.FUA9V5N=&$^.34N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXR,"XP,# P,# \+WAM<$<Z
M>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C
M:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],C4@33TR-2!9/30P($L],#PO
M>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,C4N,# P,# P/"]X
M;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA
M9V5N=&$^,C4N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXT,"XP,# P,# \+WAM<$<Z>65L
M;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP
M+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F
M.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIS=V%T8VA.86UE/D,]-# @33TT-2!9/34P($L]-3PO>&UP
M1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^-# N,# P,# P/"]X;7!'
M.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N
M=&$^-#4N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.GEE;&QO=SXU,"XP,# P,# \+WAM<$<Z>65L;&]W
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXU+C P
M,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIS=V%T8VA.86UE/D,]-3 @33TU,"!9/38P($L],C4\+WAM<$<Z
M<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C4P+C P,# P,#PO>&UP1SIC
M>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A
M/C4P+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIY96QL;W<^-C N,# P,# P/"]X;7!'.GEE;&QO=SX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,C4N,# P
M,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D
M9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.G-W871C:$YA;64^0STU-2!-/38P(%D]-C4@2STT,#PO>&UP1SIS
M=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM
M;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^-34N,# P,# P/"]X;7!'.F-Y
M86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^
M-C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.GEE;&QO=SXV-2XP,# P,# \+WAM<$<Z>65L;&]W/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXT,"XP,# P
M,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F
M.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S
M951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z<W=A=&-H3F%M93Y#/3(U($T]-# @63TV-2!+/3 \+WAM<$<Z<W=A
M=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D
M93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIC>6%N/C(U+C P,# P,#PO>&UP1SIC>6%N
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C0P
M+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIY96QL;W<^-C4N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \
M+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z<W=A=&-H3F%M93Y#/3,P($T]-3 @63TW-2!+/3$P/"]X;7!'.G-W871C
M:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^
M0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z8WEA;CXS,"XP,# P,# \+WAM<$<Z8WEA;CX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XU,"XP
M,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z>65L;&]W/C<U+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C$P+C P,# P,#PO
M>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIS=V%T8VA.86UE/D,],S4@33TV,"!9/3@P($L],C4\+WAM<$<Z<W=A=&-H
M3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#
M35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIC>6%N/C,U+C P,# P,#PO>&UP1SIC>6%N/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C8P+C P
M,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIY96QL;W<^.# N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,C4N,# P,# P/"]X
M;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*
M(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.G-W871C:$YA;64^0STT,"!-/38U(%D].3 @2STS-3PO>&UP1SIS=V%T8VA.
M86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--
M64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.F-Y86X^-# N,# P,# P/"]X;7!'.F-Y86X^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^-C4N,# P
M,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.GEE;&QO=SXY,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXS-2XP,# P,# \+WAM
M<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@
M(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4]
M(E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M<W=A=&-H3F%M93Y#/30P($T]-S @63TQ,# @2STU,#PO>&UP1SIS=V%T8VA.
M86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--
M64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.F-Y86X^-# N,# P,# P/"]X;7!'.F-Y86X^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^-S N,# P
M,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.GEE;&QO=SXQ,# N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^-3 N,# P,# P/"]X
M;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*
M(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.G-W871C:$YA;64^0STU,"!-/3<P(%D].# @2STW,#PO>&UP1SIS=V%T8VA.
M86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--
M64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.F-Y86X^-3 N,# P,# P/"]X;7!'.F-Y86X^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^-S N,# P
M,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.GEE;&QO=SXX,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXW,"XP,# P,# \+WAM
M<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@
M(" @(" @(" @(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(" @(" @
M(" @(#PO>&UP1SI#;VQO<F%N=',^"B @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @/'AM<$<Z9W)O=7!.86UE/D=R87ES
M/"]X;7!'.F=R;W5P3F%M93X*(" @(" @(" @(" @(" @(" @/'AM<$<Z9W)O
M=7!4>7!E/C$\+WAM<$<Z9W)O=7!4>7!E/@H@(" @(" @(" @(" @(" @(" \
M>&UP1SI#;VQO<F%N=',^"B @(" @(" @(" @(" @(" @(" @(#QR9&8Z4V5Q
M/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z<W=A=&-H3F%M93Y#/3 @33TP(%D],"!+/3$P,#PO>&UP1SIS=V%T8VA.
M86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--
M64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P
M,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXQ,# N,# P,# P/"]X;7!'
M.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W
M871C:$YA;64^0STP($T],"!9/3 @2STY,#PO>&UP1SIS=V%T8VA.86UE/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM
M<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP
M93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP
M1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY
M96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIB;&%C:SXX.2XY.3DT,# \+WAM<$<Z8FQA8VL^
M"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M
M93Y#/3 @33TP(%D],"!+/3@P/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%
M4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N
M=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP
M+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.F)L86-K/C<Y+CDY.#@P,#PO>&UP1SIB;&%C:SX*(" @(" @
M(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @
M(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-
M/3 @63TP($L]-S \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP
M1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N
M/C N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.FUA9V5N=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C N,# P,# P
M/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z8FQA8VL^-CDN.3DY-S P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @
M(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @
M/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STP($T],"!9/3 @
M2STV,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,"XP,# P
M,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z;6%G96YT83XP+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z
M>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C
M:SXU.2XY.3DQ,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @
M(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3 @33TP(%D],"!+/34P/"]X
M;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP
M1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E
M;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY96QL;W<^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C4P+C P
M,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIS=V%T8VA.86UE/D,],"!-/3 @63TP($L]-# \+WAM<$<Z<W=A
M=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D
M93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP
M,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,SDN.3DY-# P/"]X
M;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*
M(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.G-W871C:$YA;64^0STP($T],"!9/3 @2STS,#PO>&UP1SIS=V%T8VA.86UE
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\
M+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO
M>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXR.2XY.3@X,# \+WAM<$<Z8FQA
M8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @
M(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H
M3F%M93Y#/3 @33TP(%D],"!+/3(P/"]X;7!'.G-W871C:$YA;64^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM
M;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!2
M3T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA
M9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO
M=SXP+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.F)L86-K/C$Y+CDY.3<P,#PO>&UP1SIB;&%C:SX*(" @
M(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @
M(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,]
M,"!-/3 @63TP($L],3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO
M>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC
M>6%N/C N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C N,# P
M,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z8FQA8VL^.2XY.3DQ,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @
M(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3 @33TP(%D]
M,"!+/34\+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P
M,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.FUA9V5N=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'
M.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA
M8VL^-"XY.3@X,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @
M(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" \+W)D9CI397$^
M"B @(" @(" @(" @(" @(" @(#PO>&UP1SI#;VQO<F%N=',^"B @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'AM<$<Z
M9W)O=7!.86UE/D)R:6=H=',\+WAM<$<Z9W)O=7!.86UE/@H@(" @(" @(" @
M(" @(" @(" \>&UP1SIG<F]U<%1Y<&4^,3PO>&UP1SIG<F]U<%1Y<&4^"B @
M(" @(" @(" @(" @(" @(#QX;7!'.D-O;&]R86YT<SX*(" @(" @(" @(" @
M(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-/3$P,"!9/3$P
M,"!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P
M,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.FUA9V5N=&$^,3 P+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,3 P+C P,# P,#PO
M>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STP($T]-S4@63TQ,# @
M2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P
M,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIM86=E;G1A/C<U+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,3 P+C P,# P,#PO>&UP
M1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L
M86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @
M(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL
M:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STP($T],3 @63TY-2!+/3 \
M+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X
M;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA
M9V5N=&$^,3 N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXY-2XP,# P,# \+WAM<$<Z>65L
M;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP
M+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F
M.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIS=V%T8VA.86UE/D,].#4@33TQ,"!9/3$P,"!+/3 \+WAM
M<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C@U+C P,# P,#PO>&UP
M1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E
M;G1A/C$P+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIY96QL;W<^,3 P+C P,# P,#PO>&UP1SIY96QL
M;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N
M,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.G-W871C:$YA;64^0STQ,# @33TY,"!9/3 @2STP/"]X;7!'
M.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXQ,# N,# P,# P/"]X;7!'
M.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N
M=&$^.3 N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY96QL;W<^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P
M,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D
M9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.G-W871C:$YA;64^0STV,"!-/3DP(%D],"!+/3 \+WAM<$<Z<W=A
M=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D
M93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIC>6%N/C8P+C P,# P,#PO>&UP1SIC>6%N
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/CDP
M+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIY96QL;W<^,"XP,#,Q,# \+WAM<$<Z>65L;&]W/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,S$P,#PO
M>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @(" @
M(" @(" @/"]X;7!'.D-O;&]R86YT<SX*(" @(" @(" @(" @(" @/"]R9&8Z
M;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!44&<Z
M4W=A=&-H1W)O=7!S/@H@(" @(" @(" \<&1F.E!R;V1U8V5R/D%D;V)E(%!$
M1B!L:6)R87)Y(#$P+C Q/"]P9&8Z4')O9'5C97(^"B @(" @(#PO<F1F.D1E
M<V-R:7!T:6]N/@H@(" \+W)D9CI21$8^"CPO>#IX;7!M971A/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"CP_>'!A8VME="!E;F0](G<B/S[_VP!#  8$!08%
M! 8&!08'!P8("A *"@D)"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G
M*2HI&1\M,"TH,"4H*2C_VP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  B
M !\# 2(  A$! Q$!_\0 &@ ! 0 " P              !P "!@,$!?_$ #<0
M   % P(# @H+          $" P0%!A$2  <3(3$4(P@7&"(R056!D](5%B0T
M-4)287&"L?_$ !4! 0$                    !_\0 %!$!
M         /_:  P# 0 "$0,1 #\ Z.QFTT37]+/).5D9-NLB\,V*5L<@%$H$
M(:XY%'G<PZ1O)LIKVU._%3^31#ME1<#)T$^J.I:E?PK1N_%I]G*)BB.!! 1
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GCMDU52=N6RQ5,U,4P$YK"-LA 1YZ +U:M6BK7,S^\$]_^:M6@__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g888198g01z16.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g888198g01z16.jpg
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M2GX"$O1WW#S++9.BE1[Z.M$]>OI3YI*^&WAO/P^WSKM?F_87*>E+:(Y.U,M
M[][]Q.NG;0[[ =5$07<N*>;3IS\E62W-DNJ*O9L/J;0CT2D'0%8WWD9I^JKU
M_L7]:U.BC3;!Q)S0$$95>NGG+7]:8<#CYF#4*.VXN(\M#:4EQ;(YED#XG7<T
MD*]5C\E'RB@Z;[:9=CN\NV7% 1+BN%MQ*5!0V/(BL"BB@Y )( ^)IQVO@AET
8NVQ)*&8J4/,H< 4^G8!&^O\ =%%"O__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g888198g02x02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g888198g02x02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_[1&84&AO=&]S:&]P(#,N,  X0DE-! 0
M     "$< 5H  QLE1QP!6@ #&R5'' (   (  !P"4  %1&5L=&$ .$))300E
M       0[U)\B%>YQS-0APG\PH!EWCA"24T$.@      ]P   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4    "@!! %  3@ @ "T (  T #, .       #W!R:6YT
M4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <
M"G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@
M  EP<F]O9D--64L .$))300[      (M    $     $      !)P<FEN=$]U
M='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R8F]O;
M4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O
M;VP      $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O;VP
M $)C:V=/8FIC     0       %)'0D,    #     %)D("!D;W5B0&_@
M        1W)N(&1O=6) ;^            !";" @9&]U8D!OX
M $)R9%15;G1&(U)L=                $)L9"!5;G1&(U)L=
M     %)S;'15;G1&(U!X;$!8            "G9E8W1O<D1A=&%B;V]L 0
M  !09U!S96YU;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M            5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C
M0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T
M0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O
M<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))
M30/M       0 &     !  $ 8     $  3A"24T$)@      #@
M   _@   .$))30/R       *  #_______\  #A"24T$#0      !    '@X
M0DE-!!D       0    >.$))30/S       )           ! #A"24TG$
M    "@ !          $X0DE- _4      $@ +V9F  $ ;&9F  8       $
M+V9F  $ H9F:  8       $ ,@    $ 6@    8       $ -0    $ +0
M  8       $X0DE- _@      '   /____________________________\#
MZ     #_____________________________ ^@     ________________
M_____________P/H     /____________________________\#Z   .$))
M300(       0     0   D    )      #A"24T$'@      !      X0DE-
M!!H      T$    &               Y    D     8 9P P #( 80 P #(
M   !                          $              )     Y
M              $                         $     $       !N=6QL
M     @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L
M;VYG          !,969T;&]N9P          0G1O;6QO;F<    Y     %)G
M:'1L;VYG    D     9S;&EC97-6;$QS     4]B:F,    !       %<VQI
M8V4    2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P
M   &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E
M9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S
M3V)J8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F
M=&QO;F<          $)T;VUL;VYG    .0    !29VAT;&]N9P   )     #
M=7)L5$585     $       !N=6QL5$585     $       !-<V=E5$585
M  $       9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O
M; $    (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /
M15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0
M  ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N
M=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L
M;VYG          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T
M;&]N9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@       P
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M &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !0 00!D &\ 8@!E "
M4 !H &\ = !O ', : !O '  (  R #  ,@ Q     0 X0DE-!"(      4)-
M30 J    "  ( 1(  P    $  0   1H !0    $   !N 1L !0    $   !V
M 2@  P    $  @   3$  @   !\   !^ 3(  @   !0   "= 3L  @    8
M  "QAVD !     $   "X    Y    &     !    8     %!9&]B92!0:&]T
M;W-H;W @,C(N," H5VEN9&]W<RD ,C R-3HP,CHR." Q-3HP.#HT. !$96QT
M80    .@ 0 #     ?__  "@ @ $     0   )"@ P $     0   #D
M    !@$#  ,    !  8   $:  4    !   !,@$;  4    !   !.@$H  ,
M   !  (   (!  0    !   !0@("  0    !              !(     0
M $@    !.$))30/]       (          #_X0%*17AI9@  34T *@    @
M" $2  ,    !  $   $:  4    !    ;@$;  4    !    =@$H  ,    !
M  (   $Q  (    ?    ?@$R  (    4    G0$[  (    &    L8=I  0
M   !    N    .0   !@     0   &     !061O8F4@4&AO=&]S:&]P(#(R
M+C @*%=I;F1O=W,I #(P,C4Z,#(Z,C@@,34Z,#@Z-#@ 1&5L=&$    #H $
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M*"@H*"@H*/_  !$( +(!P@,!(@ "$0$#$0'_Q  <   !!0$! 0
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MPYNG<%[F+3;5>?73=B>T.3F.S;)Q%\F+I-TMG9"0FM/4(0JH0A" 0A" 0A"
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MLM4J/DG>2RS'#_-JO[PJP&68Y2 =$^P8DXA3#_FL]4P3[!?I&G^]9ZHP]:F
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M>@6OJA"@$UQ)@?0U#2 ;QN%[;:%.EQK=**H/_+=Z%!E>)Q=%7O;>]@-;>":
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MWTPQMF1M<!IM;?5-W8RXN^1:/\R5)Q!ALP^.IJAW^4?JF_[WP8GYE/\ D/\
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M"*8-PR("UW_FAN&Q,D:YI?<&^Z?H5VFB0VS[\DUEP^&4DN+_ ,"GB%%,&X5
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$$'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g888198g03g03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g888198g03g03.jpg
M_]C_X  02D9)1@ ! 0$#O@.^  #_[0]Z4&AO=&]S:&]P(#,N,  X0DE-! 0
M      << @   @   #A"24T$)0      $.CQ7/,OP1BAHGMGK<5DU;HX0DE-
M!#H      .4    0     0      "W!R:6YT3W5T<'5T    !0    !0<W13
M8F]O; $     26YT965N=6T     26YT90    !#;')M    #W!R:6YT4VEX
M=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$585     $       ]P<FEN
M=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8 ( !3 &4 = !U '
M  IP<F]O9E-E='5P     0    !";'1N96YU;0    QB=6EL=&EN4')O;V8
M   )<')O;V9#35E+ #A"24T$.P     "+0   !     !       2<')I;G1/
M=71P=71/<'1I;VYS    %P    !#<'1N8F]O;       0VQB<F)O;VP
M %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O;VP      $QB;'-B
M;V]L      !.9W1V8F]O;       16UL1&)O;VP      $EN=')B;V]L
M  !"8VMG3V)J8P    $       !21T)#     P    !29" @9&]U8D!OX
M         $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^
M  !"<F1456YT1B-2;'0               !";&0@56YT1B-2;'0
M      !2<VQT56YT1B-0>&Q C?            IV96-T;W)$871A8F]O; $
M    4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M             %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R
M8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C
M=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<         #6-R
M;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"
M24T#[0      $ .^     0 ! [X    !  $X0DE-!"8       X
M    /X   #A"24T$#0      !    !XX0DE-!!D       0    >.$))30/S
M       )           ! #A"24TG$       "@ !          $X0DE- _0
M     !( -0    $ +0    8       $X0DE- _<      !P  /__________
M__________________\#Z   .$))300(       0     0   D    )
M #A"24T$'@      !      X0DE-!!H      T$    &              'J
M   "ZP    8 9P P #, 9P P #,    !                          $
M             NL   'J                      $
M        $     $       !N=6QL     @    9B;W5N9'-/8FIC     0
M     %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M    0G1O;6QO;F<   'J     %)G:'1L;VYG   "ZP    9S;&EC97-6;$QS
M     4]B:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG
M      =G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/
M<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54
M>7!E     $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q    !
M  !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   !
MZ@    !29VAT;&]N9P   NL    #=7)L5$585     $       !N=6QL5$58
M5     $       !-<V=E5$585     $       9A;'1486=415A4     0
M    #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0
M    "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U
M;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F
M875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4
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M$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_
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M)3__V0 X0DE-!"$      %<    ! 0    \ 00!D &\ 8@!E "  4 !H &\
M= !O ', : !O '     4 $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P
M "  ,@ P #( ,0    $ .$))300B      %^34T *@    @ # $   ,    !
M O8   $!  ,    ! ?,   $"  ,    #    G@$&  ,    !  (   $2  ,
M   !  $   $5  ,    !  ,   $:  4    !    I $;  4    !    K $H
M  ,    !  (   $Q  (    ?    M $R  (    4    TX=I  0    !
MZ    2  "  (  @   .^     0   [X    !061O8F4@4&AO=&]S:&]P(#(R
M+C @*%=I;F1O=W,I #(P,C4Z,#,Z,30@,C,Z-30Z,S(    $D   !P    0P
M,C,QH $  P    '__P  H ( !     $   +KH , !     $   'J
M  8! P #     0 &   !&@ %     0   6X!&P %     0   78!*  #
M 0 "   " 0 $     0   7X" @ $     0              2     $   !(
M     3A"24T#_0      "           _^$!AD5X:68  $U- "H    (  P!
M   #     0+V   ! 0 #     0'S   ! @ #     P   )X!!@ #     0 "
M   !$@ #     0 !   !%0 #     0 #   !&@ %     0   *0!&P %
M 0   *P!*  #     0 "   !,0 "    'P   +0!,@ "    %    -.':0 $
M     0   .@   $@  @ "  (   #O@    $   .^     4%D;V)E(%!H;W1O
M<VAO<" R,BXP("A7:6YD;W=S*0 R,#(U.C S.C$T(#(S.C4T.C,R    !)
M  <    $,#(S,: !  ,    !__\  * "  0    !   "ZZ #  0    !   !
MZ@         & 0,  P    $ !@   1H !0    $   %N 1L !0    $   %V
M 2@  P    $  @   @$ !     $   %^ @( !     $              $@
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M".Y7<3Z"0++!!'(/(1$1$1$7&1[8V.>\AK6CDD^BH#<;4U;5.L*6-H/#VUY
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MM?H_;JIH+4-B_E8&/A$9>TGOW42U!F?]LILC7AZFR,=^3&!V*YX;1.=9@?\
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2B(B(B(B(B(B(B(B(B(B(B__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g888198g55g01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g888198g55g01.jpg
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M P,# P,# P,# P,# P,# P,# P,#_\  $0@!#P&+ P$1  (1 0,1 ?_$ /L
M 0 !!0$! 0$            *!08'" D$ P(! 0$  @(# 0$!
M!P@%!@$#! D""A    8" 0(# @0/"0L) PT! 0(#! 4&  <1$@@A$Q0Q"4$B
M%191,B/6%T=7E[?7&#C("HIA<;4V5C=W>!F!0C,DM'5VEK98F%)B<K)#LS1T
M)5-S)I&AL<&"TF-49)34-44G$0 " 0," @0%"1(,! 0%! ,! @, $002!2$&
M,4$3!U%A<2(4@9$R4I-4U!8(H;%"LM(C,W.STW24%35%5387P6)RDL,TQ'65
MQ8:'T8(D-Z+"0U/A@[0E"?!CHR9$9!C_V@ , P$  A$#$0 _ )_&*4Q2F*4Q
M2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q
M2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*5%<]_1WX]W/:CW&:6IG;SNR>UC6
M;-I-Q9YV)BH.G2B,C.DO4_%%D55K'7)ITFJ$>T32Z4U")\$ >GD1$9\[IN4^
M7>8-ER<G><5)YTRM*DLXLO9J;>:P'22:JIW^<_<W\I\QX6%R[FR8N-+A:V55
MC:[=JZW\]&/0 .'@KAG_ &RGO./][:Y?ZHZL^L/)4_=KR-^KHOY\OU=03^^?
MO/\ UO-[G!]ZI_;*>\X_WMKE_JCJSZP\?NUY&_5T7\^7ZNG[Y^\_];S>YP?>
MJ?VRGO./][:Y?ZHZL^L/'[M>1OU=%_/E^KI^^?O/_6\WN<'WJG]LI[SC_>VN
M7^J.K/K#Q^[7D;]71?SY?JZ?OG[S_P!;S>YP?>J?VRGO./\ >VN7^J.K/K#Q
M^[7D;]71?SY?JZ?OG[S_ -;S>YP?>J?VRGO./][:Y?ZHZL^L/'[M>1OU=%_/
ME^KI^^?O/_6\WN<'WJG]LI[SC_>VN7^J.K/K#Q^[7D;]71?SY?JZ?OG[S_UO
M-[G!]ZKL%_:&=YOV+?EW[.]@^5_[$+\J#UOR#2O,^SU^6-]CG[(W1\V?)^4_
MF1_Z?Z;I^3_+^/Z?S?CY&WQ/Y:]/[+T1.S^,_HUM3_8/0^T[/V71K\Z_LNJ]
MN%35^\+G'\E=OZ=)VWQ+]-OIC_K/Y1['M?86OV7F6]C;C:_&I=N5XJV],4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE0I/UFW\[/MY_J[.OPE6;+.]Q
MW[/9GX9_1)5)/E/?M;MW]W'[M)4;;)KJM5,4IBE,4IBE,4IBE=ZOM+_LX_Z?
MF1'^D_\ 67]@JPWZ$_V[_P UJ=UE4ZO53%*8I3%*8I3%*8I3%*8I3%*8I3%*
M8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*
M8I3%*8I3%*8I4*3]9M_.S[>?ZNSK\)5FRSO<=^SV9^&?T2523Y3W[6[=_=Q^
M[25&VR:ZK53%*8I3%*8I3%*8I7>K[2_[./\ I^9$?Z3_ -9?V"K#?H3_ &[_
M ,UJ:A>>XO2.M)]2K7W8U?JU@2:-7YHN5,[1<"R>@<6KHG2U.FJ@L*1@ Q3"
M'44P#X@(!27>>?.3^7\X[;O6?!C9P4-H?4#I;H/18@V/$=8(Z15ULO>MJP9O
M1\N=(YK V-[V/0>BJUKO=.JMM*2J6M[S!6]6#*T/+(Q+@YU6*;X5RM%%DEDD
M5/+7,V4 #  EY*("/.>S8>;>6N9VE78,R'*:'3K"'BH:^DD$ V-CQ\5=N%NF
MW[B6&#*DA2U['HOT?.K*&;%7OK'VPMJZZU/'L)78UOAZ@PE'IHZ.<2ZYD@>/
M2(*.3H-R)IJJJ&302$QA O24..1#D.<'OO,NP\LP)D[]E18L$CZ5+FVIK$V%
M@2; 7/@KQYNX86W(),V18T8V!/6>GA5D5/N=T'>K#&U.H;0K=AL<PHJE&0\:
M=ZN\=G0;JNU_+)Z,"@1%L@<YS&$"E*41$0S#[9WB<D[SG1[9M6XX\^?*2$1-
M19K L;>;U $DG@ *\F/OVT9<RX^-D(\[= %[GK\'@K/&;I67IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE0I/UFW\[/MY_J[.OPE6;+.]QW[/9GX9_1)5)/E/?M;MW
M]W'[M)4;;)KJM5,4IBE,4IBE,4IBE=ZOM+_LX_Z?F1'^D_\ 67]@JPWZ$_V[
M_P UJ5#[Q?1([!UHAM&!9BM:]7HN%Y$J"8G<2='<'!681$"@)E#0*P ^3#^]
M2!P >)\^;7?QR9^6^7UYCPDON6W EK#B^.>+CQ]F?K@\ U^&K;<Z;3Z9@C/A
M%\C'!OX3&?9?S?9>2_AKE+VJ;I4T7N>M6UPX.G5Y,X5F[)%$PIJ5J661*J^,
MF40\Q2#>$2>D^$01,4/ XY6KNVYM;DWFS'W21B-ND/8Y ZNR<B[6Z^S;3(/Y
M)'74?<O[F=IW-,EC]8;S7_DGK_Y39O4\=2;TE4ETDUT%$UD5DR*HK)'*HDJD
MH4#IJ)J$$2'3.00$! 1 0'D,^ABLKJ'0@H1<$<00>@@]8-3H""+CB#4=;OKW
M?]F#=4A%Q+SU%,UKZNJ0'E*=;5]*IKE^=$VGTF,FIZJ10!LF</ R#0A@^F'*
M(]\O.'QJYM?'Q7U;3M]X8['@S@_7I!U&[#0#UJ@/74,<V;K^4MT*1F^+!=%\
M!/T3>J> \0%;H^[2T0$1 RN^+"S )&S$<5^B$73^.UKC9P!9F;1ZRCTGFY%N
M""1RB ^G;&$.2K>,M?)]Y,]%PI>=,Y/K^0#%CW'1$#]<D'VQAI!]JAZGK9^1
M]I[.%MVF'GR>;'XE'LF_YCP'B'CKJYEEJD&J4I/0:+CTBTS%).N>GTRDBS(X
MZO9T^298%.>?@XSS-FX:OV;2Q"3P%EOZU[UUF:('2675X+BJH @( (" @(<@
M(>(" ^P0'Z&>FNRO[BE,4IBE,4IBE,4IBE,4JG)3$2N[,P1E(Y9\7J S))ZV
M4=E$@")@,W(J*P=(!X^'AGG7*Q7E[%)(S-[4,"WK7O7X$L9;0&4MX+B]5'/1
M7[IBE,4IBE,4IBE,4KY++H-DS+.%DD$2!R=590B29 ^B8YQ*4H?OCGY=TC77
M(0JCK)L/FUP2%%V-A7C92\3)&,2/E(Y^8G/65D];.C$X]O4""IQ+Q^[G5%E8
MN0;021N1[5@?G&ORLD;\$93Y"#51SOK]TQ2N*/?+W6[,K^[%Z+JN^S%4B:3#
M,H^>^0U6@%DK-)%"4>>H.NU<&$8Q@NV0 H"'2IY@#XY4;OB[R^8,'F]MFY;S
M9<;%PX563LROGS/Y[7N#[!2B^(ZJB_FKF'.AW0XFWS-''$H#:;<6/$]74+#R
MWKJ!VV6&;M>A=362R2;F9GIJDPTA+2KP2&=/WJZ'4LY<"F1,@JJ&\1X* ?N9
M8GD#.S-RY*VS/SY&FS9L.-G=O9,Q'$FUA<^2M[V2:7(VC'GG8M,T2DD])/AK
M-V;A65IBE4UW-0[!0J+Z6C62QN.E)V^:ME#<^SI(LJ0P\_O9YY<O%@;1-+&C
M>!F /S37X:6)#9V4'QD"O>FHFL0JJ*A%4CAU$43.4Y#E'V&*<HB4P#]$,[U9
M7 92"IZQ7Z!!%QQ%?O.:YIBE,4IBE,4IBE,4J%+^LW%$.['MW./@4W;N]*4>
M0\1)LFR&,']P#A_\N6=[C?V?S!U^F#[FM4E^4\+<V;<>K\G'[L]1L@53,)"E
M4(8R@\$*4Q1,<>0#@A0$1,(B/'ADVA'/0#ZU5GU+T7%ZJ;&)EY-1%*,B)625
M<.R1[=..C'SY1>05Z!3CT"-4%3*OE 4+THEY5-U!P7Q#.J:6+&4ODND:*NHE
MV"@*.EB6(LHZR>'CKTQ8N5.;012R$FWFHS<?!P!X^*KWA].[;L!FA836-]DO
M7O74:T.A5)DJ*\@Q3,L\8@X7:(MR.VR91$R9CE,'@''(@ ZUN//').SJS;KO
M.TXP1 [=IF8Z$*38,09 =)/7:U9:#E?F;*MZ/M^:P-[?69 .'3Q*@>O608?M
M-[BYQHV>L]4V)%!T_/'$"4-'P[E%1,RI%7+MG)O6KMI'IJHF**ZA 3$0#@1
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M8#>21L^61P/HTOTC5N^7_59/M;?.-1-R6"P^D)_\0S__ (<O_P#MRG_LP_\
MU>?,T9N=V8^OS]'_ +C_ %55[$\^GV;]'MC_ ,:EJU@1-6J\8PB8QH.)$QC"
M(F,(L&XB(B/(B(C\.?3C;N.WP$]/8I]**L/!]@3^0/G5&L[J9J=1[CMVH-IV
M:;)IWZ8(@FWEI%%)  (WZ 222<E33*0?$   #/G_ -Y.7F+S[NZ1S3*HS7L
M[@#HZ #85"&_RS#>LI5=P.V/6?%XZRWW!]\%ZV=6JI2*?+2M2K3.HUYO=GK-
MPI'35LM8Q;8DZW5?H'(Z;5QJ]ZTTTDSE%V/4=41()"!L_/'?!O/,6WXVS[7+
M)B[>F+$,AE)62:;0.T!8&XB#7  (U\2UQ8#(;QS5EY\$>+C,T< C4.1P9WL-
M0OTZ0>  Z>OA853?=_P3MSW349ZZ8/$TV4-=)3U3AFX3(J;YMO61#E<*IE*J
M85) !Y PB.>?N1PY).\C#ED1PJ19#W*D7^M,M[D<>+5^.3XF;?XF8&P5S>Q]
MJ1_#4B;+VU,]6S=*NQN]1LU/DCJIL;-!R<(Y60.=-PW3DF:K7U+=1,Q#IN&I
ME 43, @)3E 0',?NVW0[OM>1M>02(<B%XR1P(#J1<'J(O<'PBNC*@7*QWQG]
M@Z%3XKBU_4J*W9RWJD6F?JLM/V%I/U*=D(5Z/RS* 9*2AGJC85TP%UXD.J@"
MJ8^P2B ^P<^;>XC>=GW&?;<J>=<W%F:-OKC\'C8B_LO"+CQ6J 9_2\6=\>1W
M$T;E3YQZ5-O#ZM2<-$;%1VSJ#7VP"'*9Q8:VQ6E2E$OU&=:%&/GFX@7Z7R9A
MHN4 ^@ 9]#>3-^7F;E;!WL&[SXZE_%(OFR#U'5A4Z;3FC<=MAS/HG07_ )0X
M-\T&M6/>-[/6HVC$:I&/5F4WLN>:PJ:C951!TG Q IS,\NBND<BJ0',BV;&$
MH@(E="'/CD;]_7,3[/R<-LQW*9FX3B,$&Q$:6DD((XCH1#;J>L!SKGG$VH8\
M9(EG<+PZ=(\YOX!ZM<M^SFEV#;?<!285Y+3SJOUUR:[6<BDO**-SQ=<41<-F
M;DOJND4I.:4:MS%'P,10W[N5R[JMHS>9^=\/$EEG;!@;TB:[N1HB((4^=T/(
M44^$$UH7+6--N.\11,SF%#K;B>A>@'CUM8>K79;NY[FF?;C1FKF.;-9:_6M5
MTPI\0[,86:(M4TS2$_*D2,18\9$@NF'EE,4SA=0B8&* G.2U_>AWA1<A;,LF
M.JR[WDDK C>Q%@-4C@6.A+C@""S$+<"Y$F<Q[ZNRX@9 &S)+A >CATL?$.'E
M) K@39+QN3?5J32G)JY['LLLNIZ"!9 _D4P$>5#MX:L19/0,6J)1$1*@W*4I
M?$P^T<I/G[QS7SIN07,FR\_<)2=,:ZF'AM'"GFJ!_%4 #IJ(9\K<]WR+2M+/
M.QX*+G^:HX >05Y+'K+;^I!8S5GI-]UWYS@A(Z;=QLM $%V =9$F\NV\E-)X
M !R4GFE4\.0#PSJS^7N:>6"F7N.)FX%V\V1D>/SNFP<6 ;Q7OXJ_,V#N6W6E
MGBFAX\&(*\?$PZ_5KHSV7]\-K5M4'J/<TRK88VPN48FI7:3.!IF-F5QZ&$/8
M'O #*,)-8011=*\N$ES%*H<Y#<ISSW3=\&YMN4/*_-DIGQYV"09#_9$D/L4E
M;Z-7/FJ[><K$!B0;KNG+'-60<A=NW-M<;FR.?9!CT*QZP>@$\0;7N#PW.[U+
M-W!05$KT?V^PUAD)BQ3+R/LDE5H-69G86%3C5%4EF"I053B5';L03]3Y9E"_
M]F8AOC!+/>WN'/&'LT$'(\4[Y<\K+*\,9DDCC"$@J>(0EN&JQ(^A(/&MGYGG
MWB+$1-G5S*[$,46[*MNKP7/7T^"U1W9?Y5"6E GC/SSA9%Z29-*JKK2@RJ;E
M1.0"15='4<J/BNRG!45#"?K >1YRBF5Z3Z3(,W6<P2,)-9)?6"0VHGB6U7O?
MC?IJ&9.T[1NVOVNHZK]-[\;WXWOTWK,$!IKN.G82+F*OKW;<G79%FDZAG\*P
ML"L4[8*AU(+L#ME00,V.7Q*)  O'LS:<+E/GW,Q(\K;L'=),&1 8VC64HRGH
M*V-K>"U9.';-[EB62"'(:%A=2H:Q'BMU5W8[(*Y<JIV\5>%OL18(.RMYBV*N
MXZSI.T9A)!S8I!9F==-\8S@$UFQRF3Y'@2"''AER^Y_ W;;.1,;$WJ*>'<%E
MF++,&#@&5BMPW&Q%B/%4K\K09./LT<66KI.&>X:]_9&W3QZ.BN?/>5WO6^:M
MDYJ[3T^ZK-2KKMU#6"UPK@6\W:9=JH9O)-HV40,"T7 ,5R&1 [<Q%G9RF,*@
M)"4IH.[U^]_=,S<IN7.5IVQ]L@8QRS1FTDS@V<(XXI&INMU(9R"=6FP.G<R\
MU9,N0^!MKE,="59UX,Y'2 >I1T<.)\-JU'HG:UW#;EA1NM7HDK/0[PRJC:?G
MIF+C1FA3.<BJT:M8Y-J\E4_.(8OG$ R1C@( <1 <C#9>[CGGFO$_*^VX4LV(
MUR)9)$3M./$H97#.+\-0\TGKK7,38-YW.+TK'A9XS]$S :O)J()\O1XZI]8V
M+OOMANZ\:QD[/1Y^%<H_+%+G3.5H-\D8H*)I24"NLI&O6+U W*3EOP82&ZT5
M@'@V=&W;[SIW=[PV/#)D8>;"P[2"2YC8=-GC)*,K#H=>-N*/UU^(,W=]BRBB
M-)%,AXHU])\J]!!ZB/*#4A7MXW;#[_U?"[ BVX1SU4ZT59(7S16&$L<>"82+
M$JHE*99J<JI%VYQ !.W6((@!N0"\W(O-^+SMR[#O>.O9S$E)8[W[.5;:EOU@
MW#*>M6%^-Q4R;-ND>\8"YB#2_0R^U8=(\G6/$16<,W"LK6A.]^_JE:,V'-ZT
M?:[NUBG8)M$N7+QFZKD?#+$F8U"4:*-G#J54?G0*BX AS"V P*D, %$  PQ=
MSEWL\O<D;D=HW2#-?-[!94[-$*.&+* &:12+%6!)6UQ:M3W;FS&VG+?#EAE:
M55!!\T*U_ ;DVZKVZ01:M:Y/WK;LQ3!":*2(;S! JLSL40X2  ^.9M'TQ<!.
M8?#I\X  /'D?9F@97RD=C34,+;,R0V&DO)%&">&H,%,A  O8C5<VN!6%E[P%
MXB'%/5;4X'EN I]2Q/C K'LC[TK<BXC\E:VUG%E$!X]<ZM,Z8@_WOQT7M>*K
M^[\4O'L\?;F!R_E)YA+>@;1$HU#3VD[-P^B#!(UN2>@AA8=(->*3G[.)/8P1
M*+BURS<.L&VF]^H\+> UCJ3]X[W0R ']+(Z^A.KJ-S$T950R?)A$@)FF[!-%
M!,A1X^.4XF$.>H/9F"R_E&<W27]&Q-NA4O<7$KD+[0DR*#?IU *>'EKQR<[[
MT]]'8H-5Q92>'M>)XCQ\#6-YCOI[I),.AUN9W&%/R!2Q->H<0(' /C"DH6M&
M<"/[ACG /H<^.8&;OY[Q9VO#DXL85RUDQXSP/0IUZ[J.J_G>%C7BDYNWY^)R
M MF)X*@Z>H\.('5?CXZT_P!NJ06_[!&6/>CJ&VW8F\*6!@):_K1<Y(-(6/>K
MRZ["OJ. (#1!-\^,NX](4@F%0OF")0( 93:^]WY0*8AQ^7=SWZ. 2LSC$@91
MJ<*!VG907Z!9 YX"^GK-:MNN-C;YD+E;Y%#E9$::5>9$<JMRVD%P;"YO:L8?
M+/;E7S"J22TA#GF2A:2F:KT1F$B,&)NB9:E;"1-5Y'F*/EF1#SP,  0!'C,B
M-K^59S+YC1<]9*H>R\\[@H7M.E27*#2W66\T#I(%ZQXR.7L#HDVZ"_G<&QX^
MCZ+@1T>'JJCONZ+MPA$UEC;:HX^H9GLIDX=P,@L^43ZDO,!.+:K>;8C@V I&
MZHE>F*!."](D$>Z#Y-'RD]]8#)V'=39NROE9,2  \>/;9%^RX\2 4O?KO7CE
MYUY6QP=>YX@X7LLFJ_J)JN?%T^*LITJ_UW8T,E9:B]>2]=?II*,)Q1@_CV,L
M4QE4UO0EDT6CUR#)= R2IA1*F"@<$,</'(JY_P"[7F/NRW=-@YPCPX=],>MH
M(IXIY(5/L#-V19(S(#KC4L7*><54$7S.%G8NZ8:;AA2=KB2WTM9AJ -B0'53
M:X(!M8D&W15W"(C[1Y_?S2  . Z*]-<M?>8&:"SU 05(TLAZRW*>5Z4XS3AC
MZ>'3\T7Y4!3"(9N  ODG5 PKK]1""!5#%^G'_P"/7T[\D\TANT.UC)PPGG^8
MLNB<R6COP9E*%G LP4 FX J&.^8Q^A[<"1V_:S6%N.C3'?C:P4-;A?B3<#I-
M<I,^C50+3%*[U?:7_9Q_T_,B/])_ZR_L%6&_0G^W?^:U.ZRJ=7JK2'OPT0.X
M=/.IR$9>HO&M@=V6"!%,#.I.)*B4;) $XX,H9XQ0!=$GB)G+9,H!\<<B#OGY
M,^-7*S9F&FK>-OU2QV'%TM]=C\>I1J4=;HH'36K<V[3^4MM,L0OE079?"1]$
MOJ@7'C J.X E$ -X<<<@(^'Q1X'X?8&44X=-0S7>KW=6B!U[K1?:,^R%&V;/
M1;KQY%TQ(XBZ.@<58=  . '3/.K#ZY0/[Y(6X#XDRZ7<1R9^0^7VYCS4MN>X
M@%;CBF..*#Q=H?KA\(T>"I;Y+VGT/!.?,+9$XX>$1CH_G>R\EJNKWC-E>0';
M/,,F:ADOG;:ZO6'9B#TF,Q5<N)IVB(AX]#A.$\LP?"4PA[!S)=_.X2X/=]+#
M$;>E9,,)_DDF0CU1'8^(UZ.=)VAV-E7_ -21%/DOJ/KZ;5QN[5:1&[$[AM5U
M69;)/8=Q8QE)1DN4#MWK*NQSZP'9."#X*-G:D85-0H^!B&$!\!RJ7=ML^/OO
M/.V[;EJ'Q6GUNIZ&6)6ETGPAB@!'6":C38,5,W><?'E%XB]R.HA06L?$;6J3
MZ  4 *4 *4H !2@     <   '@  &?1,  6'14[U'H]X?0XJE=Q;Y]#-$6+6
M]UB)N+ILW(5-'Y96=R4/+.2D+P4IWZT45PH/]\LJ<P^(CE&>_39<;:.>WFQ%
M"1YN.DY X#M"SHYM_&*!CX6)/74-\YXD>+O1>( ++&'(_C7()]6USXR:W&]U
MC:'CVB;2IRZICM*[:H:;CDS"(@B6SQCE%ZFGS]*07,!Y@A[.M01]HCDJ?)OW
M&6;9MRVIS>*#)CD4>#MD(8#Q7COY2:V7D'(9L3(QB?-216'_ ##C\U?FUK![
MS3\X>'_HOKG\/6S(\^4+^W47]W1?=)JP///YZ7\'7Z9ZV4]U5_$W<7^EU;_@
M)?-_^39^:MU_"HON9K.<@?U;)^V+]+73.]?Q(N/^BMA_@AYE@]Z_,^7^#2_2
M-6\Y?]5E^UM\XU$A)_X0G_ER_P#=AGS%'V,>2J[#V/J5+KJW\6:[_F*(_@]O
MGU!V[\WP?:4^E%6+Q_L"?R!\X5&;[J_SE-W?T@S'_4;9\^.\K]O]W_#G_@J#
MN8/SYE?;C_!72OW=/;Q2%=?)[LM,''V"T3TQ*LZN:5:HOFM<AX1ZI&'<Q[5P
M51!*6D)%JL8[@2BJ1$I"IB4!/UV [A^1=H;8QS=N4*3[C-*ZPZP&$4<;%+J#
M<!V<,2UKA0 I'&^[\E[-BG#_ "I.@>=V(6XN%"FUP/"2#QZ;6MUUU4 A Z>"
M%#H#@G!0#H#CC@OA\4./H99*P%K#HK?["OUG-<TQ2N"_O*-5_-#<<7L1@V\N
M(V?$ =Z<B8%2):ZVFW82(")? #OH@[-7QX$YRJC]$<I;W_\ +?Y+YKCWV!;8
MNXQ>=X.VB 5OYR:&\9#&HDYWV_T;<US4'UN=>/\ +7@?7%CZ];&^ZZV5Z^J7
M[4[U?EQ6I1"X021A$3#$6  9RZ27(^"3.89D4$ \.I[^[F^_)SY@[?;<WEF9
MO/QY!/&/XDGFN!XE=0?+)6:Y"SM>/-MS'BC:U\C<#ZS"_P#S5JC[Q;907;?R
MU79N 5B-8PK6N$*0XF2&>DP3F; KQSP"J0+-FI_H&;"&1IW[\P?E?G8[=$U\
M7;H1%XNT>TDA\HNB'QI6O\Z9WI6\''4_6X%"_P#,?.;^ >I6Y_NR-5_-_6UF
MVK(M>B2V!*_)4*JHGPH2K5E59N95$X_]E)3RCGJ^ P-DQR6?D\\M^@[!D<RS
MK:?.ET1D]/8PDBX\3R%K^'0IK9N1=O['"DW!QY\S67^0O_%K^L*TL]X]97DU
MW*/X990QF=.I]7B6*//Q$S2C92Q/%"E]@'7/*D P^T03*'P!D2=_>X2Y?> ^
M(Y^M8F+"BCP:P96/JZQ?R#P5K'.L[2[X8C[&*) /5&H_/^96UWNM*-&)5/9.
MR%FJ*LT_L;:G,7AR 9=G$148REWC=N<?%,C]]+$,KQ]/Z=/GZ4,DOY..SXR[
M9N&_LH.6^0(%;K5$178#P!F<7\.E?!6P<@XL8QY\T@=J7" ^   FWE)X^05T
MEV;1X?9- MU&GFB3R-LD%(1JB:I /Y+A5N<6+U'G_!NX]Z5-=$X>)%4RB'LR
M?N8=GQ=_V3*V?-4-CY$+)QZB1YK#P,K693U$ UN^=BQ9N')BS %'0C_@?*#8
MCQU$] [J/6!1)4R+^/7ZTETQ$IT7K%7J362,7@2G2<) 8HAX@(9\S[R0-=21
M-&>!'4RG@1Y"+BJ]W9#<<'!^:*ED:WL*MNUY1+4N("O9:=69YQQX #B6A63]
M< ^#P57$,^F6P9[;IL6%N3^SR,2*0^5XU8_--6%PICDX<.0>EXE;UU!J+;M#
M^<[9/](-V_VFE,^<O,?[1;A^'9'W5Z@7/_KT_P!N?Z8U(_[2_P VK2?]'T#_
M )-E]^[+_M_M'X#'\ZIKY>_,>+]I6K^W'9G%,U+LRV-#F3>5VB6J79*%'@R;
MUC"/5V9P'Z)'1"#_ ',S?->XOM/+&X;G$;2P84SJ? RQL5^;:O7N<YQ=NGR%
M]DD+D>4*;?-J*2GP<Q/5&54*<Y!='*;ZNJ4Q@%P8IS?]LH F$##_ 'P\CGS4
M6Q([2Y!/'PGP^J?GU7X<?9>K_#79R$]YSJNNPT5 1&G[NSBH2.91,:T1DJT1
M)LQCVR;1J@0A78 4J2"10#][+8XGRAN6\'$BPL7:LQ,:&-40!XK!5 4#IZ@*
MDV+GK AB6&/&E$:* !=>  L*T@[O.XJF]R%BI]GK=-FJI*0,1)0LPO,+QBZD
MJS5=MWD21,T<JJ(_)RIG7^$^!?@/AR'^]'GO:N?L_%W' Q)L;)@B>-RY0ZU+
M!DMI)]B=?3[;A6J\Q[UC;W-%/#$T<B*5-R#<7!'1X./KUN1[JB7<F;;JKYCF
M,S1=4J;13$PB5)T\0L$>Z.0O/2!ET8Y$#?1\L,E;Y-F5(8]WPB?K0;'D \!8
M2J?7"K?R"ME[OY&TY4/T(*-ZI# _.%=>LM'4CU'W]Y-%#'=S2CW@X%GM:4N3
M+R4O08[>1M4*H<AP#D1$L60#%'Q+T@/L-E.?E&X@BYJP<L+838%B=5]1CE?Z
M&_F@!QU#42>FQJ(>>(M&\B2U@\*F][WL2.CJMP\IK*/9[V7:;WUJ)ML&YRM]
M"<"TV.$?QT'8(Z+ADTX9_P!+ B)"02DH0Z\:LB=?ET(BJ)NGI+P&;;W8]U?(
MO,G*&#OVYXT\N=()1)JED1&999$N%1QYJ@#205)(NP/7DN7.6MJW7;8\W($O
M:ZF##5938D"W78"W$$<1X*W88>[X[4(5$[B0I<K)HMDSKN'$]?KGY!"(E$YU
MUP:3T<U132(41-P4J? ")@]HY*.+W1=W&*%";5 [*I%Y#)(3<_1!W8$CH!M<
M#H-;+'RCR_"H+1%M(-RSMU]9X@7'4;"U7?4^U'L^>M4I:JZIU?96)5E4TY)/
MR;BS]20 !8 =O7TN@=R0#!U")A.7GQ]N9W"Y+Y*QT#86V;=H[/1<01-=0>@D
MJ=1N.+$EKCB:]6/L7+S('Q\>!TTZ;\'!'C))N?&>/CK,<7I33<(!0A]3:UBQ
M* <&CZ+6&A_#X140BR',8?A$1$1'VYGH-MV[&!7&@AC4H%.E%6ZCH7@!YHZA
MT"LBFW;?&+1P0@:0."+T#H!X<0*AW_K,C)FP[H>V]FQ:MV3-+M^E#)-&B*;=
MJD<=B3*8G3;HE(B0XD(!>0 !X  ]@!EJ^XQW78<T@D'TM>OP1K;UJIC\IT <
MT[:HX+^3SP_^<]1M 22#GA-,.H0,/!"AR8/8(^'B(9-A9CTDU6?2HZ *V[[4
M>VAYO:S'E; B\9:RKJXEG7R0K-%I]^"?4G785YY"J0K(G424>F 0,DW,!2B!
MU"B6N_RB>_G;.Y+E7M<;LLCG?.5EPL=N(!'!LB=00P@CZO\ W9+1CAJ*R+R#
MR4W,V6<W/##88&L_2#,]@>Q1AT=(,C#V*< 0S+;O#'Q["(8-(V-:-8Z-CVR;
M9FS:(I-6C1L@3I(FDBD5-%%,A0Y\  /ASXB;ONVZ<P;KD;UO4\N5O&7,9)97
M)9Y)'/$D]))X!5'  !5%@!5GE4 +'&H" !5518  655 Z !8 #H'"L9U7<E2
MO&QK=KJIK?+B]%A6,I9K"P=,W4$U>R;T&;*#;.6ZRHNY$OEJF7Z0\M$4^@3"
M?J*65^;NX[FWD/NSVWO&YL PVW;.$$&$Z,,A8NQDE[>:]A%JT )$07TMJ?0;
M*<5B;WMF?N61M6%()<K%16D*V**6)&C4#Q=;78 %5OI)U J-&O>7QJ0P6HIG
M_P!**NG-VF)'E(WRZNBO'1STH$7!+I&%9G;")TQ/R#AP4P%'D1"X/_X],]O_
M .U[23)H'H$XX_6P3Z1&>%_9M8<;>Q6U^ J,.^6&^VX&1PNN1*OC\Y%/K>9Q
M\=JY,9]*:@*F*5WJ^TO^SC_I^9$?Z3_UE_8*L-^A/]N_\UJ=UE4ZO57E>_\
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M2Z:M_%FN_P"8HC^#V^?4';OS?!]I3Z458K'^P)_('SA49ONK_.4W=_2#,?\
M4;9\^.\K]O\ =_PY_P""H.Y@_/F5]N/\%=M^P+\U76__ +^X?[9S^6\[DO\
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MW@&KIZR?%6R7NMY7U.D[Y#B)!&&VO(J$ H^)49:HU!X!3EX#I.+@JIOA 0,
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M;YYJN; W/E-2MM._S1ZL_HXI'M\!_BS&?!GTKY5_9C;?P#'^Y)5@=M_-V/\
M:$^E%7;8Z_$6R FJQ/LDI&$L$6^AY9BL'*;IA(MU&KI$1]I1,DJ/!@X,4>!
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M* %*4  I0     .   #P  #.T  6'17ZK^XI7\$ , E, &*8! Q1 ! 0$.!
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M%P5!/I-YG >/@/.1MWJ\U;MR=RH=ZV81'+&3$A[12RZ7)!X!E-[VL;^I6O\
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MWZ$_V[_S6IP6R[PTUIK^X; ?,',HSI\!(3[F.9*(I.WJ,>@9<[=NHX$J)%5
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M[<;GJKF_VM[MBNW[:A=A3,%)V)D6M34%\G1*[-N[\Z45CU$U_,>G(AY27HA
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M1QN#X*ZS:+[*-9Z!O![[4[%=Y25/!R$"+:P/H5Q'@TDEV*ZRH)L(*.7]00[
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M'NR[C)MFXQ92$A-0##PH39@?GCP$"I'&_! =&;B$! 0'5]Z$! >0$!K$F("
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MD'DE%M%R_P#*1<O&Z"I?_M)J"&?.?%C67(BB?V#R(I\A8 _,-0-&H:15/06
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MD!'R-WF%#11&*JKJUJM &1*9(RDXW2C6C0&[I4"&+Y!A6:E X\)\@40TK/\
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M9HI.<LR2%D>-NR-U((/UF,'BMP3<<>/EXUK1DVUI%=ZOM+_LX_Z?F1'^D_\
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M>3R!M.1MN3DIDO/D]J&5"@ T*EK%FN?-O>_766Y=V639,:2"202%Y-5P"+<
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MGI\5;[;%JZUWH%WIC9XE'N+94[!7$'ZZ)W"+)6:BG4<FZ503.D=9-N=P!S%
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M@^DVT,R772=+>JEGJ:ZC*.;I-$'"ZSQYZ8Y44RE$RJG!"@)S%*.T[IO&V[+
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MW.FX"KI%NLW)L+<?+8:KMO84@@]?T)K46D;H[;5$3;/K9"2CY[;[HPJ*,>*
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MD%"1("0"G$5D5W2 &1<A7A:./M#K XIQ\X:2W6+$<&!MPXU^8O=U>67=M[1
M6W71T*E*7MH-XC6#).4J4$1!2=E&1XB5FBI+PB3M$[MDY\A^@18AC(\<B'&-
MS?@N[1[C#E8##%?)7TA54/!'8R.I1Y+&,,I>-],BA@2G3;B/=822LZ20D1F0
M=H +HOLB+%O8W%U-F%QPK&[[?KI2\ZW%>#N5'I<K4=F729"U0,80T]7*U7HJ
M782C$8Q[-/F*S K@RBC%46C_ *52]: AX!@9N=I6WC;R\.7A[3+BY<\G;1I]
M<BBB1U==#2,I6Y)C;1)YPU)X/$^[L<N"Z2Q8K1RNVM1YRJH((L6(MTE39N(N
M*S=1;VI>6HORTVVUF/68QLI$O[&2N^EG(Z52.X:.8X\#8ITQ3>0!3J)N 04(
M"A>2\B(!M^S;TV\Q]L,3*QX"B.C2]EID5Q=2ICEDZK$AM)%QPK*8F6<M=?92
M1H0""VFS ]!&EF]8V-8=+O)]6[CO!G88&X6*LZ^LL(HI*5V$BEXZF51UKZJS
M;YS)G5?QLG+^3(.GKM5-FC(.T6_QA(4GE@.JCG&;;]UWB'.ARI]OP<B,EXHT
M*P0MC0R,7NRN]F,CL$65U7B0!I!QOY5>#)RDF25X(77BJBR(8T8D\03Q+$V#
M$#JM:KZM&\:Q6W<F@VA[1;&==K\?;+?,5-@PD8NI5N52<.F$G**NI1@X>BXC
MV:KL&T>D]=@T3\T4@*9/KS.X\X[=@2R)'%DY44$"S3O"JLD,3@E7<EU+752^
MB(2/H&K38K?US[K! S!5DD5$#N4 (13Q!-R";@$V4,;<;=%[9:;C0B;)N:0G
MI163J-9=ZM;TUC#QZ+Z0D7-ZKD>JRC(1)HF1U,/['-R*16Y3G$ %0/C$3 PA
MCX^:TQ<_=I\V0R;7CMAB!8U#,QR(E*I&%%W:61AI!/7TA;D="[F(Y\EYFU8T
M9BT!1<DR*+!;<6+,1;R]0JXD=YUU)PK&V"NV^I3K6=I4*_@IYA%>M9(;!E5(
M*JV([N)FI6'=5M]-HF9J.&[I8S9R42*D(/'/N7G+ 60X^=!E8N8LV/&T<BIJ
M49+F.&74DCQF)I 4+*[%7X, :[ANT(8I,DD<H=%*L!<=H=*-<,05+>;<$V/
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M3M(!Z/'CLRA;K*Q5"55C&%(!+,"0.F;;\\OE"!XNQRB+Z@VI!V:H2+<&-A<
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M3F50 W:$]-B;6MX_+XK7\QNNK(*^]QKN"[J]+AKGN!;W-Y*14A%V4]G:3<_
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ME,4IBE,4IBE,4IBE,4I^[G&E=6JPU>'KI3.:4Q2F*4Q2F*4S@@,-+ %32F
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M$.D1#%*NEHT:1[1JP8-6[)BR;HM&3)HBFV:-&C9,J+=JU;HE(BW;MT2 0A"
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MS_YNF[_Z+KK_  "]S3.\7]@]X_NW(^YM6)W[\RY7X._TIK+E<_B] _YFB_\
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MU>B+39E+I9(V'CV4[;58B/@%++*MFR:3Z;4@XD"Q<2>2<%,J+=N (I=723P
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;NPOZ;B6U?E+M->KM[=C;AV]^PU_6^TU\*__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g888198g55g02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g888198g55g02.jpg
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M P,# P,# P,# P,# P,# P,# P,#_\  $0@ )0 K P$1  (1 0,1 ?_$ ,0
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K;7_\DY?W7+>B7UVGNSC_  _,?N^)Z^,_XQP^OA]V>O3E]?\ #U^WJQ__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g888198g55g03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g888198g55g03.jpg
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M P,# P,# P,# P,# P,# P,# P,#_\  $0@ *@ = P$1  (1 0,1 ?_$ +$
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M0J2U;6KJBHI*0ERHI7 AU(==BA12% 'Q=H,<HCB.(("$B<(XZ^_._8>Z9*>
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6^9S?B_E8L/\ TW^AX?\ 'X_8^WC_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g888198g55g04.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g888198g55g04.jpg
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M P,# P,# P,# P,# P,# P,# P,#_\  $0@ *0 I P$1  (1 0,1 ?_$ )
M  (# 0$!               (!08'"0,* 0 " P$! 0              !00&
M!P,! A   04!  $$ @$$ P       @$#! 4&!P 1(1(($Q8402(5"287&!$
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M(W.^W1/S;=6_2?=>YQ<8K1WO7<;F6>C971N5TSMG%;.%%NF=4S2QHT.'O</
MM ?AL[S/UT)I#B>@LVD9@03XR ;)<S[+@K.+NS=DQ=<7L=8*&_095<3B,!5L
M5U<%19B55W3A9U4#B15)KV0I25IGR%9/F@?8SPD ^_J !(@/'R* ./#@ <,
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61X:-'AHT>&C1X:-'AHT>&C1X:-?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g888198g55g05.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g888198g55g05.jpg
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M P,# P,# P,# P,# P,# P,# P,#_\  $0@ *@ H P$1  (1 0,1 ?_$ )4
M  ,! 0$               8'" 4 "@$  @,! 0              !08#! <
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M_2N,OV39"CUE?3.EH_8$@GZ9I8\Q-7%#(9$C!!8NE_/;*5P[.?-7)YT>%/\
MK2>=>HCWXLBM5J IT!$5:K1+*"KT$Q0C8B)CD009L6;<OBFBD0.1$?Q,8YA$
MZAQ$QA$PB(ZM;[?"M4)JW6YI#,%E 0A"11*4C@!^I.9-222:X96&&8S*8\=(
M0R@4 '  8W/5S$N.]=CL"<S_ ".K?Q/\9;_V?Y'_ +;/^+?U_P"7_I]OT-E_
GWT;^V^/YGS>"?D_\_9IQ7=^>W\OGYO-R\GZ_A@L]$L6,=Z['8__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g888198g55g55.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g888198g55g55.jpg
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M P,# P,# P,# P,# P,# P,# P,#_\  $0@ + !D P$1  (1 0,1 ?_$ *@
M  $$ @,!               &!P@) @H! P4$ 0 !! ,! 0
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M ]0LC?"YK8RX0\/ZOPSP\C0(J1"R6R=??,>1;@+?RGS#95&Z38J<>V,8ZC.
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-HHT44:**-%%&BBO_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g888198g56g01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g888198g56g01.jpg
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M P,# P,# P,# P,# P,# P,# P,#_\  $0@ %  4 P$1  (1 0,1 ?_$ '0
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L6IUGDM'(!'O_ /=8^FL@A^FETUOWK=IZU_V\ZEW4UX:>Q^C_ !F__!D'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g888198g56g02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g888198g56g02.jpg
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M P,# P,# P,# P,# P,# P,# P,#_\  $0@ )P C P$1  (1 0,1 ?_$ ',
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=W$X'6-;%2Q<%"2WVYO2B*Z'G8E!@>M$!#V@__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
